https://www.longshineboitech.com/ https://www.longshineboitech.com/og-image.jpg Longshine Boi-Tech pharmaceutical API manufacturing facility WHO-GMP & ISO 9001:2015 certified API manufacturer in Pune, Maharashtra, India — 560+ pharmaceutical APIs, intermediates, peptides, veterinary compounds for global procurement teams. https://www.longshineboitech.com/icon-512.png Longshine Boi-Tech logo https://www.longshineboitech.com/logo.svg Longshine Boi-Tech vector logo https://www.longshineboitech.com/about https://www.longshineboitech.com/og-image.jpg Longshine Boi-Tech corporate overview — Pune, India Founded 2009. 200+ employees across manufacturing, QC, regulatory affairs, and sales teams. https://www.longshineboitech.com/capabilities https://www.longshineboitech.com/og-image.jpg API manufacturing capabilities — Longshine Boi-Tech, Pune, India Kilo lab through 6,000L commercial reactors. Solid-phase peptide synthesis. ICH Q7 compliant. https://www.longshineboitech.com/quality https://www.longshineboitech.com/og-image.jpg WHO-GMP, ISO 9001:2015, FDA DMF, EDQM CEP — Longshine Boi-Tech regulatory portfolio Six independent quality frameworks underwrite every shipment. https://www.longshineboitech.com/certifications https://www.longshineboitech.com/og-image.jpg WHO-GMP, ISO 9001:2015, FDA DMF, EDQM CEP — Longshine Boi-Tech regulatory portfolio Six independent quality frameworks underwrite every shipment. https://www.longshineboitech.com/news https://www.longshineboitech.com/news-images/news-european-partnership.jpg Longshine Boi-Tech news — european partnership Pune, India pharmaceutical industry update — european partnership. https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Longshine Boi-Tech news — fda regulatory Pune, India pharmaceutical industry update — fda regulatory. https://www.longshineboitech.com/news-images/news-iso-certification.jpg Longshine Boi-Tech news — iso certification Pune, India pharmaceutical industry update — iso certification. https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Longshine Boi-Tech news — laboratory accreditation Pune, India pharmaceutical industry update — laboratory accreditation. https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Longshine Boi-Tech news — manufacturing expansion Pune, India pharmaceutical industry update — manufacturing expansion. https://www.longshineboitech.com/news-images/news-sustainability.jpg Longshine Boi-Tech news — sustainability Pune, India pharmaceutical industry update — sustainability. https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Longshine Boi-Tech news — veterinary apis Pune, India pharmaceutical industry update — veterinary apis. https://www.longshineboitech.com/products https://www.longshineboitech.com/product-images/excipient-powder.jpg Longshine Boi-Tech product imagery — excipient powder Pharmaceutical raw material reference image — excipient powder (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/product-images/human-api-powder.jpg Longshine Boi-Tech product imagery — human api powder Pharmaceutical raw material reference image — human api powder (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/product-images/injectable-vial.jpg Longshine Boi-Tech product imagery — injectable vial Pharmaceutical raw material reference image — injectable vial (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/product-images/intermediate-powder.jpg Longshine Boi-Tech product imagery — intermediate powder Pharmaceutical raw material reference image — intermediate powder (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/product-images/peptide-vial.jpg Longshine Boi-Tech product imagery — peptide vial Pharmaceutical raw material reference image — peptide vial (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/product-images/research-chemical.jpg Longshine Boi-Tech product imagery — research chemical Pharmaceutical raw material reference image — research chemical (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Longshine Boi-Tech product imagery — veterinary api powder Pharmaceutical raw material reference image — veterinary api powder (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Longshine Boi-Tech product imagery — yellow api powder Pharmaceutical raw material reference image — yellow api powder (manufactured under WHO-GMP at our Pune, India facility). https://www.longshineboitech.com/news/2026-06-30-cdk-inhibitors-in-oncology https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg CDK Inhibitors in Oncology CDK Inhibitors in Oncology — what Palbociclib is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-30-diabetes-api-market https://www.longshineboitech.com/news-images/news-iso-certification.jpg Diabetes API Market Diabetes API Market — market trends and supplier landscape for sitagliptin from Pune, India. https://www.longshineboitech.com/news/2027-01-27-antibiotics-api-sourcing-in-gcc-levant-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Antibiotics API Sourcing in GCC + Levant — Portfolio & Regulatory Map Antibiotics formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Antibiotics portfolio https://www.longshineboitech.com/news/2027-02-04-how-to-qualify-an-indian-api-supplier-in-90-days-a-buyer-s-checklist- https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Qualify an Indian API Supplier in 90 Days — A Buyer's Checklist — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2026-06-30-parp-inhibitors-market https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg PARP Inhibitors Market PARP Inhibitors Market — market trends and supplier landscape for olaparib from Pune, India. https://www.longshineboitech.com/news/2026-06-30-sglt2-inhibitors https://www.longshineboitech.com/news-images/news-iso-certification.jpg SGLT2 Inhibitors SGLT2 Inhibitors — what Empagliflozin is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-07-25-edqm-cep-application-timeline-cost-2026 https://www.longshineboitech.com/news-images/news-european-partnership.jpg EDQM CEP Application — Timeline, Cost, Common Pitfalls EDQM CEP application walkthrough — 12-18 month timeline, €26,000 application fee, monograph compliance requirements, and the six most common Deficiency Letter triggers. https://www.longshineboitech.com/news/2026-06-30-targeted-oncology-apis https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Targeted Oncology APIs Targeted Oncology APIs — what Abemaciclib is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-11-10-dea-schedule-ii-iii-controlled-intermediates-import-quotas-2026-usa-b https://www.longshineboitech.com/product-images/intermediate-powder.jpg DEA Schedule II/III Controlled Intermediates — Import Quotas 2026 — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of DEA Schedule II/III Controlled In https://www.longshineboitech.com/news/2027-02-09-ema-variation-classification-guideline-type-ia-ib-ii-for-apis-eu-uk-b https://www.longshineboitech.com/product-images/human-api-powder.jpg EMA Variation Classification Guideline — Type IA/IB/II for APIs — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of EMA Variation Classificati https://www.longshineboitech.com/news/2026-06-30-cosmetic-peptide-applications https://www.longshineboitech.com/news-images/news-sustainability.jpg Cosmetic Peptide Applications Cosmetic Peptide Applications — what Copper Tripeptide-1 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-01-16-capability-brief-genotoxic-impurity-control-strategy-from-route-desig https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Genotoxic Impurity Control Strategy — From Route Design to Release (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Genotoxic Impurity Control Strategy — From Route Desi https://www.longshineboitech.com/news/2026-06-30-modern-diabetes-apis https://www.longshineboitech.com/news-images/news-iso-certification.jpg Modern Diabetes APIs Modern Diabetes APIs — what Dapagliflozin is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-10-24-capability-brief-genotoxic-impurity-control-strategy-from-route-desig https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Genotoxic Impurity Control Strategy — From Route Design to Release (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Genotoxic Impurity Control Strategy — From Route Desi https://www.longshineboitech.com/news/2026-06-30-custom-peptide-manufacturing https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Custom Peptide Manufacturing Custom Peptide Manufacturing — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2027-03-19-market-note-ai-assisted-route-scouting-is-cutting-api-synthesis-steps https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — AI-assisted route scouting is cutting API synthesis steps by up to 40% (LATAM angle) AIassisted route scouting is cutting API synthesis steps by up to 40%. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with https://www.longshineboitech.com/news/2026-06-30-targeted-cancer-therapies https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Targeted Cancer Therapies Targeted Cancer Therapies — what Osimertinib is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-01-21-sourcing-sodium-starch-glycolate-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Sodium Starch Glycolate: Pharmaceutical Grade Specifications and Supply Terms Sodium Starch Glycolate (CAS 9063-38-1) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical MOQ, pack https://www.longshineboitech.com/news/2026-06-30-api-process-optimization https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg API Process Optimization API Process Optimization — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2027-01-18-croscarmellose-vs-sodium-starch-glycolate-disintegrant https://www.longshineboitech.com/product-images/excipient-powder.jpg Croscarmellose Sodium vs Sodium Starch Glycolate: Disintegrant Selection The two dominant super-disintegrants - croscarmellose sodium (CCS) and sodium starch glycolate (SSG) - both work by rapid water uptake and expansion inside the tablet matrix, but their swelling mechan https://www.longshineboitech.com/news/2026-12-31-coa-cos-cep-document-stack-every-buyer-should-demand-gcc-levant-procu https://www.longshineboitech.com/product-images/human-api-powder.jpg CoA + CoS + CEP — Document Stack Every Buyer Should Demand — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2027-03-09-edqm-cep-application-2026-format-content-refresh-eu-uk-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg EDQM CEP Application — 2026 Format & Content Refresh — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of EDQM CEP Application — 202 https://www.longshineboitech.com/news/2026-06-30-reference-standards-applications https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Reference Standards Applications Reference Standards Applications — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2026-06-30-benefits-of-custom-synthesis https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Benefits of Custom Synthesis Benefits of Custom Synthesis — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2027-03-14-faq-sourcing-levetiracetam-into-latam https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg FAQ — Sourcing Levetiracetam into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-06-30-analytical-services-in-pharma https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Analytical Services in Pharma Analytical Services in Pharma — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2026-12-20-faq-sourcing-calcium-disodium-edta-into-latam https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Calcium Disodium EDTA into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2027-01-14-spot-buy-vs-annual-tender-frame-pricing-risk-like-a-cfo-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Spot-Buy vs Annual Tender — Frame Pricing Risk Like a CFO — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2027-02-21-faq-sourcing-heparin-sodium-into-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Heparin Sodium into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2027-01-28-inbound-quality-sampling-plans-statistical-basis-for-reduced-testing- https://www.longshineboitech.com/product-images/human-api-powder.jpg Inbound Quality Sampling Plans — Statistical Basis for Reduced Testing — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-06-04-api-coa-review-what-sourcing-teams-should-catch-before-approving-lots https://www.longshineboitech.com/product-images/human-api-powder.jpg API CoA Review — What Sourcing Teams Should Catch Before Approving Lots — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-09-12-capability-brief-spray-drying-for-amorphous-solid-dispersions-capabil https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Spray-Drying for Amorphous Solid Dispersions — Capability Brief (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers SprayDrying for Amorphous Solid Dispersions — Capabil https://www.longshineboitech.com/news/2026-10-29-force-majeure-clauses-for-api-supply-contracts-2026-rewrite-latam-pro https://www.longshineboitech.com/product-images/human-api-powder.jpg Force Majeure Clauses for API Supply Contracts — 2026 Rewrite — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-09-15-usp-797-sterile-compounding-api-quality-requirements-for-503b-outsour https://www.longshineboitech.com/product-images/human-api-powder.jpg USP <797> Sterile Compounding — API Quality Requirements for 503B Outsourcers — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of USP <797 Sterile Compounding — AP https://www.longshineboitech.com/news/2026-07-12-faq-sourcing-l-methionine-into-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing L-Methionine into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing amino acids. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google A https://www.longshineboitech.com/news/2026-08-26-micronised-vs-standard-api-particle-size-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Micronised vs Standard API — Particle Size Distribution Particle size distribution matters — micronised API is essential for inhalation formulations and can improve dissolution. https://www.longshineboitech.com/news/2026-06-05-market-note-antibiotic-stewardship-is-reshaping-anti-infective-api-fo https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Market Note — Antibiotic stewardship is reshaping anti-infective API forecasts (EU + UK angle) Antibiotic stewardship is reshaping antiinfective API forecasts. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics aro https://www.longshineboitech.com/news/2026-11-11-cns-neurology-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg CNS & Neurology API Sourcing in USA — Portfolio & Regulatory Map CNS & Neurology formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech CNS & Neurology https://www.longshineboitech.com/news/2026-06-30-epitalon-research-applications https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Epitalon Research Applications Epitalon Research Applications — what Epitalon is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-03-16-anmat-disp-2819-argentina-api-importer-registration-latam-buyer-s-bri https://www.longshineboitech.com/product-images/human-api-powder.jpg ANMAT Disp. 2819 — Argentina API Importer Registration — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2027-01-18-sourcing-pregelatinized-starch-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Pregelatinized Starch: Pharmaceutical Grade Specifications and Supply Terms Pregelatinized Starch (CAS 9005-25-8) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical MOQ, packag https://www.longshineboitech.com/news/2026-06-29-nucleic-acid-raw-materials https://www.longshineboitech.com/news-images/news-european-partnership.jpg Nucleic Acid Raw Materials Nucleic Acid Raw Materials — what RNA Building Blocks is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-07-faq-sourcing-risperidone-into-latam https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Risperidone into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-07-31-ich-q7-api-auditor-checklist-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg ICH Q7 for API Manufacturing — Auditor Checklist ICH Q7 GMP for APIs — auditor checklist covering the 20 most-scrutinised sections, from personnel through validation, complaints, and product recall procedures. https://www.longshineboitech.com/news/2027-01-20-sourcing-sodium-lauryl-sulfate-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Sodium Lauryl Sulfate: Pharmaceutical Grade Specifications and Supply Terms Sodium Lauryl Sulfate (CAS 151-21-3) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical MOQ, packagi https://www.longshineboitech.com/news/2026-09-13-faq-sourcing-dalbavancin-hcl-into-usa https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Dalbavancin HCl into USA Longtail FAQs we get every week from United States procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-06-29-reference-standards-applications https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Reference Standards Applications Reference Standards Applications — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2027-02-24-cardiovascular-api-sourcing-in-gcc-levant-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in GCC + Levant — Portfolio & Regulatory Map Cardiovascular formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular port https://www.longshineboitech.com/news/2027-04-25-faq-sourcing-berberine-hcl-into-usa https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Berberine HCl into USA Longtail FAQs we get every week from United States procurement teams sourcing research chemicals. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, https://www.longshineboitech.com/news/2027-01-20-sourcing-lactose-monohydrate-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Lactose Monohydrate: Pharmaceutical Grade Specifications and Supply Terms Lactose Monohydrate (CAS 64044-51-5) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical MOQ, packagi https://www.longshineboitech.com/news/2026-05-30-capability-brief-solvent-recovery-loop-how-we-cut-process-solvent-pur https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Solvent Recovery Loop — How We Cut Process Solvent Purchasing 30% (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Solvent Recovery Loop — How We Cut Process Solvent Purchasin https://www.longshineboitech.com/news/2026-08-21-usp-monograph-modernization-2027 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg USP Monograph Modernization — API Impact USP is progressively modernizing legacy monographs. API manufacturers face transition timelines from wet chemistry to modern analytical methods. https://www.longshineboitech.com/news/2026-06-30-nucleic-acid-raw-materials https://www.longshineboitech.com/news-images/news-european-partnership.jpg Nucleic Acid Raw Materials Nucleic Acid Raw Materials — what RNA Building Blocks is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-03-18-lead-time-negotiation-levers-when-the-api-is-single-source-latam-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg Lead-Time Negotiation Levers When the API is Single-Source — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-09-21-glycine-pharma-grade-cas-56-40-6-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/intermediate-powder.jpg Glycine (Pharma Grade) (CAS 56-40-6) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Glycine (Pharma Grade) (CAS 56406) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers an https://www.longshineboitech.com/news/2026-06-29-cdk-inhibitors-in-oncology https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg CDK Inhibitors in Oncology CDK Inhibitors in Oncology — what Palbociclib is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-03-01-salmeterol-xinafoate-cas-94749-08-3-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Salmeterol Xinafoate (CAS 94749-08-3) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Salmeterol Xinafoate (CAS 94749083) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States b https://www.longshineboitech.com/news/2027-04-09-market-note-scope-3-emissions-reporting-is-changing-how-formulators-p https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Scope 3 emissions reporting is changing how formulators pick API suppliers (EU + UK angle) Scope 3 emissions reporting is changing how formulators pick API suppliers. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with sp https://www.longshineboitech.com/news/2027-01-30-capability-brief-continuous-flow-crystallization-reduces-polymorph-ri https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Continuous-Flow Crystallization Reduces Polymorph Risk on Critical APIs (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers ContinuousFlow Crystallization Reduces Polymorph Risk https://www.longshineboitech.com/news/2027-01-13-gastrointestinal-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Gastrointestinal API Sourcing in EU + UK — Portfolio & Regulatory Map Gastrointestinal formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Gastrointestinal portf https://www.longshineboitech.com/news/2026-07-14-jfda-jordan-active-substance-registration-format-gcc-levant-buyer-s-b https://www.longshineboitech.com/product-images/human-api-powder.jpg JFDA Jordan — Active Substance Registration Format — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of JFDA Jordan https://www.longshineboitech.com/news/2026-06-12-market-note-continuous-flow-manufacturing-is-moving-from-pilot-to-com https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Continuous-flow manufacturing is moving from pilot to commercial (LATAM angle) Continuousflow manufacturing is moving from pilot to commercial. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with specif https://www.longshineboitech.com/news/2026-06-29-emerging-glp-1-peptides https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Emerging GLP-1 Peptides Emerging GLP-1 Peptides — what Mazdutide is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-30-anti-aging-peptides https://www.longshineboitech.com/news-images/news-sustainability.jpg Anti-aging Peptides Anti-aging Peptides — what SNAP-8 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-01-22-sourcing-hydroxypropyl-cellulose-hpc-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Hydroxypropyl Cellulose (HPC): Pharmaceutical Grade Specifications and Supply Terms Hydroxypropyl Cellulose (HPC) (CAS 9004-64-2) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical MOQ https://www.longshineboitech.com/news/2027-01-22-best-supplier-atorvastatin-calcium-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Atorvastatin Calcium API in 2026: Buyer's Checklist Selecting a Atorvastatin Calcium manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2026-05-25-desloratadine-cas-100643-71-8-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Desloratadine (CAS 100643-71-8) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Desloratadine (CAS 100643718) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers https://www.longshineboitech.com/news/2026-12-29-gcc-centralized-drug-registration-common-technical-document-path-gcc- https://www.longshineboitech.com/product-images/human-api-powder.jpg GCC Centralized Drug Registration — Common Technical Document Path — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of GCC Central https://www.longshineboitech.com/news/2027-01-26-best-supplier-buprenorphine-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Buprenorphine API in 2026: Buyer's Checklist Selecting a Buprenorphine manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2027-03-17-veterinary-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Veterinary API Sourcing in LATAM — Portfolio & Regulatory Map Veterinary formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Veterinary portfolio https://www.longshineboitech.com/news/2026-06-29-epitalon-research-applications https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Epitalon Research Applications Epitalon Research Applications — what Epitalon is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-30-peptides-in-cosmetics https://www.longshineboitech.com/news-images/news-sustainability.jpg Peptides in Cosmetics Peptides in Cosmetics — what Matrixyl 3000 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-01-30-how-to-source-pediatric-liquid-apis https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Source APIs for Pediatric Liquid Formulations This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2026-12-06-faq-sourcing-hydrochlorothiazide-into-usa https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Hydrochlorothiazide into USA Longtail FAQs we get every week from United States procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2027-02-20-capability-brief-gmp-container-closure-qualification-for-light-sensit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — GMP Container Closure Qualification for Light-Sensitive APIs (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers GMP Container Closure Qualification for LightSensitive https://www.longshineboitech.com/news/2026-08-31-ambient-vs-refrigerated-api-storage-2027 https://www.longshineboitech.com/news-images/news-sustainability.jpg Ambient vs Refrigerated API Storage Ambient vs refrigerated API storage decisions drive both stability and total cost of ownership over the shelf-life period. https://www.longshineboitech.com/news/2027-02-25-api-bridging-studies-when-you-need-one-when-you-don-t-gcc-levant-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg API Bridging Studies — When You Need One, When You Don't — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-08-15-capability-brief-continuous-flow-crystallization-reduces-polymorph-ri https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Continuous-Flow Crystallization Reduces Polymorph Risk on Critical APIs (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers ContinuousFlow Crystallization Reduces Polymorph Risk https://www.longshineboitech.com/news/2027-01-31-how-to-source-glp1-obesity-supply https://www.longshineboitech.com/product-images/peptide-vial.jpg How to Source GLP-1 APIs for Compounding Pharmacies (2026) This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2026-08-18-gdufa-iii-performance-goals-what-generic-api-suppliers-should-track-u https://www.longshineboitech.com/product-images/human-api-powder.jpg GDUFA III Performance Goals — What Generic API Suppliers Should Track — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of GDUFA III Performance Goals — Wha https://www.longshineboitech.com/news/2026-08-08-capability-brief-ich-q11-starting-material-justification-how-we-docum https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — ICH Q11 Starting Material Justification — How We Document It (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers ICH Q11 Starting Material Justification — How We Docume https://www.longshineboitech.com/news/2026-06-08-tamsulosin-hcl-cas-106463-17-6-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Tamsulosin HCl (CAS 106463-17-6) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Tamsulosin HCl (CAS 106463176) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers https://www.longshineboitech.com/news/2026-08-19-oncology-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Oncology API Sourcing in USA — Portfolio & Regulatory Map Oncology formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Oncology portfolio agai https://www.longshineboitech.com/news/2026-06-30-future-of-rna-materials https://www.longshineboitech.com/news-images/news-european-partnership.jpg Future of RNA Materials Future of RNA Materials — market trends and supplier landscape for modified nucleosides from Pune, India. https://www.longshineboitech.com/news/2027-05-09-faq-sourcing-duloxetine-hcl-into-latam https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Duloxetine HCl into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2027-02-06-capability-brief-solvent-recovery-loop-how-we-cut-process-solvent-pur https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Solvent Recovery Loop — How We Cut Process Solvent Purchasing 30% (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Solvent Recovery Loop — How We Cut Process Solvent Purchasin https://www.longshineboitech.com/news/2026-08-30-faq-sourcing-capecitabine-into-latam https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Capecitabine into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-10-02-market-note-excipient-supply-tightness-is-the-under-covered-story-of- https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Excipient supply tightness is the under-covered story of the year (LATAM angle) Excipient supply tightness is the undercovered story of the year. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with speci https://www.longshineboitech.com/news/2026-10-07-antibiotics-api-sourcing-in-gcc-levant-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Antibiotics API Sourcing in GCC + Levant — Portfolio & Regulatory Map Antibiotics formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Antibiotics portfolio https://www.longshineboitech.com/news/2026-06-30-rna-therapeutics-materials https://www.longshineboitech.com/news-images/news-european-partnership.jpg RNA Therapeutics Materials RNA Therapeutics Materials — what GalNAc Derivatives is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-08-03-ethylcellulose-cas-9004-57-3-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/excipient-powder.jpg Ethylcellulose (CAS 9004-57-3) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Ethylcellulose (CAS 9004573) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers a https://www.longshineboitech.com/news/2026-08-05-veterinary-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Veterinary API Sourcing in LATAM — Portfolio & Regulatory Map Veterinary formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Veterinary portfolio https://www.longshineboitech.com/news/2026-06-15-noopept-cas-157115-85-0-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/research-chemical.jpg Noopept (CAS 157115-85-0) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Noopept (CAS 157115850) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers and a cu https://www.longshineboitech.com/news/2026-09-10-api-bridging-studies-when-you-need-one-when-you-don-t-gcc-levant-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg API Bridging Studies — When You Need One, When You Don't — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-06-23-otc-monograph-reform-api-implications-for-foreign-manufacturers-usa-b https://www.longshineboitech.com/product-images/human-api-powder.jpg OTC Monograph Reform — API Implications for Foreign Manufacturers — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of OTC Monograph Reform — API Implic https://www.longshineboitech.com/news/2026-08-09-fda-oai-warning-letter-response-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg FDA OAI + Warning Letter Response — API Site Perspective When FDA issues OAI status or a Warning Letter to an API site, remediation follows a specific timeline. Understanding the process. https://www.longshineboitech.com/news/2026-09-19-capability-brief-hot-melt-extrusion-bridging-api-and-excipient-capabi https://www.longshineboitech.com/product-images/excipient-powder.jpg Capability Brief — Hot-Melt Extrusion — Bridging API and Excipient Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers HotMelt Extrusion — Bridging API and Excipient Capability — https://www.longshineboitech.com/news/2026-07-06-hexarelin-cas-140703-51-1-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/peptide-vial.jpg Hexarelin (CAS 140703-51-1) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Hexarelin (CAS 140703511) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers and https://www.longshineboitech.com/news/2026-06-26-market-note-companion-animal-pharma-is-outpacing-human-generics-growt https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Companion-animal pharma is outpacing human generics growth (USA angle) Companionanimal pharma is outpacing human generics growth. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with specifics ar https://www.longshineboitech.com/news/2027-03-02-otc-monograph-reform-api-implications-for-foreign-manufacturers-usa-b https://www.longshineboitech.com/product-images/human-api-powder.jpg OTC Monograph Reform — API Implications for Foreign Manufacturers — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of OTC Monograph Reform — API Implic https://www.longshineboitech.com/news/2026-09-06-faq-sourcing-dutasteride-into-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Dutasteride into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-06-13-capability-brief-gmp-container-closure-qualification-for-light-sensit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — GMP Container Closure Qualification for Light-Sensitive APIs (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers GMP Container Closure Qualification for LightSensitive https://www.longshineboitech.com/news/2026-08-04-tirzepatide-api-manufacturing-dual-agonist-2026 https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Tirzepatide API Manufacturing — Dual GIP/GLP-1 Agonist Tirzepatide API — dual GIP/GLP-1 agonist manufacturing, WHO-GMP SPPS peptide production, and pipeline for the emerging obesity therapeutic market. https://www.longshineboitech.com/news/2026-07-29-antibiotics-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Antibiotics API Sourcing in EU + UK — Portfolio & Regulatory Map Antibiotics formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Antibiotics portfolio again https://www.longshineboitech.com/news/2026-06-27-capability-brief-hot-melt-extrusion-bridging-api-and-excipient-capabi https://www.longshineboitech.com/product-images/excipient-powder.jpg Capability Brief — Hot-Melt Extrusion — Bridging API and Excipient Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers HotMelt Extrusion — Bridging API and Excipient Capability — https://www.longshineboitech.com/news/2026-06-30-copper-peptides-in-research https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Copper Peptides in Research Copper Peptides in Research — what GHK-Cu is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-04-27-gdufa-iii-performance-goals-what-generic-api-suppliers-should-track-u https://www.longshineboitech.com/product-images/human-api-powder.jpg GDUFA III Performance Goals — What Generic API Suppliers Should Track — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of GDUFA III Performance Goals — Wha https://www.longshineboitech.com/news/2027-01-19-sourcing-polyethylene-glycol-6000-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Polyethylene Glycol 6000: Pharmaceutical Grade Specifications and Supply Terms Polyethylene Glycol 6000 (CAS 25322-68-3) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical MOQ, pa https://www.longshineboitech.com/news/2026-10-15-api-stability-data-packages-what-24-month-accelerated-should-actually https://www.longshineboitech.com/product-images/human-api-powder.jpg API Stability Data Packages — What "24-Month Accelerated" Should Actually Include — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2026-09-27-faq-sourcing-aniracetam-into-latam https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Aniracetam into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing nootropics. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-11-04-cardiovascular-api-sourcing-in-gcc-levant-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in GCC + Levant — Portfolio & Regulatory Map Cardiovascular formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular port https://www.longshineboitech.com/news/2026-06-28-faq-sourcing-pramiracetam-into-eu-uk https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Pramiracetam into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing nootropics. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2026-12-16-respiratory-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Respiratory API Sourcing in EU + UK — Portfolio & Regulatory Map Respiratory formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Respiratory portfolio again https://www.longshineboitech.com/news/2026-06-25-supplier-audit-travel-free-how-remote-gmp-audits-actually-work-usa-pr https://www.longshineboitech.com/product-images/human-api-powder.jpg Supplier Audit Travel-Free — How Remote GMP Audits Actually Work — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2026-08-12-ich-q1a-q1b-stability-testing-2027 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg ICH Q1A + Q1B Stability Testing — API Perspective ICH Q1A stability + Q1B photostability testing establishes API shelf life. Climate zones I-IVb dictate storage conditions and testing. https://www.longshineboitech.com/news/2026-07-03-market-note-excipient-supply-tightness-is-the-under-covered-story-of- https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Excipient supply tightness is the under-covered story of the year (EU + UK angle) Excipient supply tightness is the undercovered story of the year. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics ar https://www.longshineboitech.com/news/2027-04-30-market-note-pepfar-and-global-fund-tenders-are-driving-anti-retrovira https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — PEPFAR and Global Fund tenders are driving anti-retroviral API consolidation (USA angle) PEPFAR and Global Fund tenders are driving antiretroviral API consolidation. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, https://www.longshineboitech.com/news/2027-04-08-spot-buy-vs-annual-tender-frame-pricing-risk-like-a-cfo-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Spot-Buy vs Annual Tender — Frame Pricing Risk Like a CFO — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-06-09-isp-chile-pharmaceutical-api-registry-2026-latam-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg ISP Chile — Pharmaceutical API Registry 2026 — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-07-02-two-source-strategy-for-critical-apis-cost-vs-risk-math-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Two-Source Strategy for Critical APIs — Cost vs Risk Math — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-05-24-faq-sourcing-magnesium-sulfate-heptahydrate-into-usa https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Magnesium Sulfate Heptahydrate into USA Longtail FAQs we get every week from United States procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2027-03-20-capability-brief-nitrosamine-mitigation-process-re-design-case-study- https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Nitrosamine Mitigation — Process Re-Design Case Study (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers Nitrosamine Mitigation — Process ReDesign Case Study — https://www.longshineboitech.com/news/2026-08-23-faq-sourcing-vorinostat-into-eu-uk https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Vorinostat into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2026-11-20-market-note-cdmo-consolidation-is-changing-the-make-vs-buy-calculus-f https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — CDMO consolidation is changing the make-vs-buy calculus for mid-cap pharma (EU + UK angle) CDMO consolidation is changing the makevsbuy calculus for midcap pharma. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with speci https://www.longshineboitech.com/news/2026-10-30-market-note-pepfar-and-global-fund-tenders-are-driving-anti-retrovira https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — PEPFAR and Global Fund tenders are driving anti-retroviral API consolidation (LATAM angle) PEPFAR and Global Fund tenders are driving antiretroviral API consolidation. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, https://www.longshineboitech.com/news/2027-01-29-how-to-source-sterile-injectable-apis https://www.longshineboitech.com/product-images/injectable-vial.jpg How to Source Sterile Injectable APIs - QC, Filling, Endotoxin Testing This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2027-01-19-sourcing-microcrystalline-cellulose-mcc-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Microcrystalline Cellulose (MCC): Pharmaceutical Grade Specifications and Supply Terms Microcrystalline Cellulose (MCC) (CAS 9004-34-6) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical https://www.longshineboitech.com/news/2026-06-01-ceritinib-cas-1032900-25-6-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Ceritinib (CAS 1032900-25-6) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Ceritinib (CAS 1032900256) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a curr https://www.longshineboitech.com/news/2027-02-17-gastrointestinal-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Gastrointestinal API Sourcing in LATAM — Portfolio & Regulatory Map Gastrointestinal formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Gastrointestina https://www.longshineboitech.com/news/2026-06-30-research-peptides-market https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Research Peptides Market Research Peptides Market — market trends and supplier landscape for bpc-157 from Pune, India. https://www.longshineboitech.com/news/2026-07-04-capability-brief-cold-chain-peptide-packaging-validated-shippers-for- https://www.longshineboitech.com/product-images/peptide-vial.jpg Capability Brief — Cold-Chain Peptide Packaging — Validated Shippers for Trans-Atlantic Lanes (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers ColdChain Peptide Packaging — Validated Shippers for https://www.longshineboitech.com/news/2026-07-10-market-note-scope-3-emissions-reporting-is-changing-how-formulators-p https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Scope 3 emissions reporting is changing how formulators pick API suppliers (LATAM angle) Scope 3 emissions reporting is changing how formulators pick API suppliers. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, https://www.longshineboitech.com/news/2026-06-29-sglt2-inhibitors https://www.longshineboitech.com/news-images/news-iso-certification.jpg SGLT2 Inhibitors SGLT2 Inhibitors — what Empagliflozin is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-07-19-faq-sourcing-epitalon-into-usa https://www.longshineboitech.com/product-images/peptide-vial.jpg FAQ — Sourcing Epitalon into USA Longtail FAQs we get every week from United States procurement teams sourcing peptides. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-12-23-cardiovascular-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in LATAM — Portfolio & Regulatory Map Cardiovascular formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular po https://www.longshineboitech.com/news/2026-07-25-capability-brief-microbial-limit-testing-in-house-usp-61-62-capabilit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Microbial Limit Testing — In-House USP <61>/<62> Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Microbial Limit Testing — InHouse USP <61/<62 Capability — w https://www.longshineboitech.com/news/2026-06-20-capability-brief-spray-drying-for-amorphous-solid-dispersions-capabil https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Spray-Drying for Amorphous Solid Dispersions — Capability Brief (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers SprayDrying for Amorphous Solid Dispersions — Capabil https://www.longshineboitech.com/news/2027-02-05-market-note-eudragit-and-hpmc-supply-realignment-is-forcing-reformula https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Eudragit and HPMC supply realignment is forcing reformulation decisions (USA angle) Eudragit and HPMC supply realignment is forcing reformulation decisions. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, wit https://www.longshineboitech.com/news/2026-06-29-rna-therapeutics-materials https://www.longshineboitech.com/news-images/news-european-partnership.jpg RNA Therapeutics Materials RNA Therapeutics Materials — what GalNAc Derivatives is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-08-02-faq-sourcing-eprinomectin-into-latam https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg FAQ — Sourcing Eprinomectin into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing veterinary apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Go https://www.longshineboitech.com/news/2026-11-03-halal-pharmaceutical-certification-implementation-for-api-manufacture https://www.longshineboitech.com/product-images/human-api-powder.jpg Halal Pharmaceutical Certification — Implementation for API Manufacturers — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of Halal Pharm https://www.longshineboitech.com/news/2026-06-14-faq-sourcing-pentamidine-isethionate-into-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Pentamidine Isethionate into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-12-18-market-note-ai-assisted-route-scouting-is-cutting-api-synthesis-steps https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — AI-assisted route scouting is cutting API synthesis steps by up to 40% (EU + UK angle) AIassisted route scouting is cutting API synthesis steps by up to 40%. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifi https://www.longshineboitech.com/news/2027-03-31-oncology-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Oncology API Sourcing in USA — Portfolio & Regulatory Map Oncology formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Oncology portfolio agai https://www.longshineboitech.com/news/2026-06-29-benefits-of-custom-synthesis https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Benefits of Custom Synthesis Benefits of Custom Synthesis — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2027-01-01-market-note-excipient-supply-tightness-is-the-under-covered-story-of- https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Excipient supply tightness is the under-covered story of the year (GCC + Levant angle) Excipient supply tightness is the undercovered story of the year. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specifi https://www.longshineboitech.com/news/2026-05-29-market-note-glp-1-receptor-agonists-are-now-the-1-driver-of-peptide-a https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — GLP-1 receptor agonists are now the #1 driver of peptide API demand (USA angle) GLP1 receptor agonists are now the 1 driver of peptide API demand. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with spec https://www.longshineboitech.com/news/2027-04-17-capability-brief-ich-q11-starting-material-justification-how-we-docum https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — ICH Q11 Starting Material Justification — How We Document It (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers ICH Q11 Starting Material Justification — How We Docume https://www.longshineboitech.com/news/2026-12-28-l-glutamine-cas-56-85-9-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg L-Glutamine (CAS 56-85-9) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade LGlutamine (CAS 56859) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers and a cur https://www.longshineboitech.com/news/2027-01-23-best-supplier-semaglutide-2026 https://www.longshineboitech.com/product-images/peptide-vial.jpg Best Supplier for Semaglutide API in 2026: Buyer's Checklist Selecting a Semaglutide manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2026-06-29-analytical-services-in-pharma https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Analytical Services in Pharma Analytical Services in Pharma — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2026-12-11-market-note-continuous-flow-manufacturing-is-moving-from-pilot-to-com https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Continuous-flow manufacturing is moving from pilot to commercial (USA angle) Continuousflow manufacturing is moving from pilot to commercial. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with specif https://www.longshineboitech.com/news/2026-08-14-market-note-nootropic-api-regulation-is-splitting-into-us-eu-apac-tra https://www.longshineboitech.com/product-images/research-chemical.jpg Market Note — Nootropic API regulation is splitting into US / EU / APAC tracks (GCC + Levant angle) Nootropic API regulation is splitting into US / EU / APAC tracks. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specifi https://www.longshineboitech.com/news/2027-03-24-diabetes-metabolic-api-sourcing-in-gcc-levant-portfolio-regulatory-ma https://www.longshineboitech.com/product-images/human-api-powder.jpg Diabetes & Metabolic API Sourcing in GCC + Levant — Portfolio & Regulatory Map Diabetes & Metabolic formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Diabetes & Me https://www.longshineboitech.com/news/2027-02-22-bleomycin-sulfate-cas-9041-93-4-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Bleomycin Sulfate (CAS 9041-93-4) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Bleomycin Sulfate (CAS 9041934) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers https://www.longshineboitech.com/news/2026-10-16-market-note-biosimilar-api-spend-is-set-to-overtake-small-molecule-by https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Biosimilar API spend is set to overtake small-molecule by 2028 (USA angle) Biosimilar API spend is set to overtake smallmolecule by 2028. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with specific https://www.longshineboitech.com/news/2026-08-25-annex-1-sterile-manufacturing-api-implications-eu-uk-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg Annex 1 Sterile Manufacturing — API Implications — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of Annex 1 Sterile Manufactur https://www.longshineboitech.com/news/2027-03-08-irinotecan-hcl-cas-100286-90-6-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Irinotecan HCl (CAS 100286-90-6) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Irinotecan HCl (CAS 100286906) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a https://www.longshineboitech.com/news/2027-02-02-api-vs-intermediate-sourcing https://www.longshineboitech.com/product-images/intermediate-powder.jpg API vs Intermediate Sourcing - When to Buy Finished vs Late-Stage Intermediate This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2026-11-21-capability-brief-particle-engineering-for-inhalation-grade-api-manufa https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Particle Engineering for Inhalation-Grade API Manufacturing (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Particle Engineering for InhalationGrade API Manufact https://www.longshineboitech.com/news/2026-08-16-ich-q12-lifecycle-management-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg ICH Q12 Lifecycle Management — Post-Approval Changes ICH Q12 provides established conditions + post-approval change categorization framework. API suppliers navigate different regional adoption. https://www.longshineboitech.com/news/2027-04-10-capability-brief-genotoxic-impurity-control-strategy-from-route-desig https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Genotoxic Impurity Control Strategy — From Route Design to Release (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Genotoxic Impurity Control Strategy — From Route Desi https://www.longshineboitech.com/news/2026-08-28-market-note-glp-1-receptor-agonists-are-now-the-1-driver-of-peptide-a https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — GLP-1 receptor agonists are now the #1 driver of peptide API demand (EU + UK angle) GLP1 receptor agonists are now the 1 driver of peptide API demand. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics a https://www.longshineboitech.com/news/2026-08-27-api-coa-review-what-sourcing-teams-should-catch-before-approving-lots https://www.longshineboitech.com/product-images/human-api-powder.jpg API CoA Review — What Sourcing Teams Should Catch Before Approving Lots — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-08-01-capability-brief-genotoxic-impurity-control-strategy-from-route-desig https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Genotoxic Impurity Control Strategy — From Route Design to Release (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Genotoxic Impurity Control Strategy — From Route Desi https://www.longshineboitech.com/news/2027-02-03-crystalline-vs-amorphous-api https://www.longshineboitech.com/product-images/human-api-powder.jpg Crystalline vs Amorphous API Forms - Solubility, Stability, and BE Impact This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2026-05-27-diabetes-metabolic-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Diabetes & Metabolic API Sourcing in USA — Portfolio & Regulatory Map Diabetes & Metabolic formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Diabetes & https://www.longshineboitech.com/news/2026-07-09-lead-time-negotiation-levers-when-the-api-is-single-source-latam-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg Lead-Time Negotiation Levers When the API is Single-Source — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-09-11-market-note-continuous-flow-manufacturing-is-moving-from-pilot-to-com https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Continuous-flow manufacturing is moving from pilot to commercial (GCC + Levant angle) Continuousflow manufacturing is moving from pilot to commercial. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specific https://www.longshineboitech.com/news/2026-12-26-capability-brief-nitrosamine-mitigation-process-re-design-case-study- https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Nitrosamine Mitigation — Process Re-Design Case Study (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers Nitrosamine Mitigation — Process ReDesign Case Study — https://www.longshineboitech.com/news/2027-04-24-capability-brief-continuous-flow-crystallization-reduces-polymorph-ri https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Continuous-Flow Crystallization Reduces Polymorph Risk on Critical APIs (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers ContinuousFlow Crystallization Reduces Polymorph Risk https://www.longshineboitech.com/news/2026-09-03-dmf-letter-of-authorization-when-to-ask-how-to-use-latam-procurement- https://www.longshineboitech.com/product-images/human-api-powder.jpg DMF Letter of Authorization — When to Ask, How to Use — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-08-21-market-note-cdmo-consolidation-is-changing-the-make-vs-buy-calculus-f https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — CDMO consolidation is changing the make-vs-buy calculus for mid-cap pharma (USA angle) CDMO consolidation is changing the makevsbuy calculus for midcap pharma. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, wit https://www.longshineboitech.com/news/2027-05-16-faq-sourcing-ethylcellulose-into-gcc-levant https://www.longshineboitech.com/product-images/excipient-powder.jpg FAQ — Sourcing Ethylcellulose into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing excipients. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2027-03-10-antibiotics-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Antibiotics API Sourcing in EU + UK — Portfolio & Regulatory Map Antibiotics formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Antibiotics portfolio again https://www.longshineboitech.com/news/2026-06-18-api-bridging-studies-when-you-need-one-when-you-don-t-gcc-levant-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg API Bridging Studies — When You Need One, When You Don't — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-11-15-faq-sourcing-ethylcellulose-into-eu-uk https://www.longshineboitech.com/product-images/excipient-powder.jpg FAQ — Sourcing Ethylcellulose into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing excipients. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2026-07-31-market-note-pepfar-and-global-fund-tenders-are-driving-anti-retrovira https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — PEPFAR and Global Fund tenders are driving anti-retroviral API consolidation (EU + UK angle) PEPFAR and Global Fund tenders are driving antiretroviral API consolidation. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with s https://www.longshineboitech.com/news/2026-06-30-peptide-research-applications https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Peptide Research Applications Peptide Research Applications — what TB-500 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-08-05-metformin-bulk-api-ndma-control-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Metformin Bulk API — NDMA Control and Multi-Ton Capacity Metformin bulk API 2026 — WHO-PQ prequalification, dedicated NDMA-free manufacturing per FDA nitrosamine guidance, and multi-ton capacity for tender-driven procurement. https://www.longshineboitech.com/news/2027-01-21-force-majeure-clauses-for-api-supply-contracts-2026-rewrite-latam-pro https://www.longshineboitech.com/product-images/human-api-powder.jpg Force Majeure Clauses for API Supply Contracts — 2026 Rewrite — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-06-30-next-generation-glp-1-products https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Next Generation GLP-1 Products Next Generation GLP-1 Products — what Survodutide is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-05-10-glecaprevir-cas-1365970-03-1-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Glecaprevir (CAS 1365970-03-1) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Glecaprevir (CAS 1365970031) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers a https://www.longshineboitech.com/news/2026-06-30-mots-c-research-trends https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg MOTS-c Research Trends MOTS-c Research Trends — market trends and supplier landscape for mots-c from Pune, India. https://www.longshineboitech.com/news/2026-07-08-peptide-synthesis-scale-manufacturing-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Peptide Synthesis at Scale — SPPS to Kilogram Manufacturing Solid-phase peptide synthesis (SPPS) from research-scale to commercial kilogram batches — GLP-1 analogues, cosmetic peptides, and custom sequences under WHO-GMP. https://www.longshineboitech.com/news/2026-07-07-veterinary-api-sourcing-india-tga-cdsco-2026 https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Veterinary API Sourcing from India — TGA, CDSCO, and Global Markets How Indian WHO-GMP veterinary API manufacturers meet TGA, Health Canada, and FAO/WHO MRL requirements across companion-animal and food-producing species applications. https://www.longshineboitech.com/news/2027-02-05-single-source-vs-dual-source-api https://www.longshineboitech.com/product-images/human-api-powder.jpg Single-Source vs Dual-Source API Strategy - Risk Management for Regulated Buyers This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2026-12-02-diabetes-metabolic-api-sourcing-in-gcc-levant-portfolio-regulatory-ma https://www.longshineboitech.com/product-images/human-api-powder.jpg Diabetes & Metabolic API Sourcing in GCC + Levant — Portfolio & Regulatory Map Diabetes & Metabolic formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Diabetes & Me https://www.longshineboitech.com/news/2026-12-14-adrafinil-cas-63547-13-7-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/research-chemical.jpg Adrafinil (CAS 63547-13-7) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Adrafinil (CAS 63547137) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a curren https://www.longshineboitech.com/news/2027-01-23-best-supplier-amoxicillin-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Amoxicillin API in 2026: Buyer's Checklist Selecting a Amoxicillin manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2027-04-23-market-note-cold-chain-peptide-logistics-is-the-new-procurement-bottl https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — Cold-chain peptide logistics is the new procurement bottleneck (GCC + Levant angle) Coldchain peptide logistics is the new procurement bottleneck. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specifics https://www.longshineboitech.com/news/2027-04-04-faq-sourcing-2-chloropyridine-into-eu-uk https://www.longshineboitech.com/product-images/intermediate-powder.jpg FAQ — Sourcing 2-Chloropyridine into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing intermediates. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI O https://www.longshineboitech.com/news/2026-07-09-pharmaceutical-intermediates-ksm-selection-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Pharmaceutical Intermediates — KSM Selection and Sourcing How to qualify Key Starting Materials (KSM) and Regulatory Starting Materials (RSM) under ICH Q11 — sourcing pharmaceutical intermediates from Indian manufacturers. https://www.longshineboitech.com/news/2027-04-01-api-stability-data-packages-what-24-month-accelerated-should-actually https://www.longshineboitech.com/product-images/human-api-powder.jpg API Stability Data Packages — What "24-Month Accelerated" Should Actually Include — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2026-07-15-diabetes-api-sourcing-metformin-semaglutide-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Diabetes API Sourcing — Metformin to Semaglutide Diabetes API landscape 2026 — GLP-1 supply pressure, DPP-4 and SGLT-2 inhibitor sourcing, metformin NDMA control, and multi-ton commercial capacity. https://www.longshineboitech.com/news/2026-06-10-anti-infective-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Anti-Infective API Sourcing in LATAM — Portfolio & Regulatory Map AntiInfective formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech AntiInfective port https://www.longshineboitech.com/news/2026-07-13-cannabidiol-cbd-research-grade-cas-13956-29-1-gcc-levant-supplier-gui https://www.longshineboitech.com/product-images/research-chemical.jpg Cannabidiol (CBD) — Research Grade (CAS 13956-29-1) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Cannabidiol (CBD) — Research Grade (CAS 13956291) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to M https://www.longshineboitech.com/news/2026-10-01-lead-time-negotiation-levers-when-the-api-is-single-source-latam-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg Lead-Time Negotiation Levers When the API is Single-Source — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-12-12-capability-brief-hot-melt-extrusion-bridging-api-and-excipient-capabi https://www.longshineboitech.com/product-images/excipient-powder.jpg Capability Brief — Hot-Melt Extrusion — Bridging API and Excipient Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers HotMelt Extrusion — Bridging API and Excipient Capability — https://www.longshineboitech.com/news/2027-02-06-direct-vs-through-distributor-sourcing https://www.longshineboitech.com/product-images/human-api-powder.jpg Direct-From-Manufacturer vs Distributor Sourcing - API Buyer Trade-offs This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2027-01-27-best-supplier-tramadol-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Tramadol API in 2026: Buyer's Checklist Selecting a Tramadol manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2026-12-08-fda-cvm-veterinary-api-registration-anada-vmf-pathways-usa-buyer-s-br https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg FDA-CVM Veterinary API Registration: ANADA & VMF Pathways — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of FDACVM Veterinary API Registratio https://www.longshineboitech.com/news/2026-07-18-antibiotic-api-manufacturing-cephalosporin-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Antibiotic API Manufacturing — Cephalosporins, Fluoroquinolones, Beta-Lactams Antibiotic API sourcing — dedicated β-lactam manufacturing per FDA cross-contamination prevention, cephalosporin generation coverage, and stewardship-conscious portfolio. https://www.longshineboitech.com/news/2027-01-17-faq-sourcing-survodutide-into-latam https://www.longshineboitech.com/product-images/peptide-vial.jpg FAQ — Sourcing Survodutide into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing peptides. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-09-22-uk-mhra-divergence-post-brexit-active-substance-master-file-path-eu-u https://www.longshineboitech.com/product-images/human-api-powder.jpg UK MHRA Divergence Post-Brexit — Active Substance Master File Path — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of UK MHRA Divergence PostBre https://www.longshineboitech.com/news/2026-08-20-how-to-qualify-an-indian-api-supplier-in-90-days-a-buyer-s-checklist- https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Qualify an Indian API Supplier in 90 Days — A Buyer's Checklist — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2027-01-24-best-supplier-metformin-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Metformin API in 2026: Buyer's Checklist Selecting a Metformin manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2026-09-29-andean-community-pharmaceutical-harmonization-status-latam-buyer-s-br https://www.longshineboitech.com/product-images/human-api-powder.jpg Andean Community Pharmaceutical Harmonization — Status — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-06-29-peptide-research-applications https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Peptide Research Applications Peptide Research Applications — what TB-500 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-29-future-of-retatrutide-development https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Future of Retatrutide Development Future of Retatrutide Development — market trends and supplier landscape for retatrutide from Pune, India. https://www.longshineboitech.com/news/2027-01-17-polyethylene-glycol-molecular-weight-selection https://www.longshineboitech.com/product-images/excipient-powder.jpg Polyethylene Glycol Molecular Weight Selection for Formulation Polyethylene glycol (PEG) grades run from PEG-200 (liquid, MW ~200) to PEG-8000 (waxy solid, MW ~8000). Each MW targets different functionality: solvent, plasticiser, matrix former, or lubricant. Pick https://www.longshineboitech.com/news/2026-06-17-antibiotics-api-sourcing-in-gcc-levant-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Antibiotics API Sourcing in GCC + Levant — Portfolio & Regulatory Map Antibiotics formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Antibiotics portfolio https://www.longshineboitech.com/news/2027-01-24-faq-sourcing-resveratrol-99-into-gcc-levant https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Resveratrol (99%) into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing research chemicals. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, G https://www.longshineboitech.com/news/2026-06-21-faq-sourcing-azithromycin-dihydrate-into-usa https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Azithromycin Dihydrate into USA Longtail FAQs we get every week from United States procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-10-27-invima-colombia-api-ctd-module-3-requirements-latam-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg INVIMA Colombia — API CTD Module 3 Requirements — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-07-12-nootropics-api-regulatory-landscape-2026 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Nootropics API Manufacturing — Regulatory Landscape 2026 Nootropics API landscape 2026 — regulatory classification varies across US (RUO), EU (unregulated in cosmetics), and Russia/Eastern Europe (approved therapeutic). https://www.longshineboitech.com/news/2027-01-24-best-supplier-rosuvastatin-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Rosuvastatin API in 2026: Buyer's Checklist Selecting a Rosuvastatin manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2027-01-21-sourcing-talc-pharmaceutical-grade-pharmaceutical-grade https://www.longshineboitech.com/product-images/excipient-powder.jpg Sourcing Talc Pharmaceutical Grade: Pharmaceutical Grade Specifications and Supply Terms Talc Pharmaceutical Grade (CAS 14807-96-6) is a pharmaceutical excipient with specific compendial requirements depending on your destination market. This article covers grade selection, typical MOQ, p https://www.longshineboitech.com/news/2027-01-27-how-to-source-metformin-hcl-api-india https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Source Metformin HCl API from India in 2026 This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2026-12-22-brazil-veterinary-api-mapa-registration-path-latam-buyer-s-brief https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Brazil Veterinary API — MAPA Registration Path — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-08-11-vitamin-b12-cyanocobalamin-fermentation-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Vitamin B12 Cyanocobalamin — Fermentation and Purification Cyanocobalamin (Vitamin B12) API — microbial fermentation with Propionibacterium or Pseudomonas, downstream purification to Ph. Eur./USP grade. https://www.longshineboitech.com/news/2026-06-29-targeted-cancer-therapies https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Targeted Cancer Therapies Targeted Cancer Therapies — what Osimertinib is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-08-17-pitavastatin-calcium-cas-147526-32-7-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Pitavastatin Calcium (CAS 147526-32-7) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Pitavastatin Calcium (CAS 147526327) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States https://www.longshineboitech.com/news/2026-06-24-cardiovascular-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in USA — Portfolio & Regulatory Map Cardiovascular formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular po https://www.longshineboitech.com/news/2026-11-18-antibiotics-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Antibiotics API Sourcing in EU + UK — Portfolio & Regulatory Map Antibiotics formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Antibiotics portfolio again https://www.longshineboitech.com/news/2026-11-07-capability-brief-continuous-flow-crystallization-reduces-polymorph-ri https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Continuous-Flow Crystallization Reduces Polymorph Risk on Critical APIs (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers ContinuousFlow Crystallization Reduces Polymorph Risk https://www.longshineboitech.com/news/2026-06-19-market-note-ai-assisted-route-scouting-is-cutting-api-synthesis-steps https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — AI-assisted route scouting is cutting API synthesis steps by up to 40% (GCC + Levant angle) AIassisted route scouting is cutting API synthesis steps by up to 40%. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with sp https://www.longshineboitech.com/news/2027-01-31-how-to-source-controlled-substance-import https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Source Controlled-Substance APIs - Import Permits, DEA Registration This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2026-07-16-coa-cos-cep-document-stack-every-buyer-should-demand-gcc-levant-procu https://www.longshineboitech.com/product-images/human-api-powder.jpg CoA + CoS + CEP — Document Stack Every Buyer Should Demand — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-11-05-inbound-quality-sampling-plans-statistical-basis-for-reduced-testing- https://www.longshineboitech.com/product-images/human-api-powder.jpg Inbound Quality Sampling Plans — Statistical Basis for Reduced Testing — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2027-05-08-capability-brief-particle-engineering-for-inhalation-grade-api-manufa https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Particle Engineering for Inhalation-Grade API Manufacturing (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Particle Engineering for InhalationGrade API Manufact https://www.longshineboitech.com/news/2026-09-02-cardiovascular-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in LATAM — Portfolio & Regulatory Map Cardiovascular formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular po https://www.longshineboitech.com/news/2026-11-24-cofepris-nom-059-mexico-gmp-audit-preparation-latam-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg COFEPRIS NOM-059 — Mexico GMP Audit Preparation — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-05-28-how-to-qualify-an-indian-api-supplier-in-90-days-a-buyer-s-checklist- https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Qualify an Indian API Supplier in 90 Days — A Buyer's Checklist — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2027-01-25-best-supplier-sitagliptin-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Sitagliptin API in 2026: Buyer's Checklist Selecting a Sitagliptin manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2027-02-07-faq-sourcing-ciprofloxacin-hcl-into-eu-uk https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Ciprofloxacin HCl into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2026-06-11-dmf-letter-of-authorization-when-to-ask-how-to-use-latam-procurement- https://www.longshineboitech.com/product-images/human-api-powder.jpg DMF Letter of Authorization — When to Ask, How to Use — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2027-02-02-fda-dmf-type-ii-filing-2026-procedural-updates-for-foreign-api-sites- https://www.longshineboitech.com/product-images/human-api-powder.jpg FDA DMF Type II Filing — 2026 Procedural Updates for Foreign API Sites — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of FDA DMF Type II Filing — 2026 Pro https://www.longshineboitech.com/news/2026-07-17-antiviral-api-sourcing-hiv-hepatitis-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Antiviral API Landscape — HIV, Hepatitis, and Emerging Pathogens Antiviral API landscape 2026 — PEPFAR + Global Fund tender-driven procurement for HIV/HCV, plus emerging antivirals for pandemic preparedness. https://www.longshineboitech.com/news/2026-08-31-bimatoprost-cas-155206-00-1-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Bimatoprost (CAS 155206-00-1) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Bimatoprost (CAS 155206001) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers an https://www.longshineboitech.com/news/2026-07-16-cardiovascular-api-sartans-statins-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Cardiovascular API Manufacturing — Statins, Sartans, NDMA Control Cardiovascular API landscape 2026 — statin generics, sartan NDMA control per FDA guidance, and antihypertensive combination-therapy sourcing. https://www.longshineboitech.com/news/2026-07-19-cns-api-sourcing-antidepressants-racetams-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg CNS API Sourcing — Antidepressants, Antipsychotics, Racetams CNS API landscape — SSRI/SNRI portfolio, atypical antipsychotic sourcing, and racetam/nootropic manufacturing under regulated + research classifications. https://www.longshineboitech.com/news/2026-11-14-capability-brief-solvent-recovery-loop-how-we-cut-process-solvent-pur https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Solvent Recovery Loop — How We Cut Process Solvent Purchasing 30% (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Solvent Recovery Loop — How We Cut Process Solvent Purchasin https://www.longshineboitech.com/news/2027-03-05-market-note-antibiotic-stewardship-is-reshaping-anti-infective-api-fo https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Market Note — Antibiotic stewardship is reshaping anti-infective API forecasts (USA angle) Antibiotic stewardship is reshaping antiinfective API forecasts. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with specif https://www.longshineboitech.com/news/2027-02-15-crizotinib-cas-877399-52-5-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Crizotinib (CAS 877399-52-5) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Crizotinib (CAS 877399525) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers and https://www.longshineboitech.com/news/2026-07-20-gastrointestinal-api-ppis-prokinetics-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Gastrointestinal API Manufacturing — PPIs, Prokinetics, IBD Therapeutics GI API sourcing — PPI enantiomer separation, IBD biologic-adjacent chemistry, and antiemetic portfolio for oncology-supportive and gastroenteric applications. https://www.longshineboitech.com/news/2026-09-05-capability-brief-gmp-container-closure-qualification-for-light-sensit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — GMP Container Closure Qualification for Light-Sensitive APIs (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers GMP Container Closure Qualification for LightSensitive https://www.longshineboitech.com/news/2026-07-21-respiratory-api-bronchodilators-corticosteroids-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Respiratory API Sourcing — Bronchodilators, Corticosteroids, Antihistamines Respiratory API sourcing — bronchodilator classes, ICS particle-size validation for inhaler formulations, and antihistamine bulk manufacturing. https://www.longshineboitech.com/news/2027-03-30-ich-q3d-elemental-impurities-us-implementation-status-usa-buyer-s-bri https://www.longshineboitech.com/product-images/human-api-powder.jpg ICH Q3D Elemental Impurities — US Implementation Status — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of ICH Q3D Elemental Impurities — US https://www.longshineboitech.com/news/2026-07-27-ribociclib-succinate-cas-1374639-75-4-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Ribociclib Succinate (CAS 1374639-75-4) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Ribociclib Succinate (CAS 1374639754) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers https://www.longshineboitech.com/news/2026-07-18-capability-brief-sterile-filtration-validation-for-parenteral-api-man https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Sterile Filtration Validation for Parenteral API Manufacturing (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers Sterile Filtration Validation for Parenteral API Manu https://www.longshineboitech.com/news/2027-03-07-faq-sourcing-ondansetron-hcl-dihydrate-into-eu-uk https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Ondansetron HCl Dihydrate into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2026-09-26-capability-brief-cold-chain-peptide-packaging-validated-shippers-for- https://www.longshineboitech.com/product-images/peptide-vial.jpg Capability Brief — Cold-Chain Peptide Packaging — Validated Shippers for Trans-Atlantic Lanes (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers ColdChain Peptide Packaging — Validated Shippers for https://www.longshineboitech.com/news/2026-09-07-linezolid-cas-165800-03-3-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Linezolid (CAS 165800-03-3) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Linezolid (CAS 165800033) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers and a https://www.longshineboitech.com/news/2027-01-29-market-note-pepfar-and-global-fund-tenders-are-driving-anti-retrovira https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — PEPFAR and Global Fund tenders are driving anti-retroviral API consolidation (GCC + Levant angle) PEPFAR and Global Fund tenders are driving antiretroviral API consolidation. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, w https://www.longshineboitech.com/news/2026-06-22-2-aminopyridine-cas-504-29-0-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/intermediate-powder.jpg 2-Aminopyridine (CAS 504-29-0) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade 2Aminopyridine (CAS 504290) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers an https://www.longshineboitech.com/news/2026-06-29-copper-peptides-in-research https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Copper Peptides in Research Copper Peptides in Research — what GHK-Cu is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-10-25-faq-sourcing-curcumin-95-into-latam https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Curcumin (95%) into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing research chemicals. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, https://www.longshineboitech.com/news/2026-05-31-faq-sourcing-daptomycin-into-eu-uk https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Daptomycin into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2027-05-07-market-note-eudragit-and-hpmc-supply-realignment-is-forcing-reformula https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Eudragit and HPMC supply realignment is forcing reformulation decisions (EU + UK angle) Eudragit and HPMC supply realignment is forcing reformulation decisions. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with speci https://www.longshineboitech.com/news/2027-01-28-how-to-source-semaglutide-post-patent https://www.longshineboitech.com/product-images/peptide-vial.jpg How to Source Semaglutide API After the 2026 Patent Cliff This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2027-01-30-how-to-source-veterinary-anthelmintic https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg How to Source Veterinary Anthelmintic APIs - Albendazole, Fenbendazole, Praziquantel This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2026-07-23-ophthalmology-api-glaucoma-anti-vegf-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Ophthalmology API Sourcing — Glaucoma, Anti-VEGF, Antibiotics Ophthalmology API sourcing — sterile-grade documentation per USP <771>, glaucoma portfolio, dry-eye therapeutics, and ophthalmic antibiotic manufacturing. https://www.longshineboitech.com/news/2026-06-30-future-of-retatrutide-development https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Future of Retatrutide Development Future of Retatrutide Development — market trends and supplier landscape for retatrutide from Pune, India. https://www.longshineboitech.com/news/2026-07-24-fda-dmf-type-ii-filing-guide-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg FDA DMF Type II Filing — Complete Guide for Foreign API Sites Step-by-step FDA DMF Type II filing for foreign API sites — 21 CFR 314.420 requirements, GDUFA fees, LoA process, and post-filing lifecycle management. https://www.longshineboitech.com/news/2026-11-08-faq-sourcing-sorafenib-tosylate-into-usa https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Sorafenib Tosylate into USA Longtail FAQs we get every week from United States procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-06-29-l-citrulline-cas-372-75-8-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg L-Citrulline (CAS 372-75-8) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade LCitrulline (CAS 372758) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a curren https://www.longshineboitech.com/news/2026-07-07-anmat-disp-2819-argentina-api-importer-registration-latam-buyer-s-bri https://www.longshineboitech.com/product-images/human-api-powder.jpg ANMAT Disp. 2819 — Argentina API Importer Registration — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2027-01-28-how-to-source-buprenorphine-schedule-iii https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Source Buprenorphine (Schedule III) API - DEA Registration Walkthrough This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2026-12-30-endocrine-hormonal-api-sourcing-in-gcc-levant-portfolio-regulatory-ma https://www.longshineboitech.com/product-images/human-api-powder.jpg Endocrine & Hormonal API Sourcing in GCC + Levant — Portfolio & Regulatory Map Endocrine & Hormonal formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Endocrine & H https://www.longshineboitech.com/news/2026-06-30-edqm-cep-application-2026-format-content-refresh-eu-uk-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg EDQM CEP Application — 2026 Format & Content Refresh — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of EDQM CEP Application — 202 https://www.longshineboitech.com/news/2026-08-24-audit-remote-vs-on-site-comparison-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Remote vs On-Site Audit — Comparison for API Buyers Post-COVID, remote GMP audits are increasingly accepted. Comparison with on-site audit for API supplier qualification. https://www.longshineboitech.com/news/2027-01-07-api-stability-data-packages-what-24-month-accelerated-should-actually https://www.longshineboitech.com/product-images/human-api-powder.jpg API Stability Data Packages — What "24-Month Accelerated" Should Actually Include — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2026-11-01-faq-sourcing-tilmicosin-premix-grade-into-gcc-levant https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg FAQ — Sourcing Tilmicosin (Premix Grade) into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing veterinary apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Goog https://www.longshineboitech.com/news/2026-05-23-capability-brief-continuous-flow-crystallization-reduces-polymorph-ri https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Continuous-Flow Crystallization Reduces Polymorph Risk on Critical APIs (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers ContinuousFlow Crystallization Reduces Polymorph Risk https://www.longshineboitech.com/news/2026-09-20-faq-sourcing-gefitinib-into-eu-uk https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Gefitinib into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2026-08-11-moh-uae-pharmaceutical-manufacturer-registration-gcc-levant-buyer-s-b https://www.longshineboitech.com/product-images/human-api-powder.jpg MOH UAE Pharmaceutical Manufacturer Registration — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of MOH UAE Pha https://www.longshineboitech.com/news/2027-02-11-api-coa-review-what-sourcing-teams-should-catch-before-approving-lots https://www.longshineboitech.com/product-images/human-api-powder.jpg API CoA Review — What Sourcing Teams Should Catch Before Approving Lots — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-10-23-market-note-cold-chain-peptide-logistics-is-the-new-procurement-bottl https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — Cold-chain peptide logistics is the new procurement bottleneck (EU + UK angle) Coldchain peptide logistics is the new procurement bottleneck. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics aroun https://www.longshineboitech.com/news/2026-11-25-veterinary-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Veterinary API Sourcing in LATAM — Portfolio & Regulatory Map Veterinary formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Veterinary portfolio https://www.longshineboitech.com/news/2026-07-01-anti-infective-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Anti-Infective API Sourcing in EU + UK — Portfolio & Regulatory Map AntiInfective formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech AntiInfective portfolio a https://www.longshineboitech.com/news/2027-04-18-faq-sourcing-ghrp-6-into-gcc-levant https://www.longshineboitech.com/product-images/peptide-vial.jpg FAQ — Sourcing GHRP-6 into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing peptides. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI O https://www.longshineboitech.com/news/2026-11-29-faq-sourcing-metoprolol-tartrate-into-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Metoprolol Tartrate into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-07-22-dermatology-api-topical-systemic-2026 https://www.longshineboitech.com/news-images/news-sustainability.jpg Dermatology API Manufacturing — Topical and Systemic Dermatology API sourcing — topical retinoid manufacturing, antifungal portfolio, and systemic dermatology therapeutics for acne, eczema, psoriasis. https://www.longshineboitech.com/news/2026-07-26-who-gmp-certification-indian-api-manufacturer-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg WHO-GMP Certification — Requirements for Indian API Manufacturers WHO-GMP certification for Indian API manufacturers — CDSCO inspection scope, certificate validity, WHO-PQ prequalification, and international recognition. https://www.longshineboitech.com/news/2027-01-12-ich-m7-mutagenic-impurities-practical-risk-assessment-for-apis-eu-uk- https://www.longshineboitech.com/product-images/human-api-powder.jpg ICH M7 Mutagenic Impurities — Practical Risk Assessment for APIs — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of ICH M7 Mutagenic Impuritie https://www.longshineboitech.com/news/2026-07-28-pmda-master-file-japan-market-entry-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg PMDA Master File Registration — Japanese Market Entry PMDA MF registration for API manufacturers — Japanese pharma market entry, MF application format, timeline, and post-approval maintenance. https://www.longshineboitech.com/news/2027-01-29-how-to-source-peptide-research-reagent https://www.longshineboitech.com/product-images/peptide-vial.jpg How to Source Research-Grade Peptides for Preclinical Studies This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2026-08-13-inbound-quality-sampling-plans-statistical-basis-for-reduced-testing- https://www.longshineboitech.com/product-images/human-api-powder.jpg Inbound Quality Sampling Plans — Statistical Basis for Reduced Testing — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-08-07-market-note-eudragit-and-hpmc-supply-realignment-is-forcing-reformula https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Eudragit and HPMC supply realignment is forcing reformulation decisions (LATAM angle) Eudragit and HPMC supply realignment is forcing reformulation decisions. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, wit https://www.longshineboitech.com/news/2026-07-27-anvisa-api-registration-difa-rdc-359-2026 https://www.longshineboitech.com/news-images/news-european-partnership.jpg ANVISA API Registration — DIFA, DMF, and RDC 359/2020 ANVISA API registration walkthrough — DIFA (Dossiê de Insumo Farmacêutico Ativo), Brazilian DMF option, RDC 359/2020, and post-approval change management. https://www.longshineboitech.com/news/2027-02-12-market-note-nootropic-api-regulation-is-splitting-into-us-eu-apac-tra https://www.longshineboitech.com/product-images/research-chemical.jpg Market Note — Nootropic API regulation is splitting into US / EU / APAC tracks (EU + UK angle) Nootropic API regulation is splitting into US / EU / APAC tracks. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics ar https://www.longshineboitech.com/news/2026-08-01-ich-m7-nitrosamine-mutagenic-impurities-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg ICH M7 Mutagenic Impurities — Nitrosamines and Aromatic Amines ICH M7 mutagenic impurity control — nitrosamine risk evaluation, aromatic amine assessment, Class 1-5 classification, and TTC-based control strategy. https://www.longshineboitech.com/news/2026-07-05-faq-sourcing-4-aminoacetophenone-into-latam https://www.longshineboitech.com/product-images/intermediate-powder.jpg FAQ — Sourcing 4-Aminoacetophenone into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing intermediates. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Goog https://www.longshineboitech.com/news/2026-08-02-ich-q3d-elemental-impurities-pde-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg ICH Q3D Elemental Impurities — PDE Calculations and Control ICH Q3D elemental impurity control — Class 1/2A/2B/3 metal categorisation, PDE calculations, ICP-MS quantification methods, and risk-based control strategy. https://www.longshineboitech.com/news/2027-02-01-metformin-hcl-vs-metformin-extended-release https://www.longshineboitech.com/product-images/human-api-powder.jpg Metformin HCl IR vs XR API Selection This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2027-04-06-eu-falsified-medicines-directive-active-substance-registration-eu-uk- https://www.longshineboitech.com/product-images/human-api-powder.jpg EU Falsified Medicines Directive — Active Substance Registration — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of EU Falsified Medicines Dir https://www.longshineboitech.com/news/2026-06-29-mots-c-research-trends https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg MOTS-c Research Trends MOTS-c Research Trends — market trends and supplier landscape for mots-c from Pune, India. https://www.longshineboitech.com/news/2027-02-01-how-to-source-api-for-ophthalmic https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Source APIs for Ophthalmic Formulations - Preservative-Free Requirements This is the practical procurement walkthrough for buyers new to sourcing these APIs - the documents you need on hand before your first RFQ, the timeline to expect, and how to compare quotes without ge https://www.longshineboitech.com/news/2027-01-15-market-note-biosimilar-api-spend-is-set-to-overtake-small-molecule-by https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Biosimilar API spend is set to overtake small-molecule by 2028 (EU + UK angle) Biosimilar API spend is set to overtake smallmolecule by 2028. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics aroun https://www.longshineboitech.com/news/2026-08-03-semaglutide-api-sourcing-2026-who-gmp-dmf https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Semaglutide API Sourcing 2026 — WHO-GMP + DMF Status Semaglutide API sourcing 2026 — WHO-GMP manufacturing capacity, active DMF status, ASMF for EMA, and supply-shortage-market pricing dynamics. https://www.longshineboitech.com/news/2027-02-16-isp-chile-pharmaceutical-api-registry-2026-latam-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg ISP Chile — Pharmaceutical API Registry 2026 — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2027-01-23-capability-brief-ich-q11-starting-material-justification-how-we-docum https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — ICH Q11 Starting Material Justification — How We Document It (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers ICH Q11 Starting Material Justification — How We Docume https://www.longshineboitech.com/news/2027-04-19-cefovecin-sodium-cas-141195-77-9-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Cefovecin Sodium (CAS 141195-77-9) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Cefovecin Sodium (CAS 141195779) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers https://www.longshineboitech.com/news/2026-10-13-pepfar-api-tenders-fda-tentative-approval-pathway-usa-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg PEPFAR API Tenders — FDA Tentative Approval Pathway — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of PEPFAR API Tenders — FDA Tentativ https://www.longshineboitech.com/news/2026-06-29-targeted-oncology-apis https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Targeted Oncology APIs Targeted Oncology APIs — what Abemaciclib is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-29-next-generation-glp-1-products https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Next Generation GLP-1 Products Next Generation GLP-1 Products — what Survodutide is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-07-26-faq-sourcing-cannabigerol-cbg-into-eu-uk https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Cannabigerol (CBG) into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing research chemicals. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2027-02-04-peptide-solution-vs-lyophilised-supply https://www.longshineboitech.com/product-images/peptide-vial.jpg Peptide API Supply Format - Solution vs Lyophilised Powder Trade-offs This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2026-06-29-parp-inhibitors-market https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg PARP Inhibitors Market PARP Inhibitors Market — market trends and supplier landscape for olaparib from Pune, India. https://www.longshineboitech.com/news/2026-06-29-cosmetic-peptide-applications https://www.longshineboitech.com/news-images/news-sustainability.jpg Cosmetic Peptide Applications Cosmetic Peptide Applications — what Copper Tripeptide-1 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-30-emerging-glp-1-peptides https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Emerging GLP-1 Peptides Emerging GLP-1 Peptides — what Mazdutide is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-06-29-tirzepatide-api-market-trends https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Tirzepatide API Market Trends Tirzepatide API Market Trends — market trends and supplier landscape for tirzepatide from Pune, India. https://www.longshineboitech.com/news/2026-06-06-capability-brief-particle-engineering-for-inhalation-grade-api-manufa https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Particle Engineering for Inhalation-Grade API Manufacturing (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Particle Engineering for InhalationGrade API Manufact https://www.longshineboitech.com/news/2026-06-29-research-peptides-market https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Research Peptides Market Research Peptides Market — market trends and supplier landscape for bpc-157 from Pune, India. https://www.longshineboitech.com/news/2026-08-26-respiratory-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Respiratory API Sourcing in EU + UK — Portfolio & Regulatory Map Respiratory formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Respiratory portfolio again https://www.longshineboitech.com/news/2026-06-29-future-of-rna-materials https://www.longshineboitech.com/news-images/news-european-partnership.jpg Future of RNA Materials Future of RNA Materials — market trends and supplier landscape for modified nucleosides from Pune, India. https://www.longshineboitech.com/news/2026-06-29-custom-peptide-manufacturing https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Custom Peptide Manufacturing Custom Peptide Manufacturing — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2026-06-29-api-process-optimization https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg API Process Optimization API Process Optimization — how WHO-GMP CDMO services from Pune support pharmaceutical buyers from Pune, India. https://www.longshineboitech.com/news/2026-06-29-diabetes-api-market https://www.longshineboitech.com/news-images/news-iso-certification.jpg Diabetes API Market Diabetes API Market — market trends and supplier landscape for sitagliptin from Pune, India. https://www.longshineboitech.com/news/2027-02-02-usp-vs-ep-vs-jp-monograph-selection https://www.longshineboitech.com/product-images/human-api-powder.jpg USP vs Ph. Eur. vs JP Monographs - Which Pharmacopoeia Should Your API Reference? This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2027-03-21-faq-sourcing-ceftriaxone-sodium-into-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Ceftriaxone Sodium into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-08-16-faq-sourcing-sorbitol-into-usa https://www.longshineboitech.com/product-images/excipient-powder.jpg FAQ — Sourcing Sorbitol into USA Longtail FAQs we get every week from United States procurement teams sourcing excipients. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-12-10-supplier-audit-travel-free-how-remote-gmp-audits-actually-work-usa-pr https://www.longshineboitech.com/product-images/human-api-powder.jpg Supplier Audit Travel-Free — How Remote GMP Audits Actually Work — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2027-03-26-market-note-companion-animal-pharma-is-outpacing-human-generics-growt https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Companion-animal pharma is outpacing human generics growth (GCC + Levant angle) Companionanimal pharma is outpacing human generics growth. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specifics arou https://www.longshineboitech.com/news/2026-08-28-chiral-vs-racemic-api-drug-development-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Chiral vs Racemic API — Development Choice Chiral switches (escitalopram from citalopram, esomeprazole from omeprazole) drove significant generic development activity. https://www.longshineboitech.com/news/2027-01-02-capability-brief-sterile-filtration-validation-for-parenteral-api-man https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Sterile Filtration Validation for Parenteral API Manufacturing (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers Sterile Filtration Validation for Parenteral API Manu https://www.longshineboitech.com/news/2026-12-01-eda-egypt-api-variation-procedures-2026-gcc-levant-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg EDA Egypt — API Variation Procedures 2026 — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of EDA Egypt — https://www.longshineboitech.com/news/2026-11-27-market-note-glp-1-receptor-agonists-are-now-the-1-driver-of-peptide-a https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — GLP-1 receptor agonists are now the #1 driver of peptide API demand (LATAM angle) GLP1 receptor agonists are now the 1 driver of peptide API demand. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with spec https://www.longshineboitech.com/news/2026-07-24-market-note-cold-chain-peptide-logistics-is-the-new-procurement-bottl https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — Cold-chain peptide logistics is the new procurement bottleneck (USA angle) Coldchain peptide logistics is the new procurement bottleneck. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with specific https://www.longshineboitech.com/news/2027-03-13-capability-brief-cold-chain-peptide-packaging-validated-shippers-for- https://www.longshineboitech.com/product-images/peptide-vial.jpg Capability Brief — Cold-Chain Peptide Packaging — Validated Shippers for Trans-Atlantic Lanes (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers ColdChain Peptide Packaging — Validated Shippers for https://www.longshineboitech.com/news/2026-12-05-capability-brief-spray-drying-for-amorphous-solid-dispersions-capabil https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Spray-Drying for Amorphous Solid Dispersions — Capability Brief (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers SprayDrying for Amorphous Solid Dispersions — Capabil https://www.longshineboitech.com/news/2026-07-28-eu-falsified-medicines-directive-active-substance-registration-eu-uk- https://www.longshineboitech.com/product-images/human-api-powder.jpg EU Falsified Medicines Directive — Active Substance Registration — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of EU Falsified Medicines Dir https://www.longshineboitech.com/news/2026-12-09-oncology-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Oncology API Sourcing in USA — Portfolio & Regulatory Map Oncology formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Oncology portfolio agai https://www.longshineboitech.com/news/2027-02-05-on-site-vs-remote-audit https://www.longshineboitech.com/product-images/human-api-powder.jpg On-Site vs Remote Factory Audit - 2026 Best Practice for API Supplier Qualification This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2026-08-06-paclitaxel-api-manufacturing-cytotoxic-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Paclitaxel API Manufacturing — Cytotoxic Containment Paclitaxel API — cytotoxic containment manufacturing per EMA guidelines, taxane semi-synthesis or plant-cell fermentation route, and injectable-grade sterile documentation. https://www.longshineboitech.com/news/2027-05-17-pantoprazole-sodium-cas-138786-67-1-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Pantoprazole Sodium (CAS 138786-67-1) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Pantoprazole Sodium (CAS 138786671) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buy https://www.longshineboitech.com/news/2026-12-19-capability-brief-cold-chain-peptide-packaging-validated-shippers-for- https://www.longshineboitech.com/product-images/peptide-vial.jpg Capability Brief — Cold-Chain Peptide Packaging — Validated Shippers for Trans-Atlantic Lanes (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers ColdChain Peptide Packaging — Validated Shippers for https://www.longshineboitech.com/news/2026-12-24-lead-time-negotiation-levers-when-the-api-is-single-source-latam-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg Lead-Time Negotiation Levers When the API is Single-Source — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-12-15-ph-eur-11-0-updates-monograph-changes-affecting-common-apis-eu-uk-buy https://www.longshineboitech.com/product-images/human-api-powder.jpg Ph. Eur. 11.0 Updates — Monograph Changes Affecting Common APIs — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of Ph. Eur. 11.0 Updates — Mo https://www.longshineboitech.com/news/2026-08-08-l-glutamine-api-injectable-usp-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg L-Glutamine API for Injectables — USP Grade L-glutamine API for injectables — USP-grade with endotoxin control per USP <85>, particulate control per USP <788>, and validated aseptic processing. https://www.longshineboitech.com/news/2026-08-24-sacubitril-cas-149709-62-6-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Sacubitril (CAS 149709-62-6) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Sacubitril (CAS 149709626) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a curr https://www.longshineboitech.com/news/2027-04-07-respiratory-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Respiratory API Sourcing in EU + UK — Portfolio & Regulatory Map Respiratory formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Respiratory portfolio again https://www.longshineboitech.com/news/2026-07-15-cardiovascular-api-sourcing-in-gcc-levant-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in GCC + Levant — Portfolio & Regulatory Map Cardiovascular formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular port https://www.longshineboitech.com/news/2026-09-30-anti-infective-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Anti-Infective API Sourcing in LATAM — Portfolio & Regulatory Map AntiInfective formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech AntiInfective port https://www.longshineboitech.com/news/2026-08-29-capability-brief-particle-engineering-for-inhalation-grade-api-manufa https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Particle Engineering for Inhalation-Grade API Manufacturing (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Particle Engineering for InhalationGrade API Manufact https://www.longshineboitech.com/news/2026-07-30-spot-buy-vs-annual-tender-frame-pricing-risk-like-a-cfo-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Spot-Buy vs Annual Tender — Frame Pricing Risk Like a CFO — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2027-03-03-cns-neurology-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg CNS & Neurology API Sourcing in USA — Portfolio & Regulatory Map CNS & Neurology formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech CNS & Neurology https://www.longshineboitech.com/news/2026-08-10-vinblastine-sulfate-cas-143-67-9-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Vinblastine Sulfate (CAS 143-67-9) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Vinblastine Sulfate (CAS 143679) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers https://www.longshineboitech.com/news/2026-10-17-capability-brief-microbial-limit-testing-in-house-usp-61-62-capabilit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Microbial Limit Testing — In-House USP <61>/<62> Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Microbial Limit Testing — InHouse USP <61/<62 Capability — w https://www.longshineboitech.com/news/2027-01-05-nitrosamine-step-2-risk-evaluation-fda-guidance-status-usa-buyer-s-br https://www.longshineboitech.com/product-images/human-api-powder.jpg Nitrosamine Step 2 Risk Evaluation — FDA Guidance Status — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of Nitrosamine Step 2 Risk Evaluatio https://www.longshineboitech.com/news/2026-10-08-coa-cos-cep-document-stack-every-buyer-should-demand-gcc-levant-procu https://www.longshineboitech.com/product-images/human-api-powder.jpg CoA + CoS + CEP — Document Stack Every Buyer Should Demand — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-08-14-who-gmp-vs-us-fda-cgmp-comparison-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg WHO-GMP vs US FDA cGMP — What EU Buyers Need to Know WHO-GMP vs FDA cGMP standard comparison — inspection scope, mutual recognition arrangements, EU/UK acceptance, and buyer decision framework. https://www.longshineboitech.com/news/2027-02-03-hplc-vs-uplc-purity-testing https://www.longshineboitech.com/product-images/human-api-powder.jpg HPLC vs UPLC for API Purity Release - When to Upgrade Your QC Lab This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2027-03-15-pramiracetam-cas-68497-62-1-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/research-chemical.jpg Pramiracetam (CAS 68497-62-1) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Pramiracetam (CAS 68497621) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers an https://www.longshineboitech.com/news/2027-01-22-market-note-cold-chain-peptide-logistics-is-the-new-procurement-bottl https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — Cold-chain peptide logistics is the new procurement bottleneck (LATAM angle) Coldchain peptide logistics is the new procurement bottleneck. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with specific https://www.longshineboitech.com/news/2026-10-03-capability-brief-nitrosamine-mitigation-process-re-design-case-study- https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Nitrosamine Mitigation — Process Re-Design Case Study (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers Nitrosamine Mitigation — Process ReDesign Case Study — https://www.longshineboitech.com/news/2027-02-08-empagliflozin-cas-864070-44-0-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Empagliflozin (CAS 864070-44-0) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Empagliflozin (CAS 864070440) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a c https://www.longshineboitech.com/news/2026-08-16-usp-vs-ep-vs-jp-pharmacopoeia-2026 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg USP vs EP vs JP Pharmacopoeia — Testing Method Differences Pharmacopoeia comparison — USP vs Ph. Eur. vs JP testing method differences, specification harmonization efforts, and impact on API compendial compliance. https://www.longshineboitech.com/news/2026-08-19-ndma-testing-methods-hrms-gc-ms-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg NDMA Testing Methods — HRMS vs GC-MS Comparison NDMA testing method comparison — HRMS vs GC-MS sensitivity, quantification limits, applicability to metformin and sartan matrices, and FDA-accepted approaches. https://www.longshineboitech.com/news/2026-08-22-buying-api-direct-vs-distributor-2026 https://www.longshineboitech.com/news-images/news-sustainability.jpg Buying API Directly vs Through Distributors — TCO Analysis Direct API purchase vs distributor comparison — total cost of ownership analysis including regulatory documentation continuity, change notification, and audit rights. https://www.longshineboitech.com/news/2026-11-23-pirfenidone-cas-53179-13-8-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Pirfenidone (CAS 53179-13-8) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Pirfenidone (CAS 53179138) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers and https://www.longshineboitech.com/news/2026-08-21-small-batch-vs-multi-ton-api-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Small Batch vs Multi-Ton API Procurement — Contract Structures API contract structure comparison — small-batch clinical supply vs multi-ton commercial generic. MOQ, volume commitments, change notification, and stability data requirements. https://www.longshineboitech.com/news/2026-06-16-neom-vision-2030-pharmaceutical-manufacturing-incentives-gcc-levant-b https://www.longshineboitech.com/product-images/human-api-powder.jpg NEOM & Vision 2030 — Pharmaceutical Manufacturing Incentives — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of NEOM & Visi https://www.longshineboitech.com/news/2027-02-13-capability-brief-particle-engineering-for-inhalation-grade-api-manufa https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Particle Engineering for Inhalation-Grade API Manufacturing (LATAM customers) Longshine BoiTech's manufacturing capability for Latin America customers extends beyond catalogue chemistry. This Saturday capability brief covers Particle Engineering for InhalationGrade API Manufact https://www.longshineboitech.com/news/2026-10-18-faq-sourcing-cartalax-into-eu-uk https://www.longshineboitech.com/product-images/peptide-vial.jpg FAQ — Sourcing Cartalax into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing peptides. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Overvi https://www.longshineboitech.com/news/2026-09-23-gastrointestinal-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Gastrointestinal API Sourcing in EU + UK — Portfolio & Regulatory Map Gastrointestinal formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Gastrointestinal portf https://www.longshineboitech.com/news/2026-11-12-how-to-qualify-an-indian-api-supplier-in-90-days-a-buyer-s-checklist- https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Qualify an Indian API Supplier in 90 Days — A Buyer's Checklist — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2026-11-19-api-coa-review-what-sourcing-teams-should-catch-before-approving-lots https://www.longshineboitech.com/product-images/human-api-powder.jpg API CoA Review — What Sourcing Teams Should Catch Before Approving Lots — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2027-02-14-faq-sourcing-sorbitol-into-latam https://www.longshineboitech.com/product-images/excipient-powder.jpg FAQ — Sourcing Sorbitol into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing excipients. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-09-08-sfda-gmp-audit-preparation-12-month-roadmap-for-foreign-api-sites-gcc https://www.longshineboitech.com/product-images/human-api-powder.jpg SFDA GMP Audit Preparation — 12-Month Roadmap for Foreign API Sites — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of SFDA GMP Au https://www.longshineboitech.com/news/2026-07-11-capability-brief-nitrosamine-mitigation-process-re-design-case-study- https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Nitrosamine Mitigation — Process Re-Design Case Study (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers Nitrosamine Mitigation — Process ReDesign Case Study — https://www.longshineboitech.com/news/2026-06-30-cagrilintide-and-weight-management https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Cagrilintide and Weight Management Cagrilintide and Weight Management — what Cagrilintide is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-02-04-dmf-vs-cep-vs-asmf https://www.longshineboitech.com/product-images/human-api-powder.jpg DMF vs CEP vs ASMF - Regulatory Pathway Selection This is a decision-framework article aimed at pharmaceutical procurement + QA managers weighing the choice named above. We stay factual (no supplier advocacy in the framework itself) and separate the https://www.longshineboitech.com/news/2026-10-04-faq-sourcing-phenylacetic-acid-into-gcc-levant https://www.longshineboitech.com/product-images/intermediate-powder.jpg FAQ — Sourcing Phenylacetic Acid into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing intermediates. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-07-10-pharmaceutical-excipients-purity-grades-2026 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Pharmaceutical Excipients from India — Purity, Grades, Regulatory Sourcing pharmaceutical excipients from Indian WHO-GMP manufacturers — compendial-grade material for oral, injectable, and topical formulations across regulated markets. https://www.longshineboitech.com/news/2026-09-28-l-carnitine-injectable-cas-541-15-1-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/injectable-vial.jpg L-Carnitine Injectable (CAS 541-15-1) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade LCarnitine Injectable (CAS 541151) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America bu https://www.longshineboitech.com/news/2026-07-06-human-apis-manufacturing-india-fda-dmf-cep-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Human API Manufacturing in India — FDA DMF, EDQM CEP, and WHO-GMP How WHO-GMP-certified Indian manufacturers meet FDA, EDQM, and PMDA filing requirements for human pharmaceutical APIs — audit-ready CoA, active DMF/CEP status, and Module 3 documentation. https://www.longshineboitech.com/news/2027-03-27-capability-brief-sterile-filtration-validation-for-parenteral-api-man https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Sterile Filtration Validation for Parenteral API Manufacturing (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers Sterile Filtration Validation for Parenteral API Manu https://www.longshineboitech.com/news/2026-07-22-cns-neurology-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg CNS & Neurology API Sourcing in USA — Portfolio & Regulatory Map CNS & Neurology formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech CNS & Neurology https://www.longshineboitech.com/news/2026-11-30-ethinyl-estradiol-cas-57-63-6-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Ethinyl Estradiol (CAS 57-63-6) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Ethinyl Estradiol (CAS 57636) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers an https://www.longshineboitech.com/news/2027-02-28-faq-sourcing-isavuconazonium-sulfate-into-usa https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Isavuconazonium Sulfate into USA Longtail FAQs we get every week from United States procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-07-08-gastrointestinal-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Gastrointestinal API Sourcing in LATAM — Portfolio & Regulatory Map Gastrointestinal formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Gastrointestina https://www.longshineboitech.com/news/2027-04-11-faq-sourcing-l-arginine-into-latam https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing L-Arginine into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing amino acids. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2027-04-02-market-note-excipient-supply-tightness-is-the-under-covered-story-of- https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Excipient supply tightness is the under-covered story of the year (USA angle) Excipient supply tightness is the undercovered story of the year. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with speci https://www.longshineboitech.com/news/2027-04-14-cardiovascular-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in LATAM — Portfolio & Regulatory Map Cardiovascular formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular po https://www.longshineboitech.com/news/2026-08-04-anvisa-rdc-359-2020-api-registration-in-brazil-step-by-step-latam-buy https://www.longshineboitech.com/product-images/human-api-powder.jpg ANVISA RDC 359/2020 — API Registration in Brazil Step-by-Step — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-07-13-research-chemicals-life-sciences-2026 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Research Chemicals for Life Sciences — Purity Grades & Analytical Standards Research-use-only chemicals and analytical reference standards — high-purity synthesis with HRMS/NMR data packages for pharmacological research and analytical method development. https://www.longshineboitech.com/news/2027-02-19-market-note-cdmo-consolidation-is-changing-the-make-vs-buy-calculus-f https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — CDMO consolidation is changing the make-vs-buy calculus for mid-cap pharma (LATAM angle) CDMO consolidation is changing the makevsbuy calculus for midcap pharma. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, wit https://www.longshineboitech.com/news/2027-04-15-force-majeure-clauses-for-api-supply-contracts-2026-rewrite-latam-pro https://www.longshineboitech.com/product-images/human-api-powder.jpg Force Majeure Clauses for API Supply Contracts — 2026 Rewrite — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-07-30-tga-australian-api-import-sponsor-2026 https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg TGA Australian API Import — Sponsors and Requirements TGA API import into Australia — sponsor obligations, GMP clearance via PIC/S mutual recognition, and post-market compliance for human and veterinary APIs. https://www.longshineboitech.com/news/2027-03-22-palladium-on-carbon-10-pd-c-wet-cas-7440-05-3-gcc-levant-supplier-gui https://www.longshineboitech.com/product-images/intermediate-powder.jpg Palladium on Carbon (10% Pd/C, Wet) (CAS 7440-05-3) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Palladium on Carbon (10% Pd/C, Wet) (CAS 7440053) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to M https://www.longshineboitech.com/news/2026-06-30-tirzepatide-api-market-trends https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Tirzepatide API Market Trends Tirzepatide API Market Trends — market trends and supplier landscape for tirzepatide from Pune, India. https://www.longshineboitech.com/news/2027-03-11-two-source-strategy-for-critical-apis-cost-vs-risk-math-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Two-Source Strategy for Critical APIs — Cost vs Risk Math — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2027-01-08-market-note-scope-3-emissions-reporting-is-changing-how-formulators-p https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Scope 3 emissions reporting is changing how formulators pick API suppliers (USA angle) Scope 3 emissions reporting is changing how formulators pick API suppliers. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, https://www.longshineboitech.com/news/2026-08-07-imatinib-tki-manufacturing-cml-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Imatinib TKI Manufacturing — Chronic Myeloid Leukemia Imatinib mesylate API — first-generation BCR-ABL TKI, polymorph control (alpha vs beta form), and generic bioequivalence reference batches for CML manufacturing. https://www.longshineboitech.com/news/2026-10-09-market-note-scope-3-emissions-reporting-is-changing-how-formulators-p https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Scope 3 emissions reporting is changing how formulators pick API suppliers (GCC + Levant angle) Scope 3 emissions reporting is changing how formulators pick API suppliers. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, wi https://www.longshineboitech.com/news/2026-10-10-capability-brief-sterile-filtration-validation-for-parenteral-api-man https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Sterile Filtration Validation for Parenteral API Manufacturing (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers Sterile Filtration Validation for Parenteral API Manu https://www.longshineboitech.com/news/2027-04-13-anvisa-rdc-359-2020-api-registration-in-brazil-step-by-step-latam-buy https://www.longshineboitech.com/product-images/human-api-powder.jpg ANVISA RDC 359/2020 — API Registration in Brazil Step-by-Step — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-06-29-modern-diabetes-apis https://www.longshineboitech.com/news-images/news-iso-certification.jpg Modern Diabetes APIs Modern Diabetes APIs — what Dapagliflozin is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-08-06-force-majeure-clauses-for-api-supply-contracts-2026-rewrite-latam-pro https://www.longshineboitech.com/product-images/human-api-powder.jpg Force Majeure Clauses for API Supply Contracts — 2026 Rewrite — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2027-01-26-best-supplier-bpc-157-2026 https://www.longshineboitech.com/product-images/peptide-vial.jpg Best Supplier for BPC-157 API in 2026: Buyer's Checklist Selecting a BPC-157 manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2026-07-29-mhra-api-notification-post-brexit-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg MHRA API Notification — Post-Brexit UK Sourcing Post-Brexit UK API sourcing — MHRA notification process, CEP + ASMF acceptance in Great Britain, Northern Ireland dual-regime, and PB-Regulation compliance. https://www.longshineboitech.com/news/2026-08-09-aniracetam-manufacturing-cognitive-research-2026 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Aniracetam Manufacturing — Cognitive Research Applications Aniracetam ≥99% purity for cognitive research — full HRMS + NMR characterization data package, research-use-only labeling, and structured supply for regulated + RUO markets. https://www.longshineboitech.com/news/2027-02-27-capability-brief-spray-drying-for-amorphous-solid-dispersions-capabil https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Spray-Drying for Amorphous Solid Dispersions — Capability Brief (USA customers) Longshine BoiTech's manufacturing capability for United States customers extends beyond catalogue chemistry. This Saturday capability brief covers SprayDrying for Amorphous Solid Dispersions — Capabil https://www.longshineboitech.com/news/2026-08-13-india-vs-china-api-suppliers-comparison-2026 https://www.longshineboitech.com/news-images/news-sustainability.jpg India vs China API Suppliers — 2026 Comparison India vs China API supplier comparison 2026 — regulatory filing depth (DMF, CEP, ASMF), cost structure, quality track record, and supply chain resilience. https://www.longshineboitech.com/news/2027-01-09-capability-brief-microbial-limit-testing-in-house-usp-61-62-capabilit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Microbial Limit Testing — In-House USP <61>/<62> Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Microbial Limit Testing — InHouse USP <61/<62 Capability — w https://www.longshineboitech.com/news/2026-10-14-cardiovascular-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in USA — Portfolio & Regulatory Map Cardiovascular formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular po https://www.longshineboitech.com/news/2026-12-03-api-bridging-studies-when-you-need-one-when-you-don-t-gcc-levant-proc https://www.longshineboitech.com/product-images/human-api-powder.jpg API Bridging Studies — When You Need One, When You Don't — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2026-09-04-market-note-antibiotic-stewardship-is-reshaping-anti-infective-api-fo https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Market Note — Antibiotic stewardship is reshaping anti-infective API forecasts (LATAM angle) Antibiotic stewardship is reshaping antiinfective API forecasts. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with specif https://www.longshineboitech.com/news/2026-10-06-israel-moh-api-registration-dmf-asmf-acceptance-gcc-levant-buyer-s-br https://www.longshineboitech.com/product-images/human-api-powder.jpg Israel MoH API Registration — DMF & ASMF Acceptance — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of Israel MoH https://www.longshineboitech.com/news/2026-09-09-endocrine-hormonal-api-sourcing-in-gcc-levant-portfolio-regulatory-ma https://www.longshineboitech.com/product-images/human-api-powder.jpg Endocrine & Hormonal API Sourcing in GCC + Levant — Portfolio & Regulatory Map Endocrine & Hormonal formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Endocrine & H https://www.longshineboitech.com/news/2027-03-23-jfda-jordan-active-substance-registration-format-gcc-levant-buyer-s-b https://www.longshineboitech.com/product-images/human-api-powder.jpg JFDA Jordan — Active Substance Registration Format — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of JFDA Jordan https://www.longshineboitech.com/news/2027-05-12-anti-infective-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Anti-Infective API Sourcing in LATAM — Portfolio & Regulatory Map AntiInfective formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech AntiInfective port https://www.longshineboitech.com/news/2027-04-22-inbound-quality-sampling-plans-statistical-basis-for-reduced-testing- https://www.longshineboitech.com/product-images/human-api-powder.jpg Inbound Quality Sampling Plans — Statistical Basis for Reduced Testing — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2027-02-03-cardiovascular-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Cardiovascular API Sourcing in USA — Portfolio & Regulatory Map Cardiovascular formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Cardiovascular po https://www.longshineboitech.com/news/2027-01-19-mercosur-api-equivalence-technical-regulation-update-latam-buyer-s-br https://www.longshineboitech.com/product-images/human-api-powder.jpg MERCOSUR API Equivalence — Technical Regulation Update — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2027-01-11-sildenafil-citrate-cas-171599-83-0-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/research-chemical.jpg Sildenafil Citrate (CAS 171599-83-0) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Sildenafil Citrate (CAS 171599830) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers an https://www.longshineboitech.com/news/2026-08-10-cephalexin-api-sourcing-first-gen-cephalosporin-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Cephalexin API Sourcing — First-Generation Cephalosporin Cephalexin API — first-generation cephalosporin manufacturing in dedicated β-lactam containment facility, USP/EP/JP compendial coverage. https://www.longshineboitech.com/news/2026-08-15-dmf-vs-asmf-when-each-applies-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Type II DMF vs ASMF — When Each Applies FDA Type II DMF vs ASMF (Active Substance Master File) — filing scope, market applicability (US vs EU), timelines, and buyer implications. https://www.longshineboitech.com/news/2026-08-29-iv-vs-oral-api-formulation-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg IV vs Oral API — Sterility + Manufacturing Split IV parenteral API requires sterility (USP <71>), endotoxin control (USP <85>), and typically dedicated sterile facility. https://www.longshineboitech.com/news/2026-12-27-faq-sourcing-piracetam-into-gcc-levant https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Piracetam into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing nootropics. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-07-11-amino-acids-pharmaceutical-applications-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Amino Acids for Pharmaceutical Applications — L-Glutamine to Custom Peptides How WHO-GMP amino acid manufacturers meet USP, Ph. Eur., and injectable-grade requirements for parenteral nutrition and downstream peptide synthesis. https://www.longshineboitech.com/news/2026-08-22-gdufa-iii-fda-goals-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg GDUFA III FDA Performance Goals — Generic Impact GDUFA III sets FDA generic drug review performance goals for 2023-2027. Impact on ANDA acceptance rates, DMF timing. https://www.longshineboitech.com/news/2026-09-18-market-note-ai-assisted-route-scouting-is-cutting-api-synthesis-steps https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — AI-assisted route scouting is cutting API synthesis steps by up to 40% (USA angle) AIassisted route scouting is cutting API synthesis steps by up to 40%. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with https://www.longshineboitech.com/news/2026-07-30-india-to-us-anda-api-timeline-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg India-to-US ANDA API Timeline — LoA to First Commercial ANDA sponsors sourcing API from India — full workflow from LoA request through DMF review, ANDA cross-reference, and PAI readiness. https://www.longshineboitech.com/news/2026-09-25-market-note-companion-animal-pharma-is-outpacing-human-generics-growt https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Companion-animal pharma is outpacing human generics growth (EU + UK angle) Companionanimal pharma is outpacing human generics growth. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics around ou https://www.longshineboitech.com/news/2026-10-26-sunitinib-malate-cas-341031-54-7-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Sunitinib Malate (CAS 341031-54-7) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Sunitinib Malate (CAS 341031547) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buye https://www.longshineboitech.com/news/2026-08-18-cmo-vs-cdmo-which-is-right-2026 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Contract Manufacturing (CMO) vs CDMO — Which Is Right CMO vs CDMO — pure contract manufacturing vs full development + manufacturing partnership. When each model fits (early-stage vs commercial, single-molecule vs pipeline). https://www.longshineboitech.com/news/2026-08-25-crystalline-vs-amorphous-api-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Crystalline vs Amorphous API — Formulation Impact Crystalline vs amorphous API forms have dramatically different solubility, bioavailability, and stability profiles. https://www.longshineboitech.com/news/2026-11-13-market-note-nootropic-api-regulation-is-splitting-into-us-eu-apac-tra https://www.longshineboitech.com/product-images/research-chemical.jpg Market Note — Nootropic API regulation is splitting into US / EU / APAC tracks (USA angle) Nootropic API regulation is splitting into US / EU / APAC tracks. This Friday market note unpacks what that means for United States procurement teams sourcing from Indian API manufacturers, with speci https://www.longshineboitech.com/news/2027-01-26-iran-api-importation-sanction-compliant-procurement-routes-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg Iran API Importation — Sanction-Compliant Procurement Routes — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of Iran API Im https://www.longshineboitech.com/news/2026-07-21-ich-q3d-elemental-impurities-us-implementation-status-usa-buyer-s-bri https://www.longshineboitech.com/product-images/human-api-powder.jpg ICH Q3D Elemental Impurities — US Implementation Status — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of ICH Q3D Elemental Impurities — US https://www.longshineboitech.com/news/2026-08-20-reference-standards-usp-vs-in-house-2026 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg Reference Standards Procurement — USP vs In-House Reference standard selection — USP/Ph. Eur. Official Standards vs qualified in-house Working Standards. Timeline, cost, and applicability for QC method validation. https://www.longshineboitech.com/news/2027-04-21-endocrine-hormonal-api-sourcing-in-gcc-levant-portfolio-regulatory-ma https://www.longshineboitech.com/product-images/human-api-powder.jpg Endocrine & Hormonal API Sourcing in GCC + Levant — Portfolio & Regulatory Map Endocrine & Hormonal formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Endocrine & H https://www.longshineboitech.com/news/2026-09-17-supplier-audit-travel-free-how-remote-gmp-audits-actually-work-usa-pr https://www.longshineboitech.com/product-images/human-api-powder.jpg Supplier Audit Travel-Free — How Remote GMP Audits Actually Work — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2027-01-17-microcrystalline-cellulose-grades-ph101-vs-ph102-vs-ph200 https://www.longshineboitech.com/product-images/excipient-powder.jpg Microcrystalline Cellulose Grades: PH-101 vs PH-102 vs PH-200 for Tablet Formulation Microcrystalline cellulose (MCC, CAS 9004-34-6) is the workhorse filler-binder in direct-compression tableting. Grade selection - PH-101, PH-102, PH-200, PH-301 - changes tablet hardness, disintegrati https://www.longshineboitech.com/news/2026-10-05-kpv-peptide-lys-pro-val-cas-47931-85-1-gcc-levant-supplier-guide-pric https://www.longshineboitech.com/product-images/peptide-vial.jpg KPV Peptide (Lys-Pro-Val) (CAS 47931-85-1) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade KPV Peptide (LysProVal) (CAS 47931851) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East https://www.longshineboitech.com/news/2027-05-02-faq-sourcing-sulfadiazine-into-eu-uk https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg FAQ — Sourcing Sulfadiazine into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing veterinary apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2027-05-01-capability-brief-solvent-recovery-loop-how-we-cut-process-solvent-pur https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Solvent Recovery Loop — How We Cut Process Solvent Purchasing 30% (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Solvent Recovery Loop — How We Cut Process Solvent Purchasin https://www.longshineboitech.com/news/2026-11-17-eudamed-udi-when-api-suppliers-get-pulled-in-eu-uk-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg EUDAMED + UDI — When API Suppliers Get Pulled In — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of EUDAMED + UDI — When API S https://www.longshineboitech.com/news/2026-08-12-diabetes-metabolic-api-sourcing-in-gcc-levant-portfolio-regulatory-ma https://www.longshineboitech.com/product-images/human-api-powder.jpg Diabetes & Metabolic API Sourcing in GCC + Levant — Portfolio & Regulatory Map Diabetes & Metabolic formulators in Middle East routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Diabetes & Me https://www.longshineboitech.com/news/2026-12-07-methotrexate-cas-59-05-2-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Methotrexate (CAS 59-05-2) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Methotrexate (CAS 59052) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers and a https://www.longshineboitech.com/news/2027-02-01-ethylcellulose-cas-9004-57-3-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/excipient-powder.jpg Ethylcellulose (CAS 9004-57-3) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Ethylcellulose (CAS 9004573) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers a https://www.longshineboitech.com/news/2027-01-31-faq-sourcing-florfenicol-into-usa https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg FAQ — Sourcing Florfenicol into USA Longtail FAQs we get every week from United States procurement teams sourcing veterinary apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Go https://www.longshineboitech.com/news/2027-01-10-faq-sourcing-l-tryptophan-into-eu-uk https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing L-Tryptophan into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing amino acids. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Ove https://www.longshineboitech.com/news/2026-07-14-atorvastatin-api-sourcing-lipid-lowering-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Atorvastatin API Sourcing — Statin Manufacturing at Scale Atorvastatin sourcing for generic-drug developers — polymorph control (Form I vs Form IV), USP monograph specifications, and multi-ton commercial capacity. https://www.longshineboitech.com/news/2027-04-20-moh-uae-pharmaceutical-manufacturer-registration-gcc-levant-buyer-s-b https://www.longshineboitech.com/product-images/human-api-powder.jpg MOH UAE Pharmaceutical Manufacturer Registration — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of MOH UAE Pha https://www.longshineboitech.com/news/2026-07-16-valsartan-api-ndma-control-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Valsartan API — NDMA Control Under FDA Guidance Valsartan sourcing after the 2018 nitrosamine recall — how the sartan class is now manufactured with NDMA control per FDA + EMA guidance and ICH M7. https://www.longshineboitech.com/news/2027-05-06-api-coa-review-what-sourcing-teams-should-catch-before-approving-lots https://www.longshineboitech.com/product-images/human-api-powder.jpg API CoA Review — What Sourcing Teams Should Catch Before Approving Lots — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-06-29-anti-aging-peptides https://www.longshineboitech.com/news-images/news-sustainability.jpg Anti-aging Peptides Anti-aging Peptides — what SNAP-8 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-05-14-market-note-nootropic-api-regulation-is-splitting-into-us-eu-apac-tra https://www.longshineboitech.com/product-images/research-chemical.jpg Market Note — Nootropic API regulation is splitting into US / EU / APAC tracks (LATAM angle) Nootropic API regulation is splitting into US / EU / APAC tracks. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with speci https://www.longshineboitech.com/news/2026-06-03-gastrointestinal-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Gastrointestinal API Sourcing in EU + UK — Portfolio & Regulatory Map Gastrointestinal formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Gastrointestinal portf https://www.longshineboitech.com/news/2026-12-25-market-note-companion-animal-pharma-is-outpacing-human-generics-growt https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Companion-animal pharma is outpacing human generics growth (LATAM angle) Companionanimal pharma is outpacing human generics growth. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with specifics ar https://www.longshineboitech.com/news/2026-05-26-fda-dmf-type-ii-filing-2026-procedural-updates-for-foreign-api-sites- https://www.longshineboitech.com/product-images/human-api-powder.jpg FDA DMF Type II Filing — 2026 Procedural Updates for Foreign API Sites — USA Buyer's Brief TL;DR. FDA compliance is the single largest determinant of API supplier viability in the United States market. This post walks through the practical implementation of FDA DMF Type II Filing — 2026 Pro https://www.longshineboitech.com/news/2026-07-20-ivermectin-cas-70288-86-7-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Ivermectin (CAS 70288-86-7) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Ivermectin (CAS 70288867) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers and https://www.longshineboitech.com/news/2027-03-12-market-note-continuous-flow-manufacturing-is-moving-from-pilot-to-com https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Continuous-flow manufacturing is moving from pilot to commercial (EU + UK angle) Continuousflow manufacturing is moving from pilot to commercial. This Friday market note unpacks what that means for Europe procurement teams sourcing from Indian API manufacturers, with specifics aro https://www.longshineboitech.com/news/2026-12-21-ethyl-4-chloroacetoacetate-cas-638-07-3-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/intermediate-powder.jpg Ethyl 4-Chloroacetoacetate (CAS 638-07-3) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Ethyl 4Chloroacetoacetate (CAS 638073) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin Americ https://www.longshineboitech.com/news/2026-07-18-anastrozole-generic-arimidex-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Anastrozole Generic Market — Post-Arimidex Landscape Anastrozole came off-patent in 2010 (Arimidex US) and generic API demand has grown steadily. Current DMF holders + emerging market opportunities. https://www.longshineboitech.com/news/2026-10-20-nitrosamine-step-2-risk-evaluation-ema-deadlines-for-2026-eu-uk-buyer https://www.longshineboitech.com/product-images/human-api-powder.jpg Nitrosamine Step 2 Risk Evaluation — EMA Deadlines for 2026 — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of Nitrosamine Step 2 Risk Ev https://www.longshineboitech.com/news/2027-01-04-b7-33-cas-1350456-56-2-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/peptide-vial.jpg B7-33 (CAS 1350456-56-2) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade B733 (CAS 1350456562) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers and a cu https://www.longshineboitech.com/news/2027-03-25-coa-cos-cep-document-stack-every-buyer-should-demand-gcc-levant-procu https://www.longshineboitech.com/product-images/human-api-powder.jpg CoA + CoS + CEP — Document Stack Every Buyer Should Demand — GCC + Levant Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Middle East requires a procurement playbook adapted to SFDA / MOH UAE / EDA / JFDA expectations. This post is a practical howto — written fo https://www.longshineboitech.com/news/2027-01-20-anti-infective-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Anti-Infective API Sourcing in LATAM — Portfolio & Regulatory Map AntiInfective formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech AntiInfective port https://www.longshineboitech.com/news/2026-07-20-tamoxifen-adjuvant-vs-atas-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Tamoxifen vs Aromatase Inhibitors — Adjuvant Choice How ATAS + BIG 1-98 + TEAM trials shifted adjuvant preference from tamoxifen alone to sequential AI or upfront AI for postmenopausal patients. https://www.longshineboitech.com/news/2027-01-18-monensin-sodium-cas-22373-78-0-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Monensin Sodium (CAS 22373-78-0) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Monensin Sodium (CAS 22373780) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buyers https://www.longshineboitech.com/news/2026-07-22-finasteride-hair-loss-market-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Finasteride Market — Hair Loss + BPH Dual Demand Telehealth prescribing has expanded finasteride 1mg (Propecia generic) access dramatically. API volume implications + supply security considerations. https://www.longshineboitech.com/news/2026-07-17-market-note-biosimilar-api-spend-is-set-to-overtake-small-molecule-by https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Biosimilar API spend is set to overtake small-molecule by 2028 (GCC + Levant angle) Biosimilar API spend is set to overtake smallmolecule by 2028. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specifics https://www.longshineboitech.com/news/2026-07-23-metformin-nitrosamine-recall-history-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Metformin Nitrosamine Recall — Industry Lessons The 2019-2020 metformin nitrosamine recall reshaped API manufacturing controls for the highest-volume oral antidiabetic globally. https://www.longshineboitech.com/news/2026-10-12-tadalafil-cas-171596-29-5-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/research-chemical.jpg Tadalafil (CAS 171596-29-5) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Tadalafil (CAS 171596295) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers and https://www.longshineboitech.com/news/2027-03-29-n-acetyl-l-cysteine-nac-cas-616-91-1-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg N-Acetyl-L-Cysteine (NAC) (CAS 616-91-1) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade NAcetylLCysteine (NAC) (CAS 616911) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States b https://www.longshineboitech.com/news/2026-08-17-cold-chain-peptide-shipping-2026 https://www.longshineboitech.com/news-images/news-sustainability.jpg Cold Chain vs Ambient API Shipping — Peptide Logistics Peptide cold chain logistics — validated temperature-controlled shippers for 2-8°C and -20°C, 96h/120h profiles, and IATA-CEIV Pharma-certified freight. https://www.longshineboitech.com/news/2026-11-16-chloroquine-phosphate-cas-50-63-5-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Chloroquine Phosphate (CAS 50-63-5) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Chloroquine Phosphate (CAS 50635) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and https://www.longshineboitech.com/news/2026-07-26-sermorelin-diagnostic-workup-ghd-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Sermorelin in GHD Diagnosis — Diagnostic Peptide API Sermorelin (GHRH 1-29) diagnostic testing for GHD in children + adults. Peptide API supply and synthesis technology. https://www.longshineboitech.com/news/2026-07-24-buprenorphine-oud-supply-security-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Buprenorphine API — OUD Treatment Supply Security X-waiver removal (2023) expanded buprenorphine prescribing eligibility. Downstream API demand implications for OUD treatment programs. https://www.longshineboitech.com/news/2026-07-14-oncology-api-sourcing-cytotoxic-containment-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Oncology API Sourcing — Cytotoxic Containment Manufacturing How to source cytotoxic oncology APIs — dedicated containment facilities, cross-contamination prevention per EMA/CHMP/CVMP/SWP/169430/2012, and ICH M7 PMI control. https://www.longshineboitech.com/news/2027-02-18-dmf-letter-of-authorization-when-to-ask-how-to-use-latam-procurement- https://www.longshineboitech.com/product-images/human-api-powder.jpg DMF Letter of Authorization — When to Ask, How to Use — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-10-22-spot-buy-vs-annual-tender-frame-pricing-risk-like-a-cfo-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Spot-Buy vs Annual Tender — Frame Pricing Risk Like a CFO — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2027-01-25-best-supplier-levothyroxine-2026 https://www.longshineboitech.com/product-images/human-api-powder.jpg Best Supplier for Levothyroxine API in 2026: Buyer's Checklist Selecting a Levothyroxine manufacturer is not only about the lowest per-kilo price. Below is the 8-point checklist procurement managers should run through before signing a supply agreement. https://www.longshineboitech.com/news/2026-09-14-oxiracetam-cas-62613-82-5-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/research-chemical.jpg Oxiracetam (CAS 62613-82-5) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Oxiracetam (CAS 62613825) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers and https://www.longshineboitech.com/news/2026-10-11-faq-sourcing-l-lysine-hcl-into-usa https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing L-Lysine HCl into USA Longtail FAQs we get every week from United States procurement teams sourcing amino acids. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-07-29-india-to-eu-api-procurement-timeline-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg India-to-EU API Procurement — Timeline + QP Workflow Full India-to-EU API procurement timeline — RFQ, sample analytics, QP audit, contract, first batch, ongoing QP release with change notification. https://www.longshineboitech.com/news/2026-09-16-diabetes-metabolic-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Diabetes & Metabolic API Sourcing in USA — Portfolio & Regulatory Map Diabetes & Metabolic formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Diabetes & https://www.longshineboitech.com/news/2026-11-02-sorbitol-cas-50-70-4-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/excipient-powder.jpg Sorbitol (CAS 50-70-4) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Sorbitol (CAS 50704) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers and a curre https://www.longshineboitech.com/news/2027-03-06-capability-brief-hot-melt-extrusion-bridging-api-and-excipient-capabi https://www.longshineboitech.com/product-images/excipient-powder.jpg Capability Brief — Hot-Melt Extrusion — Bridging API and Excipient Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers HotMelt Extrusion — Bridging API and Excipient Capability — https://www.longshineboitech.com/news/2026-07-28-dapoxetine-pe-treatment-market-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg Dapoxetine PE Treatment — International Market Analysis Dapoxetine is approved in EU, LATAM, and most APAC markets but not FDA-approved. Regional API supply for the ~65 country market. https://www.longshineboitech.com/news/2026-08-23-in-house-lab-vs-third-party-testing-2026 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg In-House Analytical Lab vs Third-Party Testing API analytical strategy — in-house lab vs third-party contract testing. Regulatory acceptance (USP <1058> AIQ), cost trade-offs, and capability scoping. https://www.longshineboitech.com/news/2026-08-01-india-to-brazil-anvisa-api-timeline-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg India-to-Brazil ANVISA API Timeline — DIFA Registration Brazilian pharma market for Indian APIs — DIFA dossier requirements, ANVISA timeline, and regional LATAM expansion path. https://www.longshineboitech.com/news/2027-05-03-sorbitol-cas-50-70-4-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/excipient-powder.jpg Sorbitol (CAS 50-70-4) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Sorbitol (CAS 50704) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a current in https://www.longshineboitech.com/news/2026-07-17-ozempic-generic-semaglutide-market-2027 https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg The Post-Ozempic Semaglutide Generic Market — Preparing for 2031 Semaglutide patent expiration in most markets is 2031-2033. Generic API developers are already positioning DMF filings and pilot manufacturing. https://www.longshineboitech.com/news/2027-01-25-loratadine-cas-79794-75-5-gcc-levant-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Loratadine (CAS 79794-75-5) — GCC + Levant Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Loratadine (CAS 79794755) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Middle East buyers and a https://www.longshineboitech.com/news/2027-05-05-gastrointestinal-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Gastrointestinal API Sourcing in EU + UK — Portfolio & Regulatory Map Gastrointestinal formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Gastrointestinal portf https://www.longshineboitech.com/news/2027-05-13-dmf-letter-of-authorization-when-to-ask-how-to-use-latam-procurement- https://www.longshineboitech.com/product-images/human-api-powder.jpg DMF Letter of Authorization — When to Ask, How to Use — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-09-24-two-source-strategy-for-critical-apis-cost-vs-risk-math-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Two-Source Strategy for Critical APIs — Cost vs Risk Math — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-11-26-dmf-letter-of-authorization-when-to-ask-how-to-use-latam-procurement- https://www.longshineboitech.com/product-images/human-api-powder.jpg DMF Letter of Authorization — When to Ask, How to Use — LATAM Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Latin America requires a procurement playbook adapted to ANVISA / COFEPRIS / ANMAT / INVIMA / ISP expectations. This post is a practical how https://www.longshineboitech.com/news/2026-08-24-generic-vs-brand-reference-impurity-2026 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Generic API vs Brand Reference — Impurity Profile Differences Generic vs brand API impurity profile comparison — how process route differences affect impurity spectrum, and EMA/FDA acceptance criteria under ICH Q3A/M7. https://www.longshineboitech.com/news/2026-08-04-india-to-turkey-titck-api-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg India-to-Turkey TITCK API Timeline Turkish pharma market for Indian APIs — TITCK registration process, EU-alignment status, and generic manufacturing landscape. https://www.longshineboitech.com/news/2027-04-03-capability-brief-microbial-limit-testing-in-house-usp-61-62-capabilit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Microbial Limit Testing — In-House USP <61>/<62> Capability (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Microbial Limit Testing — InHouse USP <61/<62 Capability — w https://www.longshineboitech.com/news/2027-03-04-supplier-audit-travel-free-how-remote-gmp-audits-actually-work-usa-pr https://www.longshineboitech.com/product-images/human-api-powder.jpg Supplier Audit Travel-Free — How Remote GMP Audits Actually Work — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2027-02-26-market-note-glp-1-receptor-agonists-are-now-the-1-driver-of-peptide-a https://www.longshineboitech.com/product-images/peptide-vial.jpg Market Note — GLP-1 receptor agonists are now the #1 driver of peptide API demand (GCC + Levant angle) GLP1 receptor agonists are now the 1 driver of peptide API demand. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specif https://www.longshineboitech.com/news/2026-08-07-india-to-south-africa-sahpra-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg India-to-South Africa SAHPRA API Registration South African + broader African market for Indian APIs — SAHPRA registration + ZAZIBONA regional harmonization. https://www.longshineboitech.com/news/2026-08-08-ich-q11-ksm-selection-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg ICH Q11 KSM Selection — API Manufacturing Boundary ICH Q11 defines the boundary between commercial starting material and GMP-regulated API manufacturing. KSM selection has real implications. https://www.longshineboitech.com/news/2026-07-15-rosuvastatin-api-manufacturing-crestor-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Rosuvastatin Calcium API — Second-Generation Statin Manufacturing Rosuvastatin sourcing — chiral synthesis, Ph. Eur. specifications, and generic bioequivalence reference batches for post-Crestor patent-expiry markets. https://www.longshineboitech.com/news/2026-07-19-letrozole-fertility-off-label-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Letrozole for Ovulation Induction — Off-Label Use Growing Recent evidence favors letrozole over clomiphene for PCOS ovulation induction. This shift is reshaping API demand for fertility applications. https://www.longshineboitech.com/news/2026-07-23-api-stability-data-packages-what-24-month-accelerated-should-actually https://www.longshineboitech.com/product-images/human-api-powder.jpg API Stability Data Packages — What "24-Month Accelerated" Should Actually Include — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2027-04-16-market-note-biosimilar-api-spend-is-set-to-overtake-small-molecule-by https://www.longshineboitech.com/product-images/human-api-powder.jpg Market Note — Biosimilar API spend is set to overtake small-molecule by 2028 (LATAM angle) Biosimilar API spend is set to overtake smallmolecule by 2028. This Friday market note unpacks what that means for Latin America procurement teams sourcing from Indian API manufacturers, with specific https://www.longshineboitech.com/news/2026-06-02-ema-variation-classification-guideline-type-ia-ib-ii-for-apis-eu-uk-b https://www.longshineboitech.com/product-images/human-api-powder.jpg EMA Variation Classification Guideline — Type IA/IB/II for APIs — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of EMA Variation Classificati https://www.longshineboitech.com/news/2027-03-28-faq-sourcing-phenylpiracetam-into-usa https://www.longshineboitech.com/product-images/research-chemical.jpg FAQ — Sourcing Phenylpiracetam into USA Longtail FAQs we get every week from United States procurement teams sourcing nootropics. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-12-13-faq-sourcing-cyclophosphamide-into-eu-uk https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Cyclophosphamide into EU + UK Longtail FAQs we get every week from Europe procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI Over https://www.longshineboitech.com/news/2027-01-06-diabetes-metabolic-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Diabetes & Metabolic API Sourcing in USA — Portfolio & Regulatory Map Diabetes & Metabolic formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Diabetes & https://www.longshineboitech.com/news/2026-08-15-ich-q10-quality-system-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg ICH Q10 Pharmaceutical Quality System — API ICH Q10 provides the PQS framework beyond ICH Q7 basic GMP. Continuous improvement + management review at the API site. https://www.longshineboitech.com/news/2027-01-03-faq-sourcing-ethyl-cyanoacetate-into-usa https://www.longshineboitech.com/product-images/intermediate-powder.jpg FAQ — Sourcing Ethyl Cyanoacetate into USA Longtail FAQs we get every week from United States procurement teams sourcing intermediates. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Goog https://www.longshineboitech.com/news/2026-07-25-levothyroxine-stability-packaging-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Levothyroxine Stability — Moisture Control in Packaging Levothyroxine potency loss under humidity is a known API stability challenge. Packaging validation + moisture control per USP monograph. https://www.longshineboitech.com/news/2026-08-11-anda-paragraph-iv-litigation-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg ANDA Paragraph IV Certification — API Perspective Paragraph IV ANDAs challenge listed patents. The API development timeline shifts significantly with a Paragraph IV strategy. https://www.longshineboitech.com/news/2026-08-14-ich-q9-quality-risk-management-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg ICH Q9 Quality Risk Management — API Applications ICH Q9 provides the risk-management framework increasingly required in API GMP. FMEA, FTA, and HACCP integration. https://www.longshineboitech.com/news/2026-08-12-diclofenac-sodium-nsaid-bulk-2026 https://www.longshineboitech.com/news-images/news-iso-certification.jpg Diclofenac Sodium Manufacturing — NSAID Bulk API Diclofenac sodium bulk API — high-volume NSAID manufacturing, USP/EP/JP compendial coverage, and injectable + topical + oral grade documentation. https://www.longshineboitech.com/news/2026-08-18-usp-1058-analytical-instrument-qualification-2027 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg USP <1058> Analytical Instrument Qualification USP <1058> provides the AIQ framework (DQ + IQ + OQ + PQ) for analytical instruments in pharmaceutical QC labs. https://www.longshineboitech.com/news/2026-12-17-two-source-strategy-for-critical-apis-cost-vs-risk-math-eu-uk-procure https://www.longshineboitech.com/product-images/human-api-powder.jpg Two-Source Strategy for Critical APIs — Cost vs Risk Math — EU + UK Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into Europe requires a procurement playbook adapted to EDQM / EMA / MHRA expectations. This post is a practical howto — written for procurement l https://www.longshineboitech.com/news/2026-12-04-market-note-antibiotic-stewardship-is-reshaping-anti-infective-api-fo https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Market Note — Antibiotic stewardship is reshaping anti-infective API forecasts (GCC + Levant angle) Antibiotic stewardship is reshaping antiinfective API forecasts. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with specific https://www.longshineboitech.com/news/2026-10-21-anti-infective-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Anti-Infective API Sourcing in EU + UK — Portfolio & Regulatory Map AntiInfective formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech AntiInfective portfolio a https://www.longshineboitech.com/news/2026-08-20-ich-q3d-elemental-impurities-implementation-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg ICH Q3D Elemental Impurities — Full Implementation ICH Q3D has replaced traditional heavy-metals testing (USP <231>) with risk-based elemental impurities framework. https://www.longshineboitech.com/news/2026-10-19-carprofen-cas-53716-49-7-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Carprofen (CAS 53716-49-7) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Carprofen (CAS 53716497) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a curren https://www.longshineboitech.com/news/2026-07-21-tadalafil-daily-vs-on-demand-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Tadalafil Daily vs On-Demand — Market Dynamics Tadalafil 5mg daily (Cialis Daily) gaining share vs on-demand. Combined ED + BPH indication driving multi-therapeutic API demand. https://www.longshineboitech.com/news/2027-04-05-humanin-cas-330936-69-1-eu-uk-supplier-guide-pricing https://www.longshineboitech.com/product-images/peptide-vial.jpg Humanin (CAS 330936-69-1) — EU + UK Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Humanin (CAS 330936691) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Europe buyers and a current https://www.longshineboitech.com/news/2026-08-17-ich-q14-analytical-procedure-development-2027 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg ICH Q14 Analytical Procedure Development — API ICH Q14 (2023) introduces enhanced analytical procedure development. Impact on API QC method design + validation strategy. https://www.longshineboitech.com/news/2026-07-31-india-to-japan-pmda-api-timeline-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg India-to-Japan PMDA API Timeline — MF Registration Japanese pharma market entry for Indian APIs — PMDA MF registration, J-NDA cross-reference, and specific regulatory nuances. https://www.longshineboitech.com/news/2027-02-10-anti-infective-api-sourcing-in-eu-uk-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Anti-Infective API Sourcing in EU + UK — Portfolio & Regulatory Map AntiInfective formulators in Europe routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech AntiInfective portfolio a https://www.longshineboitech.com/news/2026-08-27-lyophilised-vs-crystalline-peptide-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Lyophilised vs Crystalline Peptide API Peptide APIs are typically supplied as lyophilised powder — but crystalline peptide forms are emerging with better stability. https://www.longshineboitech.com/news/2027-04-26-romidepsin-cas-128517-07-7-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Romidepsin (CAS 128517-07-7) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Romidepsin (CAS 128517077) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buyers and https://www.longshineboitech.com/news/2026-08-22-capability-brief-solvent-recovery-loop-how-we-cut-process-solvent-pur https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — Solvent Recovery Loop — How We Cut Process Solvent Purchasing 30% (EU + UK customers) Longshine BoiTech's manufacturing capability for Europe customers extends beyond catalogue chemistry. This Saturday capability brief covers Solvent Recovery Loop — How We Cut Process Solvent Purchasin https://www.longshineboitech.com/news/2026-06-29-peptides-in-cosmetics https://www.longshineboitech.com/news-images/news-sustainability.jpg Peptides in Cosmetics Peptides in Cosmetics — what Matrixyl 3000 is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2027-02-23-neom-vision-2030-pharmaceutical-manufacturing-incentives-gcc-levant-b https://www.longshineboitech.com/product-images/human-api-powder.jpg NEOM & Vision 2030 — Pharmaceutical Manufacturing Incentives — GCC + Levant Buyer's Brief TL;DR. SFDA / MOH UAE / EDA / JFDA compliance is the single largest determinant of API supplier viability in the Middle East market. This post walks through the practical implementation of NEOM & Visi https://www.longshineboitech.com/news/2027-04-28-diabetes-metabolic-api-sourcing-in-usa-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Diabetes & Metabolic API Sourcing in USA — Portfolio & Regulatory Map Diabetes & Metabolic formulators in United States routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Diabetes & https://www.longshineboitech.com/news/2026-10-28-gastrointestinal-api-sourcing-in-latam-portfolio-regulatory-map https://www.longshineboitech.com/product-images/human-api-powder.jpg Gastrointestinal API Sourcing in LATAM — Portfolio & Regulatory Map Gastrointestinal formulators in Latin America routinely face two procurement challenges: catalogue depth and regulatory documentation depth. This buyer guide maps the Longshine BoiTech Gastrointestina https://www.longshineboitech.com/news/2026-09-01-anvisa-rdc-658-2022-gmp-update-impact-on-api-imports-latam-buyer-s-br https://www.longshineboitech.com/product-images/human-api-powder.jpg ANVISA RDC 658/2022 — GMP Update Impact on API Imports — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2026-08-13-ema-annex-1-sterile-manufacturing-2027 https://www.longshineboitech.com/news-images/news-iso-certification.jpg EMA Annex 1 Sterile Manufacturing — API Implications Revised Annex 1 (2022) impacts sterile drug product manufacturing. API suppliers to parenteral finished-drug makers face downstream requirements. https://www.longshineboitech.com/news/2026-07-27-triptorelin-prostate-cancer-adt-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg Triptorelin ADT — Prostate Cancer Peptide Therapy Triptorelin (Trelstar) as GnRH agonist for advanced prostate cancer androgen deprivation therapy. Peptide API supply landscape. https://www.longshineboitech.com/news/2026-08-06-india-to-vietnam-dav-api-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg India-to-Vietnam DAV API Registration Vietnamese pharma market for Indian APIs — DAV registration, ASEAN mutual recognition, and regional distribution hub. https://www.longshineboitech.com/news/2026-09-01-domestic-vs-import-api-2027 https://www.longshineboitech.com/news-images/news-sustainability.jpg Domestic vs Import API — TCO Analysis Post-COVID emphasis on domestic API supply competes with lower-cost imported API. TCO analysis + risk framework. https://www.longshineboitech.com/news/2026-06-29-cagrilintide-and-weight-management https://www.longshineboitech.com/news-images/news-veterinary-apis.jpg Cagrilintide and Weight Management Cagrilintide and Weight Management — what Cagrilintide is and how Longshine Boi-Tech supports buyer programmes from Pune, India. https://www.longshineboitech.com/news/2026-11-06-market-note-eudragit-and-hpmc-supply-realignment-is-forcing-reformula https://www.longshineboitech.com/product-images/excipient-powder.jpg Market Note — Eudragit and HPMC supply realignment is forcing reformulation decisions (GCC + Levant angle) Eudragit and HPMC supply realignment is forcing reformulation decisions. This Friday market note unpacks what that means for Middle East procurement teams sourcing from Indian API manufacturers, with https://www.longshineboitech.com/news/2026-08-23-dmf-vs-cep-vs-asmf-comparison-2027 https://www.longshineboitech.com/news-images/news-fda-regulatory.jpg DMF vs CEP vs ASMF — Regional Dossier Choice The three primary API dossier formats (FDA DMF, EDQM CEP, EU ASMF) have different scope, cost, timeline. Selecting the right combination. https://www.longshineboitech.com/news/2027-05-04-annex-1-sterile-manufacturing-api-implications-eu-uk-buyer-s-brief https://www.longshineboitech.com/product-images/human-api-powder.jpg Annex 1 Sterile Manufacturing — API Implications — EU + UK Buyer's Brief TL;DR. EDQM / EMA / MHRA compliance is the single largest determinant of API supplier viability in the Europe market. This post walks through the practical implementation of Annex 1 Sterile Manufactur https://www.longshineboitech.com/news/2027-04-29-how-to-qualify-an-indian-api-supplier-in-90-days-a-buyer-s-checklist- https://www.longshineboitech.com/product-images/human-api-powder.jpg How to Qualify an Indian API Supplier in 90 Days — A Buyer's Checklist — USA Procurement Playbook Sourcing pharmaceutical APIs from Indian manufacturers into United States requires a procurement playbook adapted to FDA expectations. This post is a practical howto — written for procurement leads at https://www.longshineboitech.com/news/2026-11-09-edoxaban-tosylate-cas-480449-71-6-usa-supplier-guide-pricing https://www.longshineboitech.com/product-images/human-api-powder.jpg Edoxaban Tosylate (CAS 480449-71-6) — USA Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Edoxaban Tosylate (CAS 480449716) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to United States buy https://www.longshineboitech.com/news/2026-08-09-faq-sourcing-bupivacaine-hcl-into-gcc-levant https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Bupivacaine HCl into GCC + Levant Longtail FAQs we get every week from Middle East procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google AI https://www.longshineboitech.com/news/2026-08-02-india-to-gcc-sfda-api-timeline-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg India-to-GCC SFDA API Timeline — Saudi + UAE Route GCC region API supply for Indian manufacturers — SFDA Saudi + MOH UAE + Kuwait/Bahrain harmonization + centralized GCC drug registration. https://www.longshineboitech.com/news/2027-05-11-anvisa-rdc-658-2022-gmp-update-impact-on-api-imports-latam-buyer-s-br https://www.longshineboitech.com/product-images/human-api-powder.jpg ANVISA RDC 658/2022 — GMP Update Impact on API Imports — LATAM Buyer's Brief TL;DR. ANVISA / COFEPRIS / ANMAT / INVIMA / ISP compliance is the single largest determinant of API supplier viability in the Latin America market. This post walks through the practical implementation https://www.longshineboitech.com/news/2027-05-15-capability-brief-gmp-container-closure-qualification-for-light-sensit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — GMP Container Closure Qualification for Light-Sensitive APIs (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers GMP Container Closure Qualification for LightSensitive https://www.longshineboitech.com/news/2026-10-31-capability-brief-ich-q11-starting-material-justification-how-we-docum https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — ICH Q11 Starting Material Justification — How We Document It (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers ICH Q11 Starting Material Justification — How We Docume https://www.longshineboitech.com/news/2026-11-28-capability-brief-gmp-container-closure-qualification-for-light-sensit https://www.longshineboitech.com/product-images/human-api-powder.jpg Capability Brief — GMP Container Closure Qualification for Light-Sensitive APIs (GCC + Levant customers) Longshine BoiTech's manufacturing capability for Middle East customers extends beyond catalogue chemistry. This Saturday capability brief covers GMP Container Closure Qualification for LightSensitive https://www.longshineboitech.com/news/2026-08-30-small-molecule-vs-biologics-cdmo-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg Small Molecule vs Biologics CDMO Selection Small molecule CDMO and biologics CDMO capabilities barely overlap. Selecting the right partner by molecule type. https://www.longshineboitech.com/news/2027-04-12-cannabigerol-cbg-cas-25654-31-3-latam-supplier-guide-pricing https://www.longshineboitech.com/product-images/research-chemical.jpg Cannabigerol (CBG) (CAS 25654-31-3) — LATAM Supplier Guide & Pricing Longshine BoiTech supplies pharmaceuticalgrade Cannabigerol (CBG) (CAS 25654313) from our WHOGMP and ISO 9001:2015 certified site in Pune, India — with regulatory support tailored to Latin America buy https://www.longshineboitech.com/news/2026-11-22-faq-sourcing-spironolactone-into-latam https://www.longshineboitech.com/product-images/human-api-powder.jpg FAQ — Sourcing Spironolactone into LATAM Longtail FAQs we get every week from Latin America procurement teams sourcing human apis. Each answer below is structured for direct citation by AI answer engines (ChatGPT, Claude, Perplexity, Google https://www.longshineboitech.com/news/2026-08-10-edqm-cep-suspended-status-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg EDQM CEP Suspended Status — Recovery Path When EDQM suspends a CEP, downstream MA holders face immediate supply-continuity questions. Recovery path + risk mitigation. https://www.longshineboitech.com/news/2026-08-19-usp-1225-validation-compendial-2027 https://www.longshineboitech.com/news-images/news-laboratory-accreditation.jpg USP <1225> Validation of Compendial Procedures USP <1225> defines the validation characteristics required for compendial analytical procedures — the baseline API QC method framework. https://www.longshineboitech.com/news/2026-08-03-india-to-mexico-cofepris-api-2027 https://www.longshineboitech.com/news-images/news-european-partnership.jpg India-to-Mexico COFEPRIS API Timeline Mexican pharma market for Indian API suppliers — COFEPRIS Sanitary Registration, timeline, and regulatory landscape. https://www.longshineboitech.com/news/2026-08-05-india-to-russia-roszdravnadzor-2027 https://www.longshineboitech.com/news-images/news-manufacturing-expansion.jpg India-to-Russia Roszdravnadzor API Timeline Russian + EAEU pharma market for Indian APIs — regulatory workflow, sanctions considerations, EAEU 5-country harmonization. https://www.longshineboitech.com/catalog/boldenone-undecylenate-equipoise-13103-34-9.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Boldenone Undecylenate (Equipoise) (CAS 13103-34-9) — pharmaceutical research chemicals Boldenone Undecylenate (Equipoise) — CAS 13103-34-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/coluracetam-135463-81-9.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Coluracetam (CAS 135463-81-9) — pharmaceutical nootropics Coluracetam — CAS 135463-81-9. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mesterolone-proviron-1424-00-6.html https://www.longshineboitech.com/product-images/research-chemical.jpg Mesterolone (Proviron) (CAS 1424-00-6) — pharmaceutical research chemicals Mesterolone (Proviron) — CAS 1424-00-6. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fmoc-cl-9-fluorenylmethyl-chloroformate-28920-43-6.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Fmoc-Cl (9-Fluorenylmethyl Chloroformate) (CAS 28920-43-6) — pharmaceutical intermediates Fmoc-Cl (9-Fluorenylmethyl Chloroformate) — CAS 28920-43-6. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/melphalan-148-82-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Melphalan (CAS 148-82-3) — pharmaceutical human apis Melphalan — CAS 148-82-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/crospovidone-25249-54-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Crospovidone (CAS 25249-54-1) — pharmaceutical excipients Crospovidone — CAS 25249-54-1. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/resveratrol-99-501-36-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Resveratrol (99%) (CAS 501-36-0) — pharmaceutical research chemicals Resveratrol (99%) — CAS 501-36-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/venetoclax-1257044-40-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Venetoclax (CAS 1257044-40-8) — pharmaceutical human apis Venetoclax — CAS 1257044-40-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nintedanib-esylate-656247-18-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Nintedanib Esylate (CAS 656247-18-6) — pharmaceutical human apis Nintedanib Esylate — CAS 656247-18-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/n-methyl-d-aspartate-nmda-6384-92-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg N-Methyl-D-Aspartate (NMDA) (CAS 6384-92-5) — pharmaceutical research chemicals N-Methyl-D-Aspartate (NMDA) — CAS 6384-92-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lidocaine-hcl-73-78-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Lidocaine HCl (CAS 73-78-9) — pharmaceutical human apis Lidocaine HCl — CAS 73-78-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ghrp-2-158861-67-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg GHRP-2 (CAS 158861-67-7) — pharmaceutical peptides GHRP-2 — CAS 158861-67-7. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/docetaxel-114977-28-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Docetaxel (CAS 114977-28-5) — pharmaceutical human apis Docetaxel — CAS 114977-28-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ritonavir-155213-67-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ritonavir (CAS 155213-67-5) — pharmaceutical human apis Ritonavir — CAS 155213-67-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/chloroquine-phosphate-50-63-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Chloroquine Phosphate (CAS 50-63-5) — pharmaceutical human apis Chloroquine Phosphate — CAS 50-63-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/4-chlorodehydromethyltestosterone-turinabol-2446-23-3.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 4-Chlorodehydromethyltestosterone (Turinabol) (CAS 2446-23-3) — pharmaceutical research chemicals 4-Chlorodehydromethyltestosterone (Turinabol) — CAS 2446-23-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/2-6-dichloropyridine-2402-78-0.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg 2,6-Dichloropyridine (CAS 2402-78-0) — pharmaceutical intermediates 2,6-Dichloropyridine — CAS 2402-78-0. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/idra-21-22503-72-6.html https://www.longshineboitech.com/product-images/research-chemical.jpg IDRA-21 (CAS 22503-72-6) — pharmaceutical nootropics IDRA-21 — CAS 22503-72-6. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/losartan-potassium-124750-99-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Losartan Potassium (CAS 124750-99-8) — pharmaceutical human apis Losartan Potassium — CAS 124750-99-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/macitentan-441798-33-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Macitentan (CAS 441798-33-0) — pharmaceutical human apis Macitentan — CAS 441798-33-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/carvedilol-72956-09-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Carvedilol (CAS 72956-09-3) — pharmaceutical human apis Carvedilol — CAS 72956-09-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-enanthate-315-37-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Testosterone Enanthate (CAS 315-37-7) — pharmaceutical research chemicals Testosterone Enanthate — CAS 315-37-7. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/melanotan-ii-121062-08-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Melanotan II (CAS 121062-08-6) — pharmaceutical peptides Melanotan II — CAS 121062-08-6. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ibrutinib-936563-96-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ibrutinib (CAS 936563-96-1) — pharmaceutical human apis Ibrutinib — CAS 936563-96-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cms-121-salk-INT-CMS-121.html https://www.longshineboitech.com/product-images/peptide-vial.jpg CMS-121 (Salk) (CAS INT-CMS-121) — pharmaceutical research chemicals CMS-121 (Salk) — CAS INT-CMS-121. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/anidulafungin-166663-25-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Anidulafungin (CAS 166663-25-8) — pharmaceutical human apis Anidulafungin — CAS 166663-25-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sermorelin-acetate-86168-78-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Sermorelin Acetate (CAS 86168-78-7) — pharmaceutical peptides Sermorelin Acetate — CAS 86168-78-7. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/caffeine-citrate-69-22-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Caffeine Citrate (CAS 69-22-7) — pharmaceutical human apis Caffeine Citrate — CAS 69-22-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/carprofen-53716-49-7.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Carprofen (CAS 53716-49-7) — pharmaceutical veterinary apis Carprofen — CAS 53716-49-7. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trenbolone-acetate-10161-34-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Trenbolone Acetate (CAS 10161-34-9) — pharmaceutical research chemicals Trenbolone Acetate — CAS 10161-34-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/etoposide-33419-42-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Etoposide (CAS 33419-42-0) — pharmaceutical human apis Etoposide — CAS 33419-42-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fenbendazole-43210-67-9.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Fenbendazole (CAS 43210-67-9) — pharmaceutical veterinary apis Fenbendazole — CAS 43210-67-9. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mots-c-1402836-58-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Mots-C (CAS 1402836-58-1) — pharmaceutical peptides Mots-C — CAS 1402836-58-1. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cyclophosphamide-6055-19-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Cyclophosphamide (CAS 6055-19-2) — pharmaceutical human apis Cyclophosphamide — CAS 6055-19-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/osimertinib-mesylate-1421373-66-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Osimertinib Mesylate (CAS 1421373-66-1) — pharmaceutical human apis Osimertinib Mesylate — CAS 1421373-66-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/omeprazole-73590-58-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Omeprazole (CAS 73590-58-6) — pharmaceutical human apis Omeprazole — CAS 73590-58-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pregabalin-148553-50-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Pregabalin (CAS 148553-50-8) — pharmaceutical human apis Pregabalin — CAS 148553-50-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/colloidal-silicon-dioxide-aerosil-7631-86-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Colloidal Silicon Dioxide (Aerosil) (CAS 7631-86-9) — pharmaceutical excipients Colloidal Silicon Dioxide (Aerosil) — CAS 7631-86-9. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trenbolone-base-10161-33-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Trenbolone Base (CAS 10161-33-8) — pharmaceutical research chemicals Trenbolone Base — CAS 10161-33-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/rifampicin-13292-46-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Rifampicin (CAS 13292-46-1) — pharmaceutical human apis Rifampicin — CAS 13292-46-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/abiraterone-acetate-154229-18-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Abiraterone Acetate (CAS 154229-18-2) — pharmaceutical human apis Abiraterone Acetate — CAS 154229-18-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tylosin-tartrate-1405-54-5.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Tylosin Tartrate (CAS 1405-54-5) — pharmaceutical veterinary apis Tylosin Tartrate — CAS 1405-54-5. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/acalabrutinib-1420477-60-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Acalabrutinib (CAS 1420477-60-6) — pharmaceutical human apis Acalabrutinib — CAS 1420477-60-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/neomycin-sulfate-1405-10-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Neomycin Sulfate (CAS 1405-10-3) — pharmaceutical human apis Neomycin Sulfate — CAS 1405-10-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vardenafil-hydrochloride-trihydrate-224785-91-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Vardenafil Hydrochloride Trihydrate (CAS 224785-91-5) — pharmaceutical human apis Vardenafil Hydrochloride Trihydrate — CAS 224785-91-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/levonorgestrel-797-63-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Levonorgestrel (CAS 797-63-7) — pharmaceutical human apis Levonorgestrel — CAS 797-63-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/regorafenib-755037-03-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Regorafenib (CAS 755037-03-7) — pharmaceutical human apis Regorafenib — CAS 755037-03-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ledipasvir-1256388-51-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ledipasvir (CAS 1256388-51-8) — pharmaceutical human apis Ledipasvir — CAS 1256388-51-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/d-4-hydroxyphenylglycine-22818-40-2.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg D-(-)-4-Hydroxyphenylglycine (CAS 22818-40-2) — pharmaceutical intermediates D-(-)-4-Hydroxyphenylglycine — CAS 22818-40-2. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trimethoprim-738-70-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Trimethoprim (CAS 738-70-5) — pharmaceutical veterinary apis Trimethoprim — CAS 738-70-5. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ara-290-906673-24-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg ARA-290 (CAS 906673-24-3) — pharmaceutical peptides ARA-290 — CAS 906673-24-3. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cephalexin-monohydrate-15686-71-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Cephalexin Monohydrate (CAS 15686-71-2) — pharmaceutical intermediates Cephalexin Monohydrate — CAS 15686-71-2. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tenofovir-disoproxil-fumarate-202138-50-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Tenofovir Disoproxil Fumarate (CAS 202138-50-9) — pharmaceutical human apis Tenofovir Disoproxil Fumarate — CAS 202138-50-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nandrolone-cypionate-601-63-8.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Nandrolone Cypionate (CAS 601-63-8) — pharmaceutical research chemicals Nandrolone Cypionate — CAS 601-63-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ceftaroline-fosamil-400827-46-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Ceftaroline Fosamil (CAS 400827-46-5) — pharmaceutical human apis Ceftaroline Fosamil — CAS 400827-46-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-decanoate-5721-91-5.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Testosterone Decanoate (CAS 5721-91-5) — pharmaceutical research chemicals Testosterone Decanoate — CAS 5721-91-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dexamethasone-50-02-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Dexamethasone (CAS 50-02-2) — pharmaceutical human apis Dexamethasone — CAS 50-02-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ranolazine-95635-55-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ranolazine (CAS 95635-55-5) — pharmaceutical human apis Ranolazine — CAS 95635-55-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-base-58-22-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Testosterone Base (CAS 58-22-0) — pharmaceutical research chemicals Testosterone Base — CAS 58-22-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/famotidine-76824-35-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Famotidine (CAS 76824-35-6) — pharmaceutical human apis Famotidine — CAS 76824-35-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vinblastine-sulfate-143-67-9.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Vinblastine Sulfate (CAS 143-67-9) — pharmaceutical human apis Vinblastine Sulfate — CAS 143-67-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vorinostat-149647-78-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Vorinostat (CAS 149647-78-9) — pharmaceutical human apis Vorinostat — CAS 149647-78-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bosentan-147536-97-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Bosentan (CAS 147536-97-8) — pharmaceutical human apis Bosentan — CAS 147536-97-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sofosbuvir-1190307-88-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Sofosbuvir (CAS 1190307-88-0) — pharmaceutical human apis Sofosbuvir — CAS 1190307-88-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trimetazidine-hcl-13171-25-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Trimetazidine HCl (CAS 13171-25-0) — pharmaceutical human apis Trimetazidine HCl — CAS 13171-25-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hydroxocobalamin-13422-51-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Hydroxocobalamin (CAS 13422-51-0) — pharmaceutical human apis Hydroxocobalamin — CAS 13422-51-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pramiracetam-68497-62-1.html https://www.longshineboitech.com/product-images/research-chemical.jpg Pramiracetam (CAS 68497-62-1) — pharmaceutical nootropics Pramiracetam — CAS 68497-62-1. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/meloxicam-71125-38-7.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Meloxicam (CAS 71125-38-7) — pharmaceutical veterinary apis Meloxicam — CAS 71125-38-7. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ipamorelin-170851-70-4.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Ipamorelin (CAS 170851-70-4) — pharmaceutical peptides Ipamorelin — CAS 170851-70-4. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/darunavir-ethanolate-635728-49-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Darunavir Ethanolate (CAS 635728-49-3) — pharmaceutical human apis Darunavir Ethanolate — CAS 635728-49-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/eltrombopag-olamine-496775-62-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Eltrombopag Olamine (CAS 496775-62-3) — pharmaceutical human apis Eltrombopag Olamine — CAS 496775-62-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/gts-21-dmxba-156223-05-1.html https://www.longshineboitech.com/product-images/research-chemical.jpg GTS-21 (DMXBA) (CAS 156223-05-1) — pharmaceutical research chemicals GTS-21 (DMXBA) — CAS 156223-05-1. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/potassium-chloride-usp-concentrate-7447-40-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Potassium Chloride USP (Concentrate) (CAS 7447-40-7) — pharmaceutical human apis Potassium Chloride USP (Concentrate) — CAS 7447-40-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/triptorelin-acetate-57773-63-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Triptorelin Acetate (CAS 57773-63-4) — pharmaceutical peptides Triptorelin Acetate — CAS 57773-63-4. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tirzepatide-2023788-19-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Tirzepatide (CAS 2023788-19-2) — pharmaceutical peptides Tirzepatide — CAS 2023788-19-2. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dapagliflozin-propanediol-960404-48-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Dapagliflozin Propanediol (CAS 960404-48-2) — pharmaceutical human apis Dapagliflozin Propanediol — CAS 960404-48-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-propionate-57-85-2.html https://www.longshineboitech.com/product-images/research-chemical.jpg Testosterone Propionate (CAS 57-85-2) — pharmaceutical research chemicals Testosterone Propionate — CAS 57-85-2. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/olanzapine-132539-06-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Olanzapine (CAS 132539-06-1) — pharmaceutical human apis Olanzapine — CAS 132539-06-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trifluoroacetic-acid-tfa-76-05-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Trifluoroacetic Acid (TFA) (CAS 76-05-1) — pharmaceutical intermediates Trifluoroacetic Acid (TFA) — CAS 76-05-1. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/5-amino-1mq-71777-79-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg 5-Amino-1MQ (CAS 71777-79-0) — pharmaceutical research chemicals 5-Amino-1MQ — CAS 71777-79-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lansoprazole-103577-45-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Lansoprazole (CAS 103577-45-3) — pharmaceutical human apis Lansoprazole — CAS 103577-45-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bpc-157-137525-51-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg BPC-157 (CAS 137525-51-0) — pharmaceutical peptides BPC-157 — CAS 137525-51-0. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/brigatinib-1197953-54-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Brigatinib (CAS 1197953-54-0) — pharmaceutical human apis Brigatinib — CAS 1197953-54-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/eravacycline-1207283-85-9.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Eravacycline (CAS 1207283-85-9) — pharmaceutical human apis Eravacycline — CAS 1207283-85-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/taurine-107-35-7.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Taurine (CAS 107-35-7) — pharmaceutical amino acids Taurine — CAS 107-35-7. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tulathromycin-217500-96-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Tulathromycin (CAS 217500-96-4) — pharmaceutical veterinary apis Tulathromycin — CAS 217500-96-4. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trametinib-871700-17-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Trametinib (CAS 871700-17-3) — pharmaceutical human apis Trametinib — CAS 871700-17-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/epinephrine-hcl-55-31-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Epinephrine HCl (CAS 55-31-2) — pharmaceutical human apis Epinephrine HCl — CAS 55-31-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/oxaliplatin-61825-94-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Oxaliplatin (CAS 61825-94-3) — pharmaceutical human apis Oxaliplatin — CAS 61825-94-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ss-31-elamipretide-736992-21-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg SS-31 (Elamipretide) (CAS 736992-21-5) — pharmaceutical peptides SS-31 (Elamipretide) — CAS 736992-21-5. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trenbolone-enanthate-472-61-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Trenbolone Enanthate (CAS 472-61-5) — pharmaceutical research chemicals Trenbolone Enanthate — CAS 472-61-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ruxolitinib-phosphate-1092939-17-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Ruxolitinib Phosphate (CAS 1092939-17-7) — pharmaceutical human apis Ruxolitinib Phosphate — CAS 1092939-17-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/epitalon-307297-39-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Epitalon (CAS 307297-39-8) — pharmaceutical peptides Epitalon — CAS 307297-39-8. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/aod-9604-221231-10-3.html https://www.longshineboitech.com/product-images/peptide-vial.jpg AOD-9604 (CAS 221231-10-3) — pharmaceutical peptides AOD-9604 — CAS 221231-10-3. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/gemcitabine-hcl-122111-03-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Gemcitabine HCl (CAS 122111-03-9) — pharmaceutical human apis Gemcitabine HCl — CAS 122111-03-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sr-17018-2134602-45-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg SR-17018 (CAS 2134602-45-0) — pharmaceutical research chemicals SR-17018 — CAS 2134602-45-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/atorvastatin-calcium-134523-03-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Atorvastatin Calcium (CAS 134523-03-8) — pharmaceutical human apis Atorvastatin Calcium — CAS 134523-03-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pinacolborane-25015-63-8.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Pinacolborane (CAS 25015-63-8) — pharmaceutical intermediates Pinacolborane — CAS 25015-63-8. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pectin-9000-69-5.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Pectin (CAS 9000-69-5) — pharmaceutical excipients Pectin — CAS 9000-69-5. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/l-carnitine-injectable-541-15-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg L-Carnitine Injectable (CAS 541-15-1) — pharmaceutical amino acids L-Carnitine Injectable — CAS 541-15-1. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hexarelin-140703-51-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Hexarelin (CAS 140703-51-1) — pharmaceutical peptides Hexarelin — CAS 140703-51-1. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ceftolozane-sulfate-689293-68-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ceftolozane Sulfate (CAS 689293-68-3) — pharmaceutical human apis Ceftolozane Sulfate — CAS 689293-68-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/atorvastatin-calcium-134523-00-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Atorvastatin Calcium (CAS 134523-00-5) — pharmaceutical human apis Atorvastatin Calcium — CAS 134523-00-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pantoprazole-sodium-138786-67-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Pantoprazole Sodium (CAS 138786-67-1) — pharmaceutical human apis Pantoprazole Sodium — CAS 138786-67-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/semax-80714-61-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Semax (CAS 80714-61-0) — pharmaceutical peptides Semax — CAS 80714-61-0. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bupivacaine-hcl-14252-80-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Bupivacaine HCl (CAS 14252-80-3) — pharmaceutical human apis Bupivacaine HCl — CAS 14252-80-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/4-dma-7-8-dhf-INT-4DMA-78DHF.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 4'-DMA-7,8-DHF (CAS INT-4DMA-78DHF) — pharmaceutical research chemicals 4'-DMA-7,8-DHF — CAS INT-4DMA-78DHF. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/l-lysine-hcl-657-27-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg L-Lysine HCl (CAS 657-27-2) — pharmaceutical amino acids L-Lysine HCl — CAS 657-27-2. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/boldenone-base-846-48-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Boldenone Base (CAS 846-48-0) — pharmaceutical research chemicals Boldenone Base — CAS 846-48-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tesamorelin-acetate-218949-48-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Tesamorelin Acetate (CAS 218949-48-5) — pharmaceutical peptides Tesamorelin Acetate — CAS 218949-48-5. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/succinic-acid-110-15-6.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Succinic Acid (CAS 110-15-6) — pharmaceutical nootropics Succinic Acid — CAS 110-15-6. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/6-apa-6-aminopenicillanic-acid-551-16-6.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg 6-APA (6-Aminopenicillanic Acid) (CAS 551-16-6) — pharmaceutical intermediates 6-APA (6-Aminopenicillanic Acid) — CAS 551-16-6. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/terbinafine-hcl-78628-80-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Terbinafine HCl (CAS 78628-80-5) — pharmaceutical human apis Terbinafine HCl — CAS 78628-80-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/doramectin-117704-25-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Doramectin (CAS 117704-25-3) — pharmaceutical veterinary apis Doramectin — CAS 117704-25-3. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dopamine-hcl-62-31-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Dopamine HCl (CAS 62-31-7) — pharmaceutical human apis Dopamine HCl — CAS 62-31-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pemetrexed-disodium-357166-29-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Pemetrexed Disodium (CAS 357166-29-1) — pharmaceutical human apis Pemetrexed Disodium — CAS 357166-29-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-alginate-9005-38-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sodium Alginate (CAS 9005-38-3) — pharmaceutical excipients Sodium Alginate — CAS 9005-38-3. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ethylcellulose-9004-57-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ethylcellulose (CAS 9004-57-3) — pharmaceutical excipients Ethylcellulose — CAS 9004-57-3. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/stearic-acid-pharma-grade-57-11-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Stearic Acid (Pharma Grade) (CAS 57-11-4) — pharmaceutical excipients Stearic Acid (Pharma Grade) — CAS 57-11-4. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methyl-acetoacetate-105-45-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Methyl Acetoacetate (CAS 105-45-3) — pharmaceutical intermediates Methyl Acetoacetate — CAS 105-45-3. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/florfenicol-73231-34-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Florfenicol (CAS 73231-34-2) — pharmaceutical veterinary apis Florfenicol — CAS 73231-34-2. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nilotinib-hcl-monohydrate-923288-90-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Nilotinib HCl Monohydrate (CAS 923288-90-8) — pharmaceutical human apis Nilotinib HCl Monohydrate — CAS 923288-90-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cetirizine-hcl-83881-51-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Cetirizine HCl (CAS 83881-51-0) — pharmaceutical human apis Cetirizine HCl — CAS 83881-51-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cjc-1295-with-dac-863288-34-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg CJC-1295 (with DAC) (CAS 863288-34-0) — pharmaceutical peptides CJC-1295 (with DAC) — CAS 863288-34-0. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/montelukast-sodium-151767-02-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Montelukast Sodium (CAS 151767-02-1) — pharmaceutical human apis Montelukast Sodium — CAS 151767-02-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pitavastatin-calcium-147526-32-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Pitavastatin Calcium (CAS 147526-32-7) — pharmaceutical human apis Pitavastatin Calcium — CAS 147526-32-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vasopressin-11000-17-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Vasopressin (CAS 11000-17-2) — pharmaceutical human apis Vasopressin — CAS 11000-17-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hydroxypropyl-cellulose-hpc-9004-64-2.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Hydroxypropyl Cellulose (HPC) (CAS 9004-64-2) — pharmaceutical excipients Hydroxypropyl Cellulose (HPC) — CAS 9004-64-2. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/teacrine-2309-49-1.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Teacrine (CAS 2309-49-1) — pharmaceutical nootropics Teacrine — CAS 2309-49-1. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nebivolol-hcl-152520-56-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Nebivolol HCl (CAS 152520-56-4) — pharmaceutical human apis Nebivolol HCl — CAS 152520-56-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/4-hydroxybenzaldehyde-123-08-0.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg 4-Hydroxybenzaldehyde (CAS 123-08-0) — pharmaceutical intermediates 4-Hydroxybenzaldehyde — CAS 123-08-0. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/9-me-bc-9-methyl-carboline-2521-07-5.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 9-Me-BC (9-Methyl-β-carboline) (CAS 2521-07-5) — pharmaceutical research chemicals 9-Me-BC (9-Methyl-β-carboline) — CAS 2521-07-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/romidepsin-128517-07-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Romidepsin (CAS 128517-07-7) — pharmaceutical human apis Romidepsin — CAS 128517-07-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/humanin-330936-69-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Humanin (CAS 330936-69-1) — pharmaceutical peptides Humanin — CAS 330936-69-1. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/enrofloxacin-93106-60-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Enrofloxacin (CAS 93106-60-6) — pharmaceutical veterinary apis Enrofloxacin — CAS 93106-60-6. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/axitinib-319460-85-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Axitinib (CAS 319460-85-0) — pharmaceutical human apis Axitinib — CAS 319460-85-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dimethyl-malonate-108-59-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Dimethyl Malonate (CAS 108-59-8) — pharmaceutical intermediates Dimethyl Malonate — CAS 108-59-8. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pyrazinamide-98-96-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Pyrazinamide (CAS 98-96-4) — pharmaceutical human apis Pyrazinamide — CAS 98-96-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/talc-pharmaceutical-grade-14807-96-6.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Talc Pharmaceutical Grade (CAS 14807-96-6) — pharmaceutical excipients Talc Pharmaceutical Grade — CAS 14807-96-6. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/l-citrulline-372-75-8.html https://www.longshineboitech.com/product-images/excipient-powder.jpg L-Citrulline (CAS 372-75-8) — pharmaceutical amino acids L-Citrulline — CAS 372-75-8. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/enoxaparin-sodium-9005-49-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Enoxaparin Sodium (CAS 9005-49-6) — pharmaceutical human apis Enoxaparin Sodium — CAS 9005-49-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/phenylacetic-acid-103-82-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Phenylacetic Acid (CAS 103-82-2) — pharmaceutical intermediates Phenylacetic Acid — CAS 103-82-2. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/polyethylene-glycol-6000-25322-68-3.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Polyethylene Glycol 6000 (CAS 25322-68-3) — pharmaceutical excipients Polyethylene Glycol 6000 — CAS 25322-68-3. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/itraconazole-84625-61-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Itraconazole (CAS 84625-61-6) — pharmaceutical human apis Itraconazole — CAS 84625-61-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/gabapentin-60142-96-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Gabapentin (CAS 60142-96-3) — pharmaceutical human apis Gabapentin — CAS 60142-96-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/liraglutide-204656-20-2.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Liraglutide (CAS 204656-20-2) — pharmaceutical peptides Liraglutide — CAS 204656-20-2. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/atazanavir-sulfate-229975-97-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Atazanavir Sulfate (CAS 229975-97-7) — pharmaceutical human apis Atazanavir Sulfate — CAS 229975-97-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/amoxicillin-trihydrate-26787-78-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Amoxicillin Trihydrate (CAS 26787-78-0) — pharmaceutical human apis Amoxicillin Trihydrate — CAS 26787-78-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cabozantinib-malate-1140909-48-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Cabozantinib Malate (CAS 1140909-48-3) — pharmaceutical human apis Cabozantinib Malate — CAS 1140909-48-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/abacavir-sulfate-188062-50-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Abacavir Sulfate (CAS 188062-50-2) — pharmaceutical human apis Abacavir Sulfate — CAS 188062-50-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sulfadiazine-68-35-9.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Sulfadiazine (CAS 68-35-9) — pharmaceutical veterinary apis Sulfadiazine — CAS 68-35-9. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/rivaroxaban-366789-02-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Rivaroxaban (CAS 366789-02-8) — pharmaceutical human apis Rivaroxaban — CAS 366789-02-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/finasteride-98319-26-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Finasteride (CAS 98319-26-7) — pharmaceutical human apis Finasteride — CAS 98319-26-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/isavuconazonium-sulfate-946075-13-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Isavuconazonium Sulfate (CAS 946075-13-4) — pharmaceutical human apis Isavuconazonium Sulfate — CAS 946075-13-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sacubitril-149709-62-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Sacubitril (CAS 149709-62-6) — pharmaceutical human apis Sacubitril — CAS 149709-62-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bendamustine-hcl-3543-75-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Bendamustine HCl (CAS 3543-75-7) — pharmaceutical human apis Bendamustine HCl — CAS 3543-75-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/olmesartan-medoxomil-144689-63-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Olmesartan Medoxomil (CAS 144689-63-4) — pharmaceutical human apis Olmesartan Medoxomil — CAS 144689-63-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ethinyl-estradiol-57-63-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ethinyl Estradiol (CAS 57-63-6) — pharmaceutical human apis Ethinyl Estradiol — CAS 57-63-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pyrantel-pamoate-22204-24-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Pyrantel Pamoate (CAS 22204-24-6) — pharmaceutical veterinary apis Pyrantel Pamoate — CAS 22204-24-6. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/iloprost-78919-13-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Iloprost (CAS 78919-13-8) — pharmaceutical human apis Iloprost — CAS 78919-13-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/boc-anhydride-di-tert-butyl-dicarbonate-24424-99-5.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Boc Anhydride (Di-tert-butyl Dicarbonate) (CAS 24424-99-5) — pharmaceutical intermediates Boc Anhydride (Di-tert-butyl Dicarbonate) — CAS 24424-99-5. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-lauryl-sulfate-151-21-3.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Sodium Lauryl Sulfate (CAS 151-21-3) — pharmaceutical excipients Sodium Lauryl Sulfate — CAS 151-21-3. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cefquinome-sulfate-118443-89-3.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Cefquinome Sulfate (CAS 118443-89-3) — pharmaceutical veterinary apis Cefquinome Sulfate — CAS 118443-89-3. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/decitabine-2353-33-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Decitabine (CAS 2353-33-5) — pharmaceutical human apis Decitabine — CAS 2353-33-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/calcium-disodium-edta-62-33-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Calcium Disodium EDTA (CAS 62-33-9) — pharmaceutical human apis Calcium Disodium EDTA — CAS 62-33-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sitagliptin-phosphate-monohydrate-654671-77-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sitagliptin Phosphate Monohydrate (CAS 654671-77-9) — pharmaceutical human apis Sitagliptin Phosphate Monohydrate — CAS 654671-77-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/b7-33-1864009-49-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg B7-33 (CAS 1864009-49-3) — pharmaceutical peptides B7-33 — CAS 1864009-49-3. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/7-aminocephalosporanic-acid-7-aca-957-68-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg 7-Aminocephalosporanic Acid (7-ACA) (CAS 957-68-6) — pharmaceutical intermediates 7-Aminocephalosporanic Acid (7-ACA) — CAS 957-68-6. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/medroxyprogesterone-acetate-71-58-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Medroxyprogesterone Acetate (CAS 71-58-9) — pharmaceutical human apis Medroxyprogesterone Acetate — CAS 71-58-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/albendazole-54965-21-8.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Albendazole (CAS 54965-21-8) — pharmaceutical veterinary apis Albendazole — CAS 54965-21-8. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tamsulosin-hcl-106463-17-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Tamsulosin HCl (CAS 106463-17-6) — pharmaceutical human apis Tamsulosin HCl — CAS 106463-17-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/clostebol-acetate-855-19-6.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Clostebol Acetate (CAS 855-19-6) — pharmaceutical research chemicals Clostebol Acetate — CAS 855-19-6. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/yohimbine-hydrochloride-65-19-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Yohimbine Hydrochloride (CAS 65-19-0) — pharmaceutical human apis Yohimbine Hydrochloride — CAS 65-19-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/palbociclib-571190-30-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Palbociclib (CAS 571190-30-2) — pharmaceutical human apis Palbociclib — CAS 571190-30-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methandienone-dianabol-72-63-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Methandienone (Dianabol) (CAS 72-63-9) — pharmaceutical research chemicals Methandienone (Dianabol) — CAS 72-63-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/d-phenylglycine-875-74-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg D-Phenylglycine (CAS 875-74-1) — pharmaceutical intermediates D-Phenylglycine — CAS 875-74-1. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tilmicosin-premix-grade-108050-54-0.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Tilmicosin (Premix Grade) (CAS 108050-54-0) — pharmaceutical veterinary apis Tilmicosin (Premix Grade) — CAS 108050-54-0. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tedizolid-phosphate-856867-39-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Tedizolid Phosphate (CAS 856867-39-5) — pharmaceutical human apis Tedizolid Phosphate — CAS 856867-39-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fluoxymesterone-halotestin-76-43-7.html https://www.longshineboitech.com/product-images/research-chemical.jpg Fluoxymesterone (Halotestin) (CAS 76-43-7) — pharmaceutical research chemicals Fluoxymesterone (Halotestin) — CAS 76-43-7. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/penicillin-g-potassium-113-98-4.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Penicillin G Potassium (CAS 113-98-4) — pharmaceutical intermediates Penicillin G Potassium — CAS 113-98-4. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fidaxomicin-873857-62-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Fidaxomicin (CAS 873857-62-6) — pharmaceutical human apis Fidaxomicin — CAS 873857-62-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/l-arginine-74-79-3.html https://www.longshineboitech.com/product-images/excipient-powder.jpg L-Arginine (CAS 74-79-3) — pharmaceutical amino acids L-Arginine — CAS 74-79-3. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/clofazimine-2030-63-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Clofazimine (CAS 2030-63-9) — pharmaceutical human apis Clofazimine — CAS 2030-63-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tadalafil-171596-29-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Tadalafil (CAS 171596-29-5) — pharmaceutical human apis Tadalafil — CAS 171596-29-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/magnesium-sulfate-heptahydrate-10034-99-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Magnesium Sulfate Heptahydrate (CAS 10034-99-8) — pharmaceutical human apis Magnesium Sulfate Heptahydrate — CAS 10034-99-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bleomycin-sulfate-9041-93-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Bleomycin Sulfate (CAS 9041-93-4) — pharmaceutical human apis Bleomycin Sulfate — CAS 9041-93-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/glimepiride-93479-97-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Glimepiride (CAS 93479-97-1) — pharmaceutical human apis Glimepiride — CAS 93479-97-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/loperamide-hydrochloride-34552-83-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Loperamide Hydrochloride (CAS 34552-83-5) — pharmaceutical human apis Loperamide Hydrochloride — CAS 34552-83-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mercaptopurine-6-mp-50-44-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Mercaptopurine (6-MP) (CAS 50-44-2) — pharmaceutical human apis Mercaptopurine (6-MP) — CAS 50-44-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/paracetamol-acetaminophen-103-90-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Paracetamol (Acetaminophen) (CAS 103-90-2) — pharmaceutical human apis Paracetamol (Acetaminophen) — CAS 103-90-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/roxithromycin-80214-83-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Roxithromycin (CAS 80214-83-1) — pharmaceutical human apis Roxithromycin — CAS 80214-83-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/amlodipine-besylate-111470-99-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Amlodipine Besylate (CAS 111470-99-6) — pharmaceutical human apis Amlodipine Besylate — CAS 111470-99-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/linezolid-165800-03-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Linezolid (CAS 165800-03-3) — pharmaceutical human apis Linezolid — CAS 165800-03-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/potassium-hydrogen-phthalate-khp-877-24-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Potassium Hydrogen Phthalate (KHP) (CAS 877-24-7) — pharmaceutical intermediates Potassium Hydrogen Phthalate (KHP) — CAS 877-24-7. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/abemaciclib-1231929-97-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Abemaciclib (CAS 1231929-97-7) — pharmaceutical human apis Abemaciclib — CAS 1231929-97-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/simvastatin-79902-63-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Simvastatin (CAS 79902-63-9) — pharmaceutical human apis Simvastatin — CAS 79902-63-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bortezomib-179324-69-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Bortezomib (CAS 179324-69-7) — pharmaceutical human apis Bortezomib — CAS 179324-69-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hatu-coupling-reagent-148893-10-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg HATU (Coupling Reagent) (CAS 148893-10-1) — pharmaceutical intermediates HATU (Coupling Reagent) — CAS 148893-10-1. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/riociguat-625115-55-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Riociguat (CAS 625115-55-1) — pharmaceutical human apis Riociguat — CAS 625115-55-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/1-testosterone-cypionate-dhb-cyp-INT-1TEST-CYP.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 1-Testosterone Cypionate (DHB Cyp) (CAS INT-1TEST-CYP) — pharmaceutical research chemicals 1-Testosterone Cypionate (DHB Cyp) — CAS INT-1TEST-CYP. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tigecycline-220620-09-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Tigecycline (CAS 220620-09-7) — pharmaceutical human apis Tigecycline — CAS 220620-09-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/4-aminobenzoic-acid-paba-150-13-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg 4-Aminobenzoic Acid (PABA) (CAS 150-13-0) — pharmaceutical intermediates 4-Aminobenzoic Acid (PABA) — CAS 150-13-0. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nalbuphine-hydrochloride-23277-43-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Nalbuphine Hydrochloride (CAS 23277-43-2) — pharmaceutical human apis Nalbuphine Hydrochloride — CAS 23277-43-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/amoxicillin-trihydrate-61336-70-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Amoxicillin Trihydrate (CAS 61336-70-7) — pharmaceutical human apis Amoxicillin Trihydrate — CAS 61336-70-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ethyl-4-chloroacetoacetate-638-07-3.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Ethyl 4-Chloroacetoacetate (CAS 638-07-3) — pharmaceutical intermediates Ethyl 4-Chloroacetoacetate — CAS 638-07-3. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tetrahydrofuran-thf-anhydrous-109-99-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Tetrahydrofuran (THF, Anhydrous) (CAS 109-99-9) — pharmaceutical intermediates Tetrahydrofuran (THF, Anhydrous) — CAS 109-99-9. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/capecitabine-154361-50-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Capecitabine (CAS 154361-50-9) — pharmaceutical human apis Capecitabine — CAS 154361-50-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sertraline-hcl-79559-97-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sertraline HCl (CAS 79559-97-0) — pharmaceutical human apis Sertraline HCl — CAS 79559-97-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cefixime-79350-37-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Cefixime (CAS 79350-37-1) — pharmaceutical human apis Cefixime — CAS 79350-37-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mitomycin-c-50-07-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Mitomycin C (CAS 50-07-7) — pharmaceutical human apis Mitomycin C — CAS 50-07-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/artesunate-88495-63-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Artesunate (CAS 88495-63-0) — pharmaceutical human apis Artesunate — CAS 88495-63-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/levetiracetam-102767-28-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Levetiracetam (CAS 102767-28-2) — pharmaceutical human apis Levetiracetam — CAS 102767-28-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/drospirenone-67392-87-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Drospirenone (CAS 67392-87-4) — pharmaceutical human apis Drospirenone — CAS 67392-87-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/artemether-71963-77-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Artemether (CAS 71963-77-4) — pharmaceutical human apis Artemether — CAS 71963-77-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cysteamine-bitartrate-27761-19-9.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Cysteamine Bitartrate (CAS 27761-19-9) — pharmaceutical human apis Cysteamine Bitartrate — CAS 27761-19-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sapropterin-dihydrochloride-17528-72-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Sapropterin Dihydrochloride (CAS 17528-72-2) — pharmaceutical human apis Sapropterin Dihydrochloride — CAS 17528-72-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/caspofungin-acetate-179463-17-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Caspofungin Acetate (CAS 179463-17-3) — pharmaceutical human apis Caspofungin Acetate — CAS 179463-17-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/rabeprazole-sodium-117976-90-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Rabeprazole Sodium (CAS 117976-90-6) — pharmaceutical human apis Rabeprazole Sodium — CAS 117976-90-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/isoniazid-54-85-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Isoniazid (CAS 54-85-3) — pharmaceutical human apis Isoniazid — CAS 54-85-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ciprofloxacin-hcl-86393-32-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Ciprofloxacin HCl (CAS 86393-32-0) — pharmaceutical human apis Ciprofloxacin HCl — CAS 86393-32-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/doxycycline-hyclate-24390-14-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Doxycycline Hyclate (CAS 24390-14-5) — pharmaceutical veterinary apis Doxycycline Hyclate — CAS 24390-14-5. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ethambutol-hcl-1070-11-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ethambutol HCl (CAS 1070-11-7) — pharmaceutical human apis Ethambutol HCl — CAS 1070-11-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pioglitazone-hcl-112529-15-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Pioglitazone HCl (CAS 112529-15-4) — pharmaceutical human apis Pioglitazone HCl — CAS 112529-15-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/oxymetholone-anadrol-434-07-1.html https://www.longshineboitech.com/product-images/research-chemical.jpg Oxymetholone (Anadrol) (CAS 434-07-1) — pharmaceutical research chemicals Oxymetholone (Anadrol) — CAS 434-07-1. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/budesonide-51333-22-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Budesonide (CAS 51333-22-3) — pharmaceutical human apis Budesonide — CAS 51333-22-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nitisinone-104206-65-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Nitisinone (CAS 104206-65-7) — pharmaceutical human apis Nitisinone — CAS 104206-65-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cefovecin-sodium-141195-77-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Cefovecin Sodium (CAS 141195-77-9) — pharmaceutical veterinary apis Cefovecin Sodium — CAS 141195-77-9. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trenbolone-hexahydrobenzylcarbonate-parabolan-23454-33-3.html https://www.longshineboitech.com/product-images/research-chemical.jpg Trenbolone Hexahydrobenzylcarbonate (Parabolan) (CAS 23454-33-3) — pharmaceutical research chemicals Trenbolone Hexahydrobenzylcarbonate (Parabolan) — CAS 23454-33-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/deferoxamine-mesylate-138-14-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Deferoxamine Mesylate (CAS 138-14-7) — pharmaceutical human apis Deferoxamine Mesylate — CAS 138-14-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ibuprofen-15687-27-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ibuprofen (CAS 15687-27-1) — pharmaceutical human apis Ibuprofen — CAS 15687-27-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/letrozole-112809-51-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Letrozole (CAS 112809-51-5) — pharmaceutical human apis Letrozole — CAS 112809-51-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/irinotecan-hcl-100286-90-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Irinotecan HCl (CAS 100286-90-6) — pharmaceutical human apis Irinotecan HCl — CAS 100286-90-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/kpv-peptide-lys-pro-val-47931-85-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg KPV Peptide (Lys-Pro-Val) (CAS 47931-85-1) — pharmaceutical peptides KPV Peptide (Lys-Pro-Val) — CAS 47931-85-1. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/raltegravir-potassium-871038-72-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Raltegravir Potassium (CAS 871038-72-1) — pharmaceutical human apis Raltegravir Potassium — CAS 871038-72-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sorafenib-tosylate-475207-59-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Sorafenib Tosylate (CAS 475207-59-1) — pharmaceutical human apis Sorafenib Tosylate — CAS 475207-59-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/marbofloxacin-115550-35-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Marbofloxacin (CAS 115550-35-1) — pharmaceutical veterinary apis Marbofloxacin — CAS 115550-35-1. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pibrentasvir-1353900-92-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Pibrentasvir (CAS 1353900-92-1) — pharmaceutical human apis Pibrentasvir — CAS 1353900-92-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-phenylbutyrate-1716-12-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Sodium Phenylbutyrate (CAS 1716-12-7) — pharmaceutical human apis Sodium Phenylbutyrate — CAS 1716-12-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ambrisentan-177036-94-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ambrisentan (CAS 177036-94-1) — pharmaceutical human apis Ambrisentan — CAS 177036-94-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/aciclovir-59277-89-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Aciclovir (CAS 59277-89-3) — pharmaceutical human apis Aciclovir — CAS 59277-89-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cefpodoxime-proxetil-87239-81-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Cefpodoxime Proxetil (CAS 87239-81-4) — pharmaceutical human apis Cefpodoxime Proxetil — CAS 87239-81-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sorbitol-50-70-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sorbitol (CAS 50-70-4) — pharmaceutical excipients Sorbitol — CAS 50-70-4. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/butorphanol-tartrate-58786-99-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Butorphanol Tartrate (CAS 58786-99-5) — pharmaceutical human apis Butorphanol Tartrate — CAS 58786-99-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/2-methylimidazole-693-98-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg 2-Methylimidazole (CAS 693-98-1) — pharmaceutical intermediates 2-Methylimidazole — CAS 693-98-1. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/halodrol-35937-40-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Halodrol (CAS 35937-40-7) — pharmaceutical research chemicals Halodrol — CAS 35937-40-7. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/snap-8-acetyl-octapeptide-3-868844-74-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg SNAP-8 (Acetyl Octapeptide-3) (CAS 868844-74-0) — pharmaceutical peptides SNAP-8 (Acetyl Octapeptide-3) — CAS 868844-74-0. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fluorenol-myristate-INT-FLUOR-MYR.html https://www.longshineboitech.com/product-images/research-chemical.jpg Fluorenol Myristate (CAS INT-FLUOR-MYR) — pharmaceutical research chemicals Fluorenol Myristate — CAS INT-FLUOR-MYR. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/desoxymethyltestosterone-madol-dmt-3137-71-1.html https://www.longshineboitech.com/product-images/research-chemical.jpg Desoxymethyltestosterone (Madol / DMT) (CAS 3137-71-1) — pharmaceutical research chemicals Desoxymethyltestosterone (Madol / DMT) — CAS 3137-71-1. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/forskolin-66575-29-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Forskolin (CAS 66575-29-9) — pharmaceutical research chemicals Forskolin — CAS 66575-29-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/metformin-hcl-1115-70-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Metformin HCl (CAS 1115-70-4) — pharmaceutical human apis Metformin HCl — CAS 1115-70-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pazopanib-hcl-635702-64-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Pazopanib HCl (CAS 635702-64-6) — pharmaceutical human apis Pazopanib HCl — CAS 635702-64-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/acacia-gum-gum-arabic-9000-01-5.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Acacia Gum (Gum Arabic) (CAS 9000-01-5) — pharmaceutical excipients Acacia Gum (Gum Arabic) — CAS 9000-01-5. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/unifiram-272786-64-8.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Unifiram (CAS 272786-64-8) — pharmaceutical research chemicals Unifiram — CAS 272786-64-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fosfomycin-sodium-26016-99-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Fosfomycin Sodium (CAS 26016-99-9) — pharmaceutical human apis Fosfomycin Sodium — CAS 26016-99-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lactose-monohydrate-10039-26-6.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Lactose Monohydrate (CAS 10039-26-6) — pharmaceutical excipients Lactose Monohydrate — CAS 10039-26-6. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bromantane-87913-26-6.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Bromantane (CAS 87913-26-6) — pharmaceutical nootropics Bromantane — CAS 87913-26-6. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/duloxetine-hcl-136434-34-9.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Duloxetine HCl (CAS 136434-34-9) — pharmaceutical human apis Duloxetine HCl — CAS 136434-34-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pentamidine-isethionate-1115-32-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Pentamidine Isethionate (CAS 1115-32-0) — pharmaceutical human apis Pentamidine Isethionate — CAS 1115-32-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/levofloxacin-100986-85-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Levofloxacin (CAS 100986-85-4) — pharmaceutical human apis Levofloxacin — CAS 100986-85-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/piperacillin-sodium-59703-84-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Piperacillin Sodium (CAS 59703-84-3) — pharmaceutical human apis Piperacillin Sodium — CAS 59703-84-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cartalax-1207647-05-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Cartalax (CAS 1207647-05-7) — pharmaceutical peptides Cartalax — CAS 1207647-05-7. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/metribolone-methyltrienolone-965-93-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Metribolone (Methyltrienolone) (CAS 965-93-5) — pharmaceutical research chemicals Metribolone (Methyltrienolone) — CAS 965-93-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lamivudine-134678-17-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Lamivudine (CAS 134678-17-4) — pharmaceutical human apis Lamivudine — CAS 134678-17-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/colistin-sulfate-1264-72-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Colistin Sulfate (CAS 1264-72-8) — pharmaceutical human apis Colistin Sulfate — CAS 1264-72-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lactose-monohydrate-64044-51-5.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Lactose Monohydrate (CAS 64044-51-5) — pharmaceutical excipients Lactose Monohydrate — CAS 64044-51-5. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/aniracetam-72432-10-1.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Aniracetam (CAS 72432-10-1) — pharmaceutical nootropics Aniracetam — CAS 72432-10-1. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/loratadine-79794-75-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Loratadine (CAS 79794-75-5) — pharmaceutical human apis Loratadine — CAS 79794-75-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/latanoprost-130209-82-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Latanoprost (CAS 130209-82-4) — pharmaceutical human apis Latanoprost — CAS 130209-82-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/linagliptin-668270-12-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Linagliptin (CAS 668270-12-0) — pharmaceutical human apis Linagliptin — CAS 668270-12-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/prednisolone-50-24-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Prednisolone (CAS 50-24-8) — pharmaceutical human apis Prednisolone — CAS 50-24-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/palladium-on-carbon-10-pd-c-wet-7440-05-3.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Palladium on Carbon (10% Pd/C, Wet) (CAS 7440-05-3) — pharmaceutical intermediates Palladium on Carbon (10% Pd/C, Wet) — CAS 7440-05-3. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/azithromycin-dihydrate-117772-70-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Azithromycin Dihydrate (CAS 117772-70-0) — pharmaceutical human apis Azithromycin Dihydrate — CAS 117772-70-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/n-methylmorpholine-nmm-109-02-4.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg N-Methylmorpholine (NMM) (CAS 109-02-4) — pharmaceutical intermediates N-Methylmorpholine (NMM) — CAS 109-02-4. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/codeine-phosphate-hemihydrate-41444-62-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Codeine Phosphate Hemihydrate (CAS 41444-62-6) — pharmaceutical human apis Codeine Phosphate Hemihydrate — CAS 41444-62-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nicotinamide-mononucleotide-nmn-1094-61-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Nicotinamide Mononucleotide (NMN) (CAS 1094-61-7) — pharmaceutical research chemicals Nicotinamide Mononucleotide (NMN) — CAS 1094-61-7. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/oxandrolone-anavar-53-39-4.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Oxandrolone (Anavar) (CAS 53-39-4) — pharmaceutical research chemicals Oxandrolone (Anavar) — CAS 53-39-4. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/piracetam-7491-74-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Piracetam (CAS 7491-74-9) — pharmaceutical nootropics Piracetam — CAS 7491-74-9. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/2-chloropyridine-109-09-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg 2-Chloropyridine (CAS 109-09-3) — pharmaceutical intermediates 2-Chloropyridine — CAS 109-09-3. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pemvidutide-2271470-71-4.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Pemvidutide (CAS 2271470-71-4) — pharmaceutical peptides Pemvidutide — CAS 2271470-71-4. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/benzaldehyde-100-52-7.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Benzaldehyde (CAS 100-52-7) — pharmaceutical intermediates Benzaldehyde — CAS 100-52-7. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dehydronandrolone-acetate-2590-41-2.html https://www.longshineboitech.com/product-images/research-chemical.jpg Dehydronandrolone Acetate (CAS 2590-41-2) — pharmaceutical research chemicals Dehydronandrolone Acetate — CAS 2590-41-2. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dsip-delta-sleep-inducing-peptide-62568-57-4.html https://www.longshineboitech.com/product-images/peptide-vial.jpg DSIP (Delta Sleep-Inducing Peptide) (CAS 62568-57-4) — pharmaceutical peptides DSIP (Delta Sleep-Inducing Peptide) — CAS 62568-57-4. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ifosfamide-3778-73-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ifosfamide (CAS 3778-73-2) — pharmaceutical human apis Ifosfamide — CAS 3778-73-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nefiracetam-77191-36-7.html https://www.longshineboitech.com/product-images/research-chemical.jpg Nefiracetam (CAS 77191-36-7) — pharmaceutical nootropics Nefiracetam — CAS 77191-36-7. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/5-fluorouracil-51-21-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg 5-Fluorouracil (CAS 51-21-8) — pharmaceutical human apis 5-Fluorouracil — CAS 51-21-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/miglustat-72599-27-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Miglustat (CAS 72599-27-0) — pharmaceutical human apis Miglustat — CAS 72599-27-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/propofol-2078-54-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Propofol (CAS 2078-54-8) — pharmaceutical human apis Propofol — CAS 2078-54-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vemurafenib-918504-65-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Vemurafenib (CAS 918504-65-1) — pharmaceutical human apis Vemurafenib — CAS 918504-65-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/imatinib-mesylate-220127-57-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Imatinib Mesylate (CAS 220127-57-1) — pharmaceutical human apis Imatinib Mesylate — CAS 220127-57-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/leucovorin-calcium-folinic-acid-1492-18-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Leucovorin Calcium (Folinic Acid) (CAS 1492-18-8) — pharmaceutical human apis Leucovorin Calcium (Folinic Acid) — CAS 1492-18-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/protamine-sulfate-9009-65-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Protamine Sulfate (CAS 9009-65-8) — pharmaceutical human apis Protamine Sulfate — CAS 9009-65-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/prasugrel-hcl-389574-19-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Prasugrel HCl (CAS 389574-19-0) — pharmaceutical human apis Prasugrel HCl — CAS 389574-19-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hydrochlorothiazide-58-93-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Hydrochlorothiazide (CAS 58-93-5) — pharmaceutical human apis Hydrochlorothiazide — CAS 58-93-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/voriconazole-137234-62-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Voriconazole (CAS 137234-62-9) — pharmaceutical human apis Voriconazole — CAS 137234-62-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dapsone-80-08-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Dapsone (CAS 80-08-0) — pharmaceutical human apis Dapsone — CAS 80-08-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nandrolone-decanoate-deca-360-70-3.html https://www.longshineboitech.com/product-images/research-chemical.jpg Nandrolone Decanoate (Deca) (CAS 360-70-3) — pharmaceutical research chemicals Nandrolone Decanoate (Deca) — CAS 360-70-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/clarithromycin-81103-11-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Clarithromycin (CAS 81103-11-9) — pharmaceutical human apis Clarithromycin — CAS 81103-11-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bictegravir-sodium-1611493-60-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Bictegravir Sodium (CAS 1611493-60-7) — pharmaceutical human apis Bictegravir Sodium — CAS 1611493-60-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/apixaban-503612-47-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Apixaban (CAS 503612-47-3) — pharmaceutical human apis Apixaban — CAS 503612-47-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/erlotinib-hcl-183321-74-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Erlotinib HCl (CAS 183321-74-6) — pharmaceutical human apis Erlotinib HCl — CAS 183321-74-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ceftazidime-pentahydrate-72558-82-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Ceftazidime Pentahydrate (CAS 72558-82-8) — pharmaceutical human apis Ceftazidime Pentahydrate — CAS 72558-82-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/aripiprazole-129722-12-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Aripiprazole (CAS 129722-12-9) — pharmaceutical human apis Aripiprazole — CAS 129722-12-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tafamidis-meglumine-951395-08-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Tafamidis Meglumine (CAS 951395-08-7) — pharmaceutical human apis Tafamidis Meglumine — CAS 951395-08-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/4-aminoacetophenone-99-92-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg 4-Aminoacetophenone (CAS 99-92-3) — pharmaceutical intermediates 4-Aminoacetophenone — CAS 99-92-3. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/clavulanate-potassium-61177-45-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Clavulanate Potassium (CAS 61177-45-5) — pharmaceutical human apis Clavulanate Potassium — CAS 61177-45-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ticagrelor-274693-27-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ticagrelor (CAS 274693-27-5) — pharmaceutical human apis Ticagrelor — CAS 274693-27-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-undecanoate-5949-44-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Testosterone Undecanoate (CAS 5949-44-0) — pharmaceutical research chemicals Testosterone Undecanoate — CAS 5949-44-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cannabidiol-cbd-research-grade-13956-29-1.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Cannabidiol (CBD) — Research Grade (CAS 13956-29-1) — pharmaceutical research chemicals Cannabidiol (CBD) — Research Grade — CAS 13956-29-1. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hydroxypropyl-methylcellulose-hpmc-9004-65-3.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Hydroxypropyl Methylcellulose (HPMC) (CAS 9004-65-3) — pharmaceutical excipients Hydroxypropyl Methylcellulose (HPMC) — CAS 9004-65-3. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/posaconazole-171228-49-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Posaconazole (CAS 171228-49-2) — pharmaceutical human apis Posaconazole — CAS 171228-49-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/7-8-dihydroxyflavone-7-8-dhf-38183-03-8.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 7,8-Dihydroxyflavone (7,8-DHF) (CAS 38183-03-8) — pharmaceutical nootropics 7,8-Dihydroxyflavone (7,8-DHF) — CAS 38183-03-8. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hydroxychloroquine-sulfate-747-36-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Hydroxychloroquine Sulfate (CAS 747-36-4) — pharmaceutical human apis Hydroxychloroquine Sulfate — CAS 747-36-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/clomiphene-citrate-50-41-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Clomiphene Citrate (CAS 50-41-9) — pharmaceutical human apis Clomiphene Citrate — CAS 50-41-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lenalidomide-191732-72-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Lenalidomide (CAS 191732-72-6) — pharmaceutical human apis Lenalidomide — CAS 191732-72-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/praziquantel-55268-74-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Praziquantel (CAS 55268-74-1) — pharmaceutical veterinary apis Praziquantel — CAS 55268-74-1. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nandrolone-phenylpropionate-npp-62-90-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Nandrolone Phenylpropionate (NPP) (CAS 62-90-8) — pharmaceutical research chemicals Nandrolone Phenylpropionate (NPP) — CAS 62-90-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/deferasirox-201530-41-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Deferasirox (CAS 201530-41-8) — pharmaceutical human apis Deferasirox — CAS 201530-41-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methenolone-acetate-primobolan-434-05-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Methenolone Acetate (Primobolan) (CAS 434-05-9) — pharmaceutical research chemicals Methenolone Acetate (Primobolan) — CAS 434-05-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/retatrutide-2381089-83-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Retatrutide (CAS 2381089-83-2) — pharmaceutical peptides Retatrutide — CAS 2381089-83-2. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/heparin-sodium-9041-08-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Heparin Sodium (CAS 9041-08-1) — pharmaceutical human apis Heparin Sodium — CAS 9041-08-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fludarabine-phosphate-75607-67-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Fludarabine Phosphate (CAS 75607-67-9) — pharmaceutical human apis Fludarabine Phosphate — CAS 75607-67-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/phenibut-hcl-1078-21-3.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Phenibut HCl (CAS 1078-21-3) — pharmaceutical nootropics Phenibut HCl — CAS 1078-21-3. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/escitalopram-oxalate-219861-08-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Escitalopram Oxalate (CAS 219861-08-2) — pharmaceutical human apis Escitalopram Oxalate — CAS 219861-08-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ceftriaxone-sodium-104376-79-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ceftriaxone Sodium (CAS 104376-79-6) — pharmaceutical human apis Ceftriaxone Sodium — CAS 104376-79-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dutasteride-164656-23-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Dutasteride (CAS 164656-23-9) — pharmaceutical human apis Dutasteride — CAS 164656-23-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/j-147-salk-1146963-51-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg J-147 (Salk) (CAS 1146963-51-0) — pharmaceutical research chemicals J-147 (Salk) — CAS 1146963-51-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nitrofurantoin-67-20-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Nitrofurantoin (CAS 67-20-9) — pharmaceutical human apis Nitrofurantoin — CAS 67-20-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methasterone-superdrol-3381-88-2.html https://www.longshineboitech.com/product-images/research-chemical.jpg Methasterone (Superdrol) (CAS 3381-88-2) — pharmaceutical research chemicals Methasterone (Superdrol) — CAS 3381-88-2. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/eprinomectin-123997-26-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Eprinomectin (CAS 123997-26-2) — pharmaceutical veterinary apis Eprinomectin — CAS 123997-26-2. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bimatoprost-155206-00-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Bimatoprost (CAS 155206-00-1) — pharmaceutical human apis Bimatoprost — CAS 155206-00-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/topotecan-hcl-119413-54-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Topotecan HCl (CAS 119413-54-6) — pharmaceutical human apis Topotecan HCl — CAS 119413-54-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/7-aminodesacetoxycephalosporanic-acid-7-adca-2635-13-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg 7-Aminodesacetoxycephalosporanic Acid (7-ADCA) (CAS 2635-13-4) — pharmaceutical intermediates 7-Aminodesacetoxycephalosporanic Acid (7-ADCA) — CAS 2635-13-4. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/boldenone-cypionate-106505-90-2.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Boldenone Cypionate (CAS 106505-90-2) — pharmaceutical research chemicals Boldenone Cypionate — CAS 106505-90-2. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cagrilintide-1415456-99-3.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Cagrilintide (CAS 1415456-99-3) — pharmaceutical peptides Cagrilintide — CAS 1415456-99-3. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ivermectin-70288-86-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ivermectin (CAS 70288-86-7) — pharmaceutical veterinary apis Ivermectin — CAS 70288-86-7. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/semaglutide-910463-68-2.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Semaglutide (CAS 910463-68-2) — pharmaceutical peptides Semaglutide — CAS 910463-68-2. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/diclofenac-sodium-15307-86-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Diclofenac Sodium (CAS 15307-86-5) — pharmaceutical human apis Diclofenac Sodium — CAS 15307-86-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fluticasone-propionate-80474-14-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Fluticasone Propionate (CAS 80474-14-2) — pharmaceutical human apis Fluticasone Propionate — CAS 80474-14-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/glycine-pharma-grade-56-40-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Glycine (Pharma Grade) (CAS 56-40-6) — pharmaceutical intermediates Glycine (Pharma Grade) — CAS 56-40-6. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/17-methyltestosterone-58-18-4.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 17-Methyltestosterone (CAS 58-18-4) — pharmaceutical research chemicals 17-Methyltestosterone — CAS 58-18-4. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/boldenone-propionate-INT-BOLD-PROP.html https://www.longshineboitech.com/product-images/research-chemical.jpg Boldenone Propionate (CAS INT-BOLD-PROP) — pharmaceutical research chemicals Boldenone Propionate — CAS INT-BOLD-PROP. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/eudragit-s-100-25086-15-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Eudragit S 100 (CAS 25086-15-1) — pharmaceutical excipients Eudragit S 100 — CAS 25086-15-1. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ondansetron-hcl-dihydrate-99614-01-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ondansetron HCl Dihydrate (CAS 99614-01-4) — pharmaceutical human apis Ondansetron HCl Dihydrate — CAS 99614-01-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/anastrozole-120511-73-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Anastrozole (CAS 120511-73-1) — pharmaceutical human apis Anastrozole — CAS 120511-73-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/daptomycin-103060-53-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Daptomycin (CAS 103060-53-3) — pharmaceutical human apis Daptomycin — CAS 103060-53-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/agmatine-sulfate-2482-00-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Agmatine Sulfate (CAS 2482-00-0) — pharmaceutical nootropics Agmatine Sulfate — CAS 2482-00-0. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/hydroxyurea-127-07-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Hydroxyurea (CAS 127-07-1) — pharmaceutical human apis Hydroxyurea — CAS 127-07-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/adrafinil-63547-13-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Adrafinil (CAS 63547-13-7) — pharmaceutical nootropics Adrafinil — CAS 63547-13-7. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/calcium-gluconate-299-28-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Calcium Gluconate (CAS 299-28-5) — pharmaceutical human apis Calcium Gluconate — CAS 299-28-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/doxorubicin-hcl-25316-40-9.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Doxorubicin HCl (CAS 25316-40-9) — pharmaceutical human apis Doxorubicin HCl — CAS 25316-40-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/salmeterol-xinafoate-94749-08-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Salmeterol Xinafoate (CAS 94749-08-3) — pharmaceutical human apis Salmeterol Xinafoate — CAS 94749-08-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fosfomycin-tromethamine-78964-85-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Fosfomycin Tromethamine (CAS 78964-85-9) — pharmaceutical human apis Fosfomycin Tromethamine — CAS 78964-85-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/eudragit-rl-100-33434-24-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Eudragit RL 100 (CAS 33434-24-1) — pharmaceutical excipients Eudragit RL 100 — CAS 33434-24-1. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/oxiracetam-62613-82-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Oxiracetam (CAS 62613-82-5) — pharmaceutical nootropics Oxiracetam — CAS 62613-82-5. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/diethyl-malonate-105-53-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Diethyl Malonate (CAS 105-53-3) — pharmaceutical intermediates Diethyl Malonate — CAS 105-53-3. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tb-500-thymosin-beta-4-77591-33-4.html https://www.longshineboitech.com/product-images/peptide-vial.jpg TB-500 (Thymosin Beta-4) (CAS 77591-33-4) — pharmaceutical peptides TB-500 (Thymosin Beta-4) — CAS 77591-33-4. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/thymulin-63958-90-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Thymulin (CAS 63958-90-7) — pharmaceutical peptides Thymulin — CAS 63958-90-7. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methoxydienone-2322-77-2.html https://www.longshineboitech.com/product-images/research-chemical.jpg Methoxydienone (CAS 2322-77-2) — pharmaceutical research chemicals Methoxydienone — CAS 2322-77-2. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/carboplatin-41575-94-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Carboplatin (CAS 41575-94-4) — pharmaceutical human apis Carboplatin — CAS 41575-94-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-starch-glycolate-9063-38-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sodium Starch Glycolate (CAS 9063-38-1) — pharmaceutical excipients Sodium Starch Glycolate — CAS 9063-38-1. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/aspirin-acetylsalicylic-acid-50-78-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Aspirin (Acetylsalicylic Acid) (CAS 50-78-2) — pharmaceutical human apis Aspirin (Acetylsalicylic Acid) — CAS 50-78-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/naproxen-sodium-26159-34-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Naproxen Sodium (CAS 26159-34-2) — pharmaceutical human apis Naproxen Sodium — CAS 26159-34-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ribociclib-succinate-1374639-75-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Ribociclib Succinate (CAS 1374639-75-4) — pharmaceutical human apis Ribociclib Succinate — CAS 1374639-75-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/travoprost-157283-68-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Travoprost (CAS 157283-68-6) — pharmaceutical human apis Travoprost — CAS 157283-68-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/crizotinib-877399-52-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Crizotinib (CAS 877399-52-5) — pharmaceutical human apis Crizotinib — CAS 877399-52-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/poloxamer-188-kolliphor-p-188-9003-11-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Poloxamer 188 (Kolliphor P 188) (CAS 9003-11-6) — pharmaceutical excipients Poloxamer 188 (Kolliphor P 188) — CAS 9003-11-6. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methylamine-hcl-593-51-1.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Methylamine HCl (CAS 593-51-1) — pharmaceutical intermediates Methylamine HCl — CAS 593-51-1. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ivabradine-hcl-148849-67-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ivabradine HCl (CAS 148849-67-6) — pharmaceutical human apis Ivabradine HCl — CAS 148849-67-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/olaparib-763113-22-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Olaparib (CAS 763113-22-0) — pharmaceutical human apis Olaparib — CAS 763113-22-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tazobactam-sodium-89785-84-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Tazobactam Sodium (CAS 89785-84-2) — pharmaceutical human apis Tazobactam Sodium — CAS 89785-84-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/l-tryptophan-73-22-3.html https://www.longshineboitech.com/product-images/excipient-powder.jpg L-Tryptophan (CAS 73-22-3) — pharmaceutical amino acids L-Tryptophan — CAS 73-22-3. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nandrolone-undecylenate-862-89-5.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Nandrolone Undecylenate (CAS 862-89-5) — pharmaceutical research chemicals Nandrolone Undecylenate — CAS 862-89-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/quetiapine-fumarate-111974-72-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Quetiapine Fumarate (CAS 111974-72-2) — pharmaceutical human apis Quetiapine Fumarate — CAS 111974-72-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/valsartan-137862-53-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Valsartan (CAS 137862-53-4) — pharmaceutical human apis Valsartan — CAS 137862-53-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mazdutide-2143187-25-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Mazdutide (CAS 2143187-25-3) — pharmaceutical peptides Mazdutide — CAS 2143187-25-3. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tilmicosin-phosphate-137330-13-3.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Tilmicosin Phosphate (CAS 137330-13-3) — pharmaceutical veterinary apis Tilmicosin Phosphate — CAS 137330-13-3. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nandrolone-propionate-7207-92-3.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Nandrolone Propionate (CAS 7207-92-3) — pharmaceutical research chemicals Nandrolone Propionate — CAS 7207-92-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/drostanolone-enanthate-13425-31-5.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Drostanolone Enanthate (CAS 13425-31-5) — pharmaceutical research chemicals Drostanolone Enanthate — CAS 13425-31-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/domperidone-57808-66-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Domperidone (CAS 57808-66-9) — pharmaceutical human apis Domperidone — CAS 57808-66-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/irbesartan-138402-11-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Irbesartan (CAS 138402-11-6) — pharmaceutical human apis Irbesartan — CAS 138402-11-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nandrolone-base-434-22-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Nandrolone Base (CAS 434-22-0) — pharmaceutical research chemicals Nandrolone Base — CAS 434-22-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mannitol-pharma-grade-69-65-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Mannitol (Pharma Grade) (CAS 69-65-8) — pharmaceutical excipients Mannitol (Pharma Grade) — CAS 69-65-8. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dolutegravir-sodium-1051375-19-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Dolutegravir Sodium (CAS 1051375-19-9) — pharmaceutical human apis Dolutegravir Sodium — CAS 1051375-19-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sulbutiamine-3286-46-2.html https://www.longshineboitech.com/product-images/research-chemical.jpg Sulbutiamine (CAS 3286-46-2) — pharmaceutical nootropics Sulbutiamine — CAS 3286-46-2. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/adipotide-ftpp-685898-44-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Adipotide (FTPP) (CAS 685898-44-6) — pharmaceutical peptides Adipotide (FTPP) — CAS 685898-44-6. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/donepezil-hcl-110119-84-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Donepezil HCl (CAS 110119-84-1) — pharmaceutical human apis Donepezil HCl — CAS 110119-84-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pt-141-bremelanotide-189691-06-3.html https://www.longshineboitech.com/product-images/peptide-vial.jpg PT-141 (Bremelanotide) (CAS 189691-06-3) — pharmaceutical peptides PT-141 (Bremelanotide) — CAS 189691-06-3. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/folic-acid-injectable-59-30-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Folic Acid (Injectable) (CAS 59-30-3) — pharmaceutical human apis Folic Acid (Injectable) — CAS 59-30-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/phenylpiracetam-77472-70-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Phenylpiracetam (CAS 77472-70-9) — pharmaceutical nootropics Phenylpiracetam — CAS 77472-70-9. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/alpha-gpc-28319-77-9.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Alpha-GPC (CAS 28319-77-9) — pharmaceutical nootropics Alpha-GPC — CAS 28319-77-9. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/risperidone-106266-06-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Risperidone (CAS 106266-06-2) — pharmaceutical human apis Risperidone — CAS 106266-06-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ethyl-cyanoacetate-105-56-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Ethyl Cyanoacetate (CAS 105-56-6) — pharmaceutical intermediates Ethyl Cyanoacetate — CAS 105-56-6. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/carglumic-acid-1188-38-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Carglumic Acid (CAS 1188-38-1) — pharmaceutical human apis Carglumic Acid — CAS 1188-38-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/5-amino-1mq-42464-96-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 5-amino-1MQ (CAS 42464-96-0) — pharmaceutical peptides 5-amino-1MQ — CAS 42464-96-0. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nicorandil-65141-46-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Nicorandil (CAS 65141-46-0) — pharmaceutical human apis Nicorandil — CAS 65141-46-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/7-adca-7-aminodeacetoxycephalosporanic-acid-1126-28-9.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg 7-ADCA (7-Aminodeacetoxycephalosporanic Acid) (CAS 1126-28-9) — pharmaceutical intermediates 7-ADCA (7-Aminodeacetoxycephalosporanic Acid) — CAS 1126-28-9. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/meropenem-trihydrate-119478-56-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Meropenem Trihydrate (CAS 119478-56-7) — pharmaceutical human apis Meropenem Trihydrate — CAS 119478-56-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/memantine-hcl-41100-52-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Memantine HCl (CAS 41100-52-1) — pharmaceutical human apis Memantine HCl — CAS 41100-52-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/morphine-sulfate-pentahydrate-6211-15-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Morphine Sulfate Pentahydrate (CAS 6211-15-0) — pharmaceutical human apis Morphine Sulfate Pentahydrate — CAS 6211-15-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/enzalutamide-915087-33-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Enzalutamide (CAS 915087-33-1) — pharmaceutical human apis Enzalutamide — CAS 915087-33-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/5-amino-1mq-463356-04-9.html https://www.longshineboitech.com/product-images/injectable-vial.jpg 5-Amino-1MQ (CAS 463356-04-9) — pharmaceutical peptides 5-Amino-1MQ — CAS 463356-04-9. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/copper-tripeptide-1-ghk-cu-49557-75-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Copper Tripeptide-1 (GHK-Cu) (CAS 49557-75-7) — pharmaceutical peptides Copper Tripeptide-1 (GHK-Cu) — CAS 49557-75-7. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/norepinephrine-bitartrate-51-40-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Norepinephrine Bitartrate (CAS 51-40-1) — pharmaceutical human apis Norepinephrine Bitartrate — CAS 51-40-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/streptomycin-sulfate-3810-74-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Streptomycin Sulfate (CAS 3810-74-0) — pharmaceutical human apis Streptomycin Sulfate — CAS 3810-74-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/rosuvastatin-calcium-147098-20-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Rosuvastatin Calcium (CAS 147098-20-2) — pharmaceutical human apis Rosuvastatin Calcium — CAS 147098-20-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/croscarmellose-sodium-74811-65-7.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Croscarmellose Sodium (CAS 74811-65-7) — pharmaceutical excipients Croscarmellose Sodium — CAS 74811-65-7. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/boldenone-acetate-2363-59-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Boldenone Acetate (CAS 2363-59-9) — pharmaceutical research chemicals Boldenone Acetate — CAS 2363-59-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-cypionate-58-20-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Testosterone Cypionate (CAS 58-20-8) — pharmaceutical research chemicals Testosterone Cypionate — CAS 58-20-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/levamisole-hcl-16595-80-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Levamisole HCl (CAS 16595-80-5) — pharmaceutical veterinary apis Levamisole HCl — CAS 16595-80-5. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/1h-tetrazole-288-94-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg 1H-Tetrazole (CAS 288-94-8) — pharmaceutical intermediates 1H-Tetrazole — CAS 288-94-8. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dabrafenib-mesylate-1195768-06-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Dabrafenib Mesylate (CAS 1195768-06-9) — pharmaceutical human apis Dabrafenib Mesylate — CAS 1195768-06-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bedaquiline-843663-66-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Bedaquiline (CAS 843663-66-1) — pharmaceutical human apis Bedaquiline — CAS 843663-66-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/furazabol-1239-29-8.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Furazabol (CAS 1239-29-8) — pharmaceutical research chemicals Furazabol — CAS 1239-29-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dabigatran-etexilate-mesylate-872728-81-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Dabigatran Etexilate Mesylate (CAS 872728-81-9) — pharmaceutical human apis Dabigatran Etexilate Mesylate — CAS 872728-81-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-methoxide-30-in-meoh-124-41-4.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Sodium Methoxide (30% in MeOH) (CAS 124-41-4) — pharmaceutical intermediates Sodium Methoxide (30% in MeOH) — CAS 124-41-4. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/gliclazide-21187-98-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Gliclazide (CAS 21187-98-4) — pharmaceutical human apis Gliclazide — CAS 21187-98-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dapoxetine-hydrochloride-129938-20-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Dapoxetine Hydrochloride (CAS 129938-20-1) — pharmaceutical human apis Dapoxetine Hydrochloride — CAS 129938-20-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/monensin-sodium-22373-78-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Monensin Sodium (CAS 22373-78-0) — pharmaceutical veterinary apis Monensin Sodium — CAS 22373-78-0. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fluoxetine-hcl-56296-78-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Fluoxetine HCl (CAS 56296-78-7) — pharmaceutical human apis Fluoxetine HCl — CAS 56296-78-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/erythromycin-estolate-1264-62-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Erythromycin Estolate (CAS 1264-62-6) — pharmaceutical human apis Erythromycin Estolate — CAS 1264-62-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/decoquinate-18507-89-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Decoquinate (CAS 18507-89-6) — pharmaceutical veterinary apis Decoquinate — CAS 18507-89-6. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/naloxone-hydrochloride-357-08-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Naloxone Hydrochloride (CAS 357-08-4) — pharmaceutical human apis Naloxone Hydrochloride — CAS 357-08-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pregelatinized-starch-9005-25-8.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Pregelatinized Starch (CAS 9005-25-8) — pharmaceutical excipients Pregelatinized Starch — CAS 9005-25-8. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/drostanolone-propionate-masteron-521-12-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Drostanolone Propionate (Masteron) (CAS 521-12-0) — pharmaceutical research chemicals Drostanolone Propionate (Masteron) — CAS 521-12-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sulfamethoxazole-723-46-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Sulfamethoxazole (CAS 723-46-6) — pharmaceutical veterinary apis Sulfamethoxazole — CAS 723-46-6. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fluconazole-86386-73-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Fluconazole (CAS 86386-73-4) — pharmaceutical human apis Fluconazole — CAS 86386-73-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/survodutide-2230751-94-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Survodutide (CAS 2230751-94-1) — pharmaceutical peptides Survodutide — CAS 2230751-94-1. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fasoracetam-110958-19-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Fasoracetam (CAS 110958-19-5) — pharmaceutical nootropics Fasoracetam — CAS 110958-19-5. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/valacyclovir-hcl-124832-27-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Valacyclovir HCl (CAS 124832-27-5) — pharmaceutical human apis Valacyclovir HCl — CAS 124832-27-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/s-2-amino-3-methyl-1-butanol-2026-48-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg (S)-(+)-2-Amino-3-Methyl-1-Butanol (CAS 2026-48-4) — pharmaceutical intermediates (S)-(+)-2-Amino-3-Methyl-1-Butanol — CAS 2026-48-4. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mibolerone-3704-09-4.html https://www.longshineboitech.com/product-images/research-chemical.jpg Mibolerone (CAS 3704-09-4) — pharmaceutical research chemicals Mibolerone — CAS 3704-09-4. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/glecaprevir-1365970-03-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Glecaprevir (CAS 1365970-03-1) — pharmaceutical human apis Glecaprevir — CAS 1365970-03-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/edoxaban-tosylate-480449-71-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Edoxaban Tosylate (CAS 480449-71-6) — pharmaceutical human apis Edoxaban Tosylate — CAS 480449-71-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-thiosulfate-7772-98-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sodium Thiosulfate (CAS 7772-98-7) — pharmaceutical human apis Sodium Thiosulfate — CAS 7772-98-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ghrp-6-87616-84-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg GHRP-6 (CAS 87616-84-0) — pharmaceutical peptides GHRP-6 — CAS 87616-84-0. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/glibenclamide-10238-21-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Glibenclamide (CAS 10238-21-8) — pharmaceutical human apis Glibenclamide — CAS 10238-21-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/n-acetyl-l-cysteine-nac-616-91-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg N-Acetyl-L-Cysteine (NAC) (CAS 616-91-1) — pharmaceutical amino acids N-Acetyl-L-Cysteine (NAC) — CAS 616-91-1. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/levothyroxine-sodium-25416-65-3.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Levothyroxine Sodium (CAS 25416-65-3) — pharmaceutical human apis Levothyroxine Sodium — CAS 25416-65-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/daclatasvir-dihydrochloride-1009119-65-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Daclatasvir Dihydrochloride (CAS 1009119-65-6) — pharmaceutical human apis Daclatasvir Dihydrochloride — CAS 1009119-65-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sunifiram-314728-85-3.html https://www.longshineboitech.com/product-images/research-chemical.jpg Sunifiram (CAS 314728-85-3) — pharmaceutical research chemicals Sunifiram — CAS 314728-85-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dihexa-pnb-0408-1401708-83-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Dihexa (PNB-0408) (CAS 1401708-83-5) — pharmaceutical research chemicals Dihexa (PNB-0408) — CAS 1401708-83-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-bicarbonate-usp-injection-144-55-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sodium Bicarbonate USP (Injection) (CAS 144-55-8) — pharmaceutical human apis Sodium Bicarbonate USP (Injection) — CAS 144-55-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/clopidogrel-bisulfate-135046-48-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Clopidogrel Bisulfate (CAS 135046-48-9) — pharmaceutical human apis Clopidogrel Bisulfate — CAS 135046-48-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/exemestane-107868-30-4.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Exemestane (CAS 107868-30-4) — pharmaceutical human apis Exemestane — CAS 107868-30-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dasatinib-302962-49-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Dasatinib (CAS 302962-49-8) — pharmaceutical human apis Dasatinib — CAS 302962-49-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/thymosin-alpha-1-62304-98-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Thymosin Alpha 1 (CAS 62304-98-7) — pharmaceutical peptides Thymosin Alpha 1 — CAS 62304-98-7. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/l-glutamine-56-85-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg L-Glutamine (CAS 56-85-9) — pharmaceutical amino acids L-Glutamine — CAS 56-85-9. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/esomeprazole-magnesium-trihydrate-217087-09-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Esomeprazole Magnesium Trihydrate (CAS 217087-09-7) — pharmaceutical human apis Esomeprazole Magnesium Trihydrate — CAS 217087-09-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/spironolactone-52-01-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Spironolactone (CAS 52-01-7) — pharmaceutical human apis Spironolactone — CAS 52-01-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sunitinib-malate-341031-54-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Sunitinib Malate (CAS 341031-54-7) — pharmaceutical human apis Sunitinib Malate — CAS 341031-54-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/moxidectin-113507-06-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Moxidectin (CAS 113507-06-5) — pharmaceutical veterinary apis Moxidectin — CAS 113507-06-5. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vancomycin-hcl-1404-93-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Vancomycin HCl (CAS 1404-93-9) — pharmaceutical human apis Vancomycin HCl — CAS 1404-93-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pirfenidone-53179-13-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Pirfenidone (CAS 53179-13-8) — pharmaceutical human apis Pirfenidone — CAS 53179-13-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/stanozolol-winstrol-10418-03-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Stanozolol (Winstrol) (CAS 10418-03-8) — pharmaceutical research chemicals Stanozolol (Winstrol) — CAS 10418-03-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sustanon-250-test-blend-68924-89-0.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Sustanon 250 (Test Blend) (CAS 68924-89-0) — pharmaceutical research chemicals Sustanon 250 (Test Blend) — CAS 68924-89-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/liothyronine-sodium-55-06-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Liothyronine Sodium (CAS 55-06-1) — pharmaceutical human apis Liothyronine Sodium — CAS 55-06-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/atropine-sulfate-5908-99-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Atropine Sulfate (CAS 5908-99-6) — pharmaceutical human apis Atropine Sulfate — CAS 5908-99-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/gefitinib-184475-35-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Gefitinib (CAS 184475-35-2) — pharmaceutical human apis Gefitinib — CAS 184475-35-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vincristine-sulfate-2068-78-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Vincristine Sulfate (CAS 2068-78-2) — pharmaceutical human apis Vincristine Sulfate — CAS 2068-78-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/edc-hcl-edac-25952-53-8.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg EDC HCl (EDAC) (CAS 25952-53-8) — pharmaceutical intermediates EDC HCl (EDAC) — CAS 25952-53-8. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/diltiazem-hcl-33286-22-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Diltiazem HCl (CAS 33286-22-5) — pharmaceutical human apis Diltiazem HCl — CAS 33286-22-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/glucagon-recombinant-16941-32-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Glucagon (Recombinant) (CAS 16941-32-5) — pharmaceutical human apis Glucagon (Recombinant) — CAS 16941-32-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cytarabine-147-94-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Cytarabine (CAS 147-94-4) — pharmaceutical human apis Cytarabine — CAS 147-94-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bisoprolol-fumarate-104344-23-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Bisoprolol Fumarate (CAS 104344-23-2) — pharmaceutical human apis Bisoprolol Fumarate — CAS 104344-23-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/toltrazuril-69004-03-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Toltrazuril (CAS 69004-03-1) — pharmaceutical veterinary apis Toltrazuril — CAS 69004-03-1. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methenamine-hippurate-5714-73-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Methenamine Hippurate (CAS 5714-73-8) — pharmaceutical human apis Methenamine Hippurate — CAS 5714-73-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cyanocobalamin-b12-injectable-68-19-9.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Cyanocobalamin (B12, Injectable) (CAS 68-19-9) — pharmaceutical human apis Cyanocobalamin (B12, Injectable) — CAS 68-19-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/carrageenan-9000-07-1.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Carrageenan (CAS 9000-07-1) — pharmaceutical excipients Carrageenan — CAS 9000-07-1. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/salinomycin-sodium-53003-10-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Salinomycin Sodium (CAS 53003-10-4) — pharmaceutical veterinary apis Salinomycin Sodium — CAS 53003-10-4. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/empagliflozin-864070-44-0.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Empagliflozin (CAS 864070-44-0) — pharmaceutical human apis Empagliflozin — CAS 864070-44-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ceritinib-1032900-25-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Ceritinib (CAS 1032900-25-6) — pharmaceutical human apis Ceritinib — CAS 1032900-25-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lumefantrine-82186-77-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Lumefantrine (CAS 82186-77-4) — pharmaceutical human apis Lumefantrine — CAS 82186-77-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methadone-hydrochloride-1095-90-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Methadone Hydrochloride (CAS 1095-90-5) — pharmaceutical human apis Methadone Hydrochloride — CAS 1095-90-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ceftiofur-sodium-104010-37-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ceftiofur Sodium (CAS 104010-37-9) — pharmaceutical veterinary apis Ceftiofur Sodium — CAS 104010-37-9. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/curcumin-95-458-37-7.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Curcumin (95%) (CAS 458-37-7) — pharmaceutical research chemicals Curcumin (95%) — CAS 458-37-7. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mestanolone-521-11-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Mestanolone (CAS 521-11-9) — pharmaceutical research chemicals Mestanolone — CAS 521-11-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/pravastatin-sodium-81131-70-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Pravastatin Sodium (CAS 81131-70-6) — pharmaceutical human apis Pravastatin Sodium — CAS 81131-70-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/celecoxib-169590-42-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Celecoxib (CAS 169590-42-5) — pharmaceutical human apis Celecoxib — CAS 169590-42-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/l-methionine-63-68-3.html https://www.longshineboitech.com/product-images/excipient-powder.jpg L-Methionine (CAS 63-68-3) — pharmaceutical amino acids L-Methionine — CAS 63-68-3. WHO-GMP + FDA DMF pharmaceutical amino acids manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dcc-n-n-dicyclohexylcarbodiimide-538-75-0.html https://www.longshineboitech.com/product-images/human-api-powder.jpg DCC (N,N-Dicyclohexylcarbodiimide) (CAS 538-75-0) — pharmaceutical intermediates DCC (N,N-Dicyclohexylcarbodiimide) — CAS 538-75-0. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methylstenbolone-5197-58-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Methylstenbolone (CAS 5197-58-0) — pharmaceutical research chemicals Methylstenbolone — CAS 5197-58-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/berberine-hcl-633-65-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Berberine HCl (CAS 633-65-8) — pharmaceutical research chemicals Berberine HCl — CAS 633-65-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cannabigerol-cbg-25654-31-3.html https://www.longshineboitech.com/product-images/research-chemical.jpg Cannabigerol (CBG) (CAS 25654-31-3) — pharmaceutical research chemicals Cannabigerol (CBG) — CAS 25654-31-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/3-aminopyridine-462-08-8.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg 3-Aminopyridine (CAS 462-08-8) — pharmaceutical intermediates 3-Aminopyridine — CAS 462-08-8. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/microcrystalline-cellulose-mcc-9004-34-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Microcrystalline Cellulose (MCC) (CAS 9004-34-6) — pharmaceutical excipients Microcrystalline Cellulose (MCC) — CAS 9004-34-6. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/prl-8-53-51352-87-5.html https://www.longshineboitech.com/product-images/peptide-vial.jpg PRL-8-53 (CAS 51352-87-5) — pharmaceutical nootropics PRL-8-53 — CAS 51352-87-5. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sodium-triacetoxyborohydride-stab-56553-60-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Sodium Triacetoxyborohydride (STAB) (CAS 56553-60-7) — pharmaceutical intermediates Sodium Triacetoxyborohydride (STAB) — CAS 56553-60-7. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/4-bromobenzaldehyde-1122-91-4.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg 4-Bromobenzaldehyde (CAS 1122-91-4) — pharmaceutical intermediates 4-Bromobenzaldehyde — CAS 1122-91-4. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nooglutyl-112193-35-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Nooglutyl (CAS 112193-35-8) — pharmaceutical nootropics Nooglutyl — CAS 112193-35-8. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/magnesium-stearate-557-04-0.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Magnesium Stearate (CAS 557-04-0) — pharmaceutical excipients Magnesium Stearate — CAS 557-04-0. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/naltrexone-hydrochloride-16676-29-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Naltrexone Hydrochloride (CAS 16676-29-2) — pharmaceutical human apis Naltrexone Hydrochloride — CAS 16676-29-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/diclazuril-101831-37-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Diclazuril (CAS 101831-37-2) — pharmaceutical veterinary apis Diclazuril — CAS 101831-37-2. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/fexofenadine-hcl-153439-40-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Fexofenadine HCl (CAS 153439-40-8) — pharmaceutical human apis Fexofenadine HCl — CAS 153439-40-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ethyl-acetoacetate-141-97-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ethyl Acetoacetate (CAS 141-97-9) — pharmaceutical intermediates Ethyl Acetoacetate — CAS 141-97-9. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ghk-cu-130120-57-9.html https://www.longshineboitech.com/product-images/injectable-vial.jpg GHK-Cu (CAS 130120-57-9) — pharmaceutical peptides GHK-Cu — CAS 130120-57-9. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/daunorubicin-hcl-23541-50-6.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Daunorubicin HCl (CAS 23541-50-6) — pharmaceutical human apis Daunorubicin HCl — CAS 23541-50-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/warfarin-sodium-129-06-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Warfarin Sodium (CAS 129-06-6) — pharmaceutical human apis Warfarin Sodium — CAS 129-06-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/alectinib-1256580-46-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Alectinib (CAS 1256580-46-7) — pharmaceutical human apis Alectinib — CAS 1256580-46-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/diisopropylethylamine-dipea-hunig-base-7087-68-5.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Diisopropylethylamine (DIPEA, Hünig Base) (CAS 7087-68-5) — pharmaceutical intermediates Diisopropylethylamine (DIPEA, Hünig Base) — CAS 7087-68-5. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/selank-129954-34-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Selank (CAS 129954-34-3) — pharmaceutical peptides Selank — CAS 129954-34-3. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/2-2-dimethyl-1-3-dioxolane-4-methanol-solketal-100-79-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg 2,2-Dimethyl-1,3-Dioxolane-4-Methanol (Solketal) (CAS 100-79-8) — pharmaceutical intermediates 2,2-Dimethyl-1,3-Dioxolane-4-Methanol (Solketal) — CAS 100-79-8. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tibolone-5630-53-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Tibolone (CAS 5630-53-5) — pharmaceutical research chemicals Tibolone — CAS 5630-53-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bupropion-hcl-31677-93-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Bupropion HCl (CAS 31677-93-7) — pharmaceutical human apis Bupropion HCl — CAS 31677-93-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/b7-33-1350456-56-2.html https://www.longshineboitech.com/product-images/peptide-vial.jpg B7-33 (CAS 1350456-56-2) — pharmaceutical peptides B7-33 — CAS 1350456-56-2. WHO-GMP + FDA DMF pharmaceutical peptides manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/felodipine-72509-76-3.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Felodipine (CAS 72509-76-3) — pharmaceutical human apis Felodipine — CAS 72509-76-3. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cefuroxime-axetil-64544-07-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Cefuroxime Axetil (CAS 64544-07-6) — pharmaceutical human apis Cefuroxime Axetil — CAS 64544-07-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/amprolium-137-88-2.html https://www.longshineboitech.com/product-images/veterinary-api-powder.jpg Amprolium (CAS 137-88-2) — pharmaceutical veterinary apis Amprolium — CAS 137-88-2. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/metoprolol-tartrate-56392-17-7.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Metoprolol Tartrate (CAS 56392-17-7) — pharmaceutical human apis Metoprolol Tartrate — CAS 56392-17-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/sildenafil-citrate-171599-83-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Sildenafil Citrate (CAS 171599-83-0) — pharmaceutical research chemicals Sildenafil Citrate — CAS 171599-83-0. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/ampicillin-trihydrate-7177-48-2.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Ampicillin Trihydrate (CAS 7177-48-2) — pharmaceutical human apis Ampicillin Trihydrate — CAS 7177-48-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/norethindrone-68-22-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Norethindrone (CAS 68-22-4) — pharmaceutical human apis Norethindrone — CAS 68-22-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/anisaldehyde-4-methoxybenzaldehyde-123-11-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Anisaldehyde (4-Methoxybenzaldehyde) (CAS 123-11-5) — pharmaceutical intermediates Anisaldehyde (4-Methoxybenzaldehyde) — CAS 123-11-5. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/capreomycin-sulfate-1405-37-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Capreomycin Sulfate (CAS 1405-37-4) — pharmaceutical human apis Capreomycin Sulfate — CAS 1405-37-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lapatinib-ditosylate-388082-78-8.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Lapatinib Ditosylate (CAS 388082-78-8) — pharmaceutical human apis Lapatinib Ditosylate — CAS 388082-78-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vinpocetine-42971-09-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Vinpocetine (CAS 42971-09-5) — pharmaceutical nootropics Vinpocetine — CAS 42971-09-5. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/idelalisib-870281-82-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Idelalisib (CAS 870281-82-6) — pharmaceutical human apis Idelalisib — CAS 870281-82-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bicalutamide-90357-06-5.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Bicalutamide (CAS 90357-06-5) — pharmaceutical human apis Bicalutamide — CAS 90357-06-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/velpatasvir-1377049-84-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Velpatasvir (CAS 1377049-84-7) — pharmaceutical human apis Velpatasvir — CAS 1377049-84-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dalbavancin-hcl-171500-79-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Dalbavancin HCl (CAS 171500-79-1) — pharmaceutical human apis Dalbavancin HCl — CAS 171500-79-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/mebolazine-dymethazine-3625-07-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Mebolazine (Dymethazine) (CAS 3625-07-8) — pharmaceutical research chemicals Mebolazine (Dymethazine) — CAS 3625-07-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/lithium-orotate-5266-20-6.html https://www.longshineboitech.com/product-images/research-chemical.jpg Lithium Orotate (CAS 5266-20-6) — pharmaceutical nootropics Lithium Orotate — CAS 5266-20-6. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/robenidine-hcl-25875-50-7.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Robenidine HCl (CAS 25875-50-7) — pharmaceutical veterinary apis Robenidine HCl — CAS 25875-50-7. WHO-GMP + FDA DMF pharmaceutical veterinary apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/noopept-157115-85-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Noopept (CAS 157115-85-0) — pharmaceutical nootropics Noopept — CAS 157115-85-0. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-acetate-1045-69-8.html https://www.longshineboitech.com/product-images/research-chemical.jpg Testosterone Acetate (CAS 1045-69-8) — pharmaceutical research chemicals Testosterone Acetate — CAS 1045-69-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/anacardic-acid-aca-16611-84-0.html https://www.longshineboitech.com/product-images/research-chemical.jpg Anacardic Acid (ACA) (CAS 16611-84-0) — pharmaceutical nootropics Anacardic Acid (ACA) — CAS 16611-84-0. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/telmisartan-144701-48-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Telmisartan (CAS 144701-48-4) — pharmaceutical human apis Telmisartan — CAS 144701-48-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/calcium-d-pantothenate-vitamin-b5-137-08-6.html https://www.longshineboitech.com/product-images/excipient-powder.jpg Calcium D-Pantothenate (Vitamin B5) (CAS 137-08-6) — pharmaceutical excipients Calcium D-Pantothenate (Vitamin B5) — CAS 137-08-6. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trestolone-acetate-ment-6157-87-5.html https://www.longshineboitech.com/product-images/research-chemical.jpg Trestolone Acetate (MENT) (CAS 6157-87-5) — pharmaceutical research chemicals Trestolone Acetate (MENT) — CAS 6157-87-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methylene-blue-usp-grade-61-73-4.html https://www.longshineboitech.com/product-images/research-chemical.jpg Methylene Blue (USP grade) (CAS 61-73-4) — pharmaceutical nootropics Methylene Blue (USP grade) — CAS 61-73-4. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/bacitracin-zinc-1405-89-6.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Bacitracin Zinc (CAS 1405-89-6) — pharmaceutical human apis Bacitracin Zinc — CAS 1405-89-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tris-hydroxymethyl-aminomethane-tris-buffer-77-86-1.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Tris(hydroxymethyl)aminomethane (Tris buffer) (CAS 77-86-1) — pharmaceutical intermediates Tris(hydroxymethyl)aminomethane (Tris buffer) — CAS 77-86-1. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/stanolone-androstanolone-dht-521-18-6.html https://www.longshineboitech.com/product-images/research-chemical.jpg Stanolone (Androstanolone, DHT) (CAS 521-18-6) — pharmaceutical research chemicals Stanolone (Androstanolone, DHT) — CAS 521-18-6. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-phenylpropionate-1255-49-8.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Testosterone Phenylpropionate (CAS 1255-49-8) — pharmaceutical research chemicals Testosterone Phenylpropionate — CAS 1255-49-8. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methenolone-enanthate-primobolan-depot-303-42-4.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Methenolone Enanthate (Primobolan Depot) (CAS 303-42-4) — pharmaceutical research chemicals Methenolone Enanthate (Primobolan Depot) — CAS 303-42-4. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/17a-methyl-1-testosterone-m1t-65-04-3.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 17a-Methyl-1-Testosterone (M1T) (CAS 65-04-3) — pharmaceutical research chemicals 17a-Methyl-1-Testosterone (M1T) — CAS 65-04-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/vildagliptin-274901-16-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Vildagliptin (CAS 274901-16-5) — pharmaceutical human apis Vildagliptin — CAS 274901-16-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/1-testosterone-dhb-base-65-06-5.html https://www.longshineboitech.com/product-images/peptide-vial.jpg 1-Testosterone (DHB Base) (CAS 65-06-5) — pharmaceutical research chemicals 1-Testosterone (DHB Base) — CAS 65-06-5. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/trenavar-trendione-4642-95-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Trenavar (Trendione) (CAS 4642-95-9) — pharmaceutical research chemicals Trenavar (Trendione) — CAS 4642-95-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/emoxypine-succinate-mexidol-127464-43-1.html https://www.longshineboitech.com/product-images/peptide-vial.jpg Emoxypine Succinate (Mexidol) (CAS 127464-43-1) — pharmaceutical nootropics Emoxypine Succinate (Mexidol) — CAS 127464-43-1. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/testosterone-isocaproate-15262-86-9.html https://www.longshineboitech.com/product-images/research-chemical.jpg Testosterone Isocaproate (CAS 15262-86-9) — pharmaceutical research chemicals Testosterone Isocaproate — CAS 15262-86-9. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/azacitidine-320-67-2.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Azacitidine (CAS 320-67-2) — pharmaceutical human apis Azacitidine — CAS 320-67-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/nsi-189-phosphate-1270138-40-3.html https://www.longshineboitech.com/product-images/research-chemical.jpg NSI-189 Phosphate (CAS 1270138-40-3) — pharmaceutical research chemicals NSI-189 Phosphate — CAS 1270138-40-3. WHO-GMP + FDA DMF pharmaceutical research chemicals manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/phenylephrine-hcl-61-76-7.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Phenylephrine HCl (CAS 61-76-7) — pharmaceutical human apis Phenylephrine HCl — CAS 61-76-7. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/methotrexate-59-05-2.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Methotrexate (CAS 59-05-2) — pharmaceutical human apis Methotrexate — CAS 59-05-2. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/furosemide-54-31-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Furosemide (CAS 54-31-9) — pharmaceutical human apis Furosemide — CAS 54-31-9. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/povidone-pvp-9003-39-8.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Povidone (PVP) (CAS 9003-39-8) — pharmaceutical excipients Povidone (PVP) — CAS 9003-39-8. WHO-GMP + FDA DMF pharmaceutical excipients manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/magnesium-l-threonate-778571-57-6.html https://www.longshineboitech.com/product-images/research-chemical.jpg Magnesium L-Threonate (CAS 778571-57-6) — pharmaceutical nootropics Magnesium L-Threonate — CAS 778571-57-6. WHO-GMP + FDA DMF pharmaceutical nootropics manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/2-aminopyridine-504-29-0.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg 2-Aminopyridine (CAS 504-29-0) — pharmaceutical intermediates 2-Aminopyridine — CAS 504-29-0. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/paclitaxel-33069-62-4.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Paclitaxel (CAS 33069-62-4) — pharmaceutical human apis Paclitaxel — CAS 33069-62-4. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/timolol-maleate-26921-17-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Timolol Maleate (CAS 26921-17-5) — pharmaceutical human apis Timolol Maleate — CAS 26921-17-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/emtricitabine-143491-57-0.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Emtricitabine (CAS 143491-57-0) — pharmaceutical human apis Emtricitabine — CAS 143491-57-0. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/cisplatin-15663-27-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Cisplatin (CAS 15663-27-1) — pharmaceutical human apis Cisplatin — CAS 15663-27-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/tamoxifen-citrate-54965-24-1.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Tamoxifen Citrate (CAS 54965-24-1) — pharmaceutical human apis Tamoxifen Citrate — CAS 54965-24-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/phthalic-acid-88-99-3.html https://www.longshineboitech.com/product-images/intermediate-powder.jpg Phthalic Acid (CAS 88-99-3) — pharmaceutical intermediates Phthalic Acid — CAS 88-99-3. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/micafungin-sodium-235114-32-6.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Micafungin Sodium (CAS 235114-32-6) — pharmaceutical human apis Micafungin Sodium — CAS 235114-32-6. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/dobutamine-hcl-49745-95-1.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Dobutamine HCl (CAS 49745-95-1) — pharmaceutical human apis Dobutamine HCl — CAS 49745-95-1. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/adipic-acid-124-04-9.html https://www.longshineboitech.com/product-images/yellow-api-powder.jpg Adipic Acid (CAS 124-04-9) — pharmaceutical intermediates Adipic Acid — CAS 124-04-9. WHO-GMP + FDA DMF pharmaceutical intermediates manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/polymyxin-b-sulfate-1405-20-5.html https://www.longshineboitech.com/product-images/human-api-powder.jpg Polymyxin B Sulfate (CAS 1405-20-5) — pharmaceutical human apis Polymyxin B Sulfate — CAS 1405-20-5. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India. https://www.longshineboitech.com/catalog/desloratadine-100643-71-8.html https://www.longshineboitech.com/product-images/injectable-vial.jpg Desloratadine (CAS 100643-71-8) — pharmaceutical human apis Desloratadine — CAS 100643-71-8. WHO-GMP + FDA DMF pharmaceutical human apis manufactured by Longshine Boi-Tech, Pune, India.